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Protein Kinase R (PKR) is a central component of the innate immunity antiviral pathway
and is activated by dsRNA. PKR contains two tandem dsRNA binding domains and a C-terminal
kinase domain. In the canonical activation model, binding of multiple PKR monomers to dsRNA
enhances dimerization of the kinase domain, leading to enzymatic activation. A minimal dsRNA
length of 30 bp is required for activation. However, short (~15 bp) stem-loop RNAs containing
flanking single stranded tails (ss-dsRNAs) are capable of activating PKR. Here, we characterize
the structural features of ss-dsRNAs that contribute to activation. We have designed a model
ss-dsRNA containing 15 nt single stranded tails and a 15 bp stem and made systematic
truncations of the tail and stem regions. Activation potency and binding affinity decrease as the
ssRNA tails are truncated and activation is abolished in cases where the binding affinity is
strongly reduced. We demonstrate that isolated single-stranded RNAs bind to PKR with
micromolar dissociation constants and can induce activation. Single-stranded RNAs also
activate PKR constructs lacking the double-stranded RNA binding domain and bind to a basic
region adjacent to the N-terminus of the kinase. The length of the duplex regions in several
natural RNA activators of PKR is below the minimum of 30 bp required for activation and similar
interactions with single stranded regions may contribute to PKR activation in these cases.
We have also solved the crystal structure of the PKR kinase domain. PKR forms a
unique oligomeric assembly of alternating front-to-front and back-to-back interfaces. Within the
front-to-front interface activation segments from each protomer are exchanged and oriented
toward the active site of the reciprocal protomer. Similar complexes have been reported for
other kinases and are interpreted to represent a trans-autophosphorylation complex. This
structure has profound implications for PKR activation models.
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Chapter 1: Introduction
1.1 Introduction
Protein kinase R (PKR) is a key component of the interferon-induced viral response
pathway (1). The protein is comprised of tandem N-terminal dsRNA binding domains (dsRBD1
and dsRBD2) and a C-terminal serine/threonine kinase domain connected by an ~80 residue
flexible linker (Fig. 1.1). PKR is synthesized in a latent state and is activated by
autophosphorylation upon binding to double-stranded regions present in RNAs (dsRNA) (2).
Stimulatory RNAs typically originate from viral infection but several endogenous RNAs have
also been identified as PKR activators (3-7). Activated PKR phosphorylates the alpha subunit of
eukaryotic initiation factor 2 (eIF2α) leading to inhibition of protein synthesis and viral replication
in infected cells (8). The myriad of virally-encoded PKR inhibitors highlights the importance of
the PKR antiviral pathway (9). PKR also phosphorylates insulin receptor substrate (10) and
participates in pathways regulating stress response, cellular growth and proliferation, nutrient
signaling and metabolism (8, 11).

Figure 1.1 PKR domain organization. Each dsRBD is ~70 amino acids long and are
separated by a 25 residue linker. An ~80 residue region separates dsRBD2 from the kinase
domain which is composed of 300 amino acids.
1.2 Interaction with dsRNA
Nature has produced a variety of RNA-binding modules which are appended to RNAbinding proteins to bestow specificity toward certain RNA forms. Multiple copies are typically
present to confer increased binding affinity (12). PKR contains two copies of a highly conserved
domain, the dsRBD, which binds duplex RNA (13). The structure of the dsRBDs was solved by
NMR (14) however a structure in complex with dsRNA is unavailable. Both dsRBDs adopt a
canonical αβββα fold where the two helices pack against a three stranded anti-parallel beta
sheet (Fig. 1.2A). The dsRBD selectively interacts with A-form RNA duplexes over other forms
1

of nucleic acid (15). Structures of homologous dsRBDs in complex with dsRNA provide insight
into the recognition mechanism (16-22). The structure of Xlrbpa2 from Xenopus laevis in
complex with a coaxially stacked RNA duplex (23) is presented in Figure 1.2B as a model for
how PKR presumably engages dsRNA. Basic and polar residues along the RNA binding surface
interact with the phosphates and 2′-hydroxyls which decorate the RNA backbone in a geometric
pattern which is specific for the morphology of the A-form RNA duplex. The interface spans two
minor grooves and the intervening major groove with a binding footprint of ~15 bp. Three
regions mediate RNA recognition. Their amino acid composition is highly conserved within the
dsRBD family (Fig. 1.2B) (13). Regions one and three also contact bases within the minor
groove however the deep major groove precludes contact with bases at region three. These
interactions are not sequence specific, which is attributed to minimal interactions with nucleotide
bases and a lack of sufficient sequence-specific functional groups within the minor groove (13).
RNA structural features can contribute to the interaction. In Rnt1p RNaseIII and ADAR2, an
RNA tetraloop engages the dsRBD to orient the catalytic domain of the protein (24, 25). Affinity
cleavage and NMR experiments indicate loops and bulges can modulate PKR binding although
the functional relevance is unclear (26-28).

2

Figure 1.2 dsRBD interaction with dsRNA. (A) NMR structure of dsRBD1-dsRBD2 from PKR
(1QU6). Enlarged images of the dsRBD1 (purple) and dsRBD2 (red) are shown below with the
residues at conserved RNA interaction sites shown as sticks. (B) Crystal structure of the Xlrbpa
dsRBD2 in complex with dsRNA (1DI2). 10 bp helices coaxially stack to form an extended
duplex within the crystal. The path of the duplex is indicated by green and purple traces of the
phosphates. Atoms are colored by the standard coloring scheme (red: oxygen, blue: nitrogen,
phosphorous: orange). The ribose sugar is yellow. Nucleotide bases are white with exception to
those involved in protein interaction. Oxygens from water molecules are shown is red spheres.
Protein residues participating in the interaction are rendered as grey sticks and hydrogen bonds
are depicted as black dashed lines. An alignment between the structures shown in the Figure is
included. Side chains which are shown as sticks are indicated in the alignment. The consensus
RNA-binding residues are included (13).
1.3 General mechanisms of kinase activation applied to PKR
Two structural analyses of the PKR kinase domain have yielded three structures all
solved by X-ray crystallography. One study reports the kinase domain in its active form, as
categorized by a phosphorylated activation loop, and in complex with its substrate, eIF2α (29).
Two structures were obtained: one containing AMP-PNP and magnesium in the active site
(PDB: 2A19) and the other without (PDB: 2A1A). The other study reports a structure containing
an inactivating mutation, K296R, in the absence of ligands (30) (PDB: 3UIU). Both structures
exhibit a similar domain architecture and back-to-back dimeric configuration of PKR molecules.
The kinase domain has a bilobal structure typical of eukaryotic protein kinases (31) consisting of
3

a smaller N-terminal lobe and larger C-terminal lobe connected by a flexible hinge region (Fig.
1.3). The active site is formed in the cleft between the two lobes. The back-to-back dimer
interface is formed between the N-lobes and orients the active sites toward opposite faces of
the complex (Fig 1.3A). In the structure of K296R PKR a face-to-face dimer is also reported
which is formed across a crystallographic symmetry axis (30). The biological relevance of the
interface remains unclear. In PKR and many eukaryotic kinases the transition from an inactive
to active state is controlled by activation loop phosphorylation (32). An upstream activating
kinase has not been identified so PKR must phosphorylate its own activation loop indicating a
basal level of activity in the latent state (33). Both intra (cis) (34) and intermolecular (trans) (3538) autophosphorylation mechanisms have been proposed. An allosteric pathway is proposed
to link the active site to the back-to-back dimer interface via a critical regulatory structural
element, helix αC (29). The functional relevance of the back-to-back dimer is supported by
mutagenesis of key interfacial residues which abrogates enzymatic activity (39). The conserved
structural features of eukaryotic kinases are discussed below and described in the context of
PKR.

4

Figure 1.3 Structure of the PKR kinase domain (PDB: 2A19). Color coding in the key
underneath panel A applies to the entire figure. (A) Back-to-back dimer interface. (B) Enlarged
view of the dimer interface. Residues contributing to the interaction are shown as sticks with
hydrogen bonds drawn as black dashed lines. I288 packs into a hydrophobic pocket on the back
of helix αC shown as a surface representation. (C) View looking into the active site. Canonical
structural motifs are annotated onto PKR. (D) Enlarged view of C-terminal anchor.
The inactive conformations of eukaryotic kinases are quite divergent however the active
state is conserved and characterized by a group of canonical structural motifs and interactions
(40). The prototypical Ser/Thr kinase PKA has served as a model to define the features of the
active kinase core structure (41). The nomenclature which has been adopted to describe the
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anatomy of the kinase is annotated onto PKR in Figure 1.3B. Two hydrophobic spines bridge
the kinase domain connecting the N- and C-lobes (42). The catalytic spine (C-spine) provides a
binding pocket for the adenosine purine ring and orients the catalytic loop and is typically
assembled even in inactive kinases. The regulatory spine (R-spine) is more dynamic and is
usually disassembled in inactive structures due to conformational changes to αC (43). In PKR,
the R-spine is intimately linked to the dimer interface by Y323 which completes the spine at the
back of the N-lobe. Y323 participates in dimerization by engaging in a hydrogen bond triad with
Y293 and D289 from the reciprocal protomer (Fig. 1.3B).
The catalytic loop runs along the base of the active site and contains the canonical
tripeptide motif HRD (NRD in PKR). The aspartate within NRD (D414) acts as a catalytic base
during the phosphoryl transfer reaction. In kinases regulated by activation loop phosphorylation
the catalytic aspartate is typically preceded by an arginine (R413) which interacts with the
phosphorylated moiety in the activation loop (44). Also contained within the catalytic loop are
N419 which chelates a magnesium ion (MgII) and K416 which typically interacts with the
terminal phosphate.
The activation segment is commonly defined as the region lying between two conserved
tripeptide motifs DFG and APE (SPE in PKR). The aspartate (D432) from DFG chelates a
magnesium ion (MgI) and the phenylalanine (F433) is a component of the R-spine. When the
regulatory spine is broken a destabilizing effect is imposed upon the aspartate which impairs
magnesium binding and catalysis. The SPE motif forms part of a short helix, αEF, at the Cterminal end of the activation segment. A conserved salt bridge interaction between the glutamic
acid and an arginine from the base of the C-lobe anchors the C-terminal portion of the activation
segment (Fig. 1.3D). The activation segment is sometimes further delineated into the activation
loop and the P+1 loop. The activation loop contains the primary phosphorylation site which
corresponds to T446 in PKR and is phosphorylated in the structure presented in Figure 1.3.
Activation loop phosphorylation significantly enhances activity (45) although the nuances of the
6

structural regulatory mechanism are still a subject of some debate (32, 46). Generally, the
improved catalytic activity can be ascribed to a disordered to ordered transition of the activation
loop mediated by coordination of the phosphorylated residue. Kinases regulated by activation
loop phosphorylation typically contain the tripeptide motif HRD within the catalytic loop and are
classified as ‘RD’ kinases (44). The histidine is less conserved (32). In PKA, this residue is a
tyrosine and proposed to contributed to the hydrophobic R-spine (42) however in PKR an
asparagine fills this position so the hydrophobic character is lost. The arginine from HRD
promotes folding of the activation loop by an anchoring interaction with the phosphorylated side
chain. In PKR, basic residues emanating from helix αC also contribute to phosphate
coordination (Fig. 1.3C). The P+1 portion of the activation segment forms the docking site for
the substrate peptide. However, PKR may not use this canonical substrate docking platform to
achieve specificity. In the structure of PKR in complex with its protein substrate, eIF2α, the
region containing the substrate serine (S51) is disordered (29). eIF2α binds at a site remote to
the active site on helix αG. The interaction is postulated to induce a conformational change
within eIF2α which increases flexibility of the S51 loop to promote a transient interaction within
the active site (47). PKR possesses a noncanonical secondary phosphorylation site within the
P+1 loop at residue T451 (48). A serine or threonine residue occupies this position in all Ser/Thr
kinases however it is not typically phosphorylated (32). In PKA, a catalytic function has been
proposed (49, 50) although it is unclear whether phosphorylation is compatible with the catalytic
mechanism.
The final structural element which will be discussed here is the αC helix. By now, a few
of its regulatory mechanisms have been addressed. L312 from helix αC interdigitates into the Rspine to stabilize the active site region. Basic residues (K304 and R307) protrude from the helix
and interact with T446 to stabilize the activation loop. The final regulatory role is an invariant salt
bridge formed between a glutamate from helix αC (E308) and a lysine from β3 (K296). This
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interaction favorably orients the lysine to coordinate the α- and β- phosphates and position ATP
for catalysis.
Conformational changes to the activation loop and helix αC are most commonly
associated with the on/off regulatory switch (51). These dynamic elements form the periphery of
the active site and the interactions they make with the catalytic machinery rationalizes their
regulatory role (44). As previously stated, the conformations adopted by inactive kinases are
quite diverse (40). However, the general molecular motions associated with the switch to the
active state are characterized by a more closed and rigid conformation. The dynamic elements
of the kinase which include the glycine rich loop (G-loop) above ATP, helix αC, and the
activation segment clamp around the active site. These conformational changes protect the
active site from solvent, provide necessary stabilizing interactions, and provide a docking site for
the substrate. In PKR, the dimer interface regulates kinase activation by an allosteric pathway
that involves helix αC (29).
1.4 Mechanism of PKR activation
Two models have been proposed to describe how RNA binding at the N-terminus
activates the C-terminal kinase domain which is separated by an ~80 residue linker. In the
autoinhibition model, an intramolecular interaction between the dsRBDs and the kinase domain
maintains PKR in a closed conformation which prohibits access of ATP substrate to the active
site (52, 53). Interaction with RNA relieves the inhibition activating the kinase. The most
convincing evidence in support of this model are NMR experiments which demonstrate chemical
shift perturbations within dsRBD2 and the kinase domain when the isolated components are
mixed (54, 55). Additionally, affinity cleavage (56), analytical ultracentrifugation, and NMR
experiments (57) indicate that only dsRBD1 interacts with nonactivating RNAs whereas both
dsRBDs engage activating RNAs. ATP crosslinking experiments indicate that active site
becomes more accessible following RNA binding or kinase phosphorylation (53).
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The dimerization model emphasizes intermolecular interactions mediated by RNA
binding (58). More recent investigations dispute the aforementioned intramolecular interaction or
indicate it is insufficient to induce autoinhibition. A dsRBD1/2 construct interacts only very
weakly with the isolated kinase domain (Kd ~ 250 µM) (59). This is consistent with SAXS
analysis which indicates PKR samples multiple compact and extended conformations in solution
with an intramolecular equilibria of ~1-10 (60). These affinities are too weak to maintain the
closed conformation required for inhibition. Finally, the resonance assignments for the isolated
dsRBDs and kinase domains superimpose with the NMR spectra of full length PKR indicating
the two domains behave independently in solution (38).
Biochemical and biophysical data indicate that dimerization plays a critical role in the
PKR activation mechanism (61). The structural relevance of the dimer interface was addressed
in the previous section. PKR dimerizes weakly in solution and dimerization is sufficient to
activate PKR in the absence of RNA (35). Consistent with the dimerization model, activation by
dsRNAs requires a lattice length of 30 bp which correlates with the minimal length capable of
binding at least two PKR monomers (62-64). FRET measurements indicate activating RNAs
induce kinase domain dimerization (65). Activation of PKR by dsRNA shows a characteristic
bell-shaped dependence on dsRNA concentration (Fig. 1.4) (64, 66). This behavior is
rationalized in a model where high dsRNA concentration reduces the number of PKR monomers
bound to the same dsRNA and thus inhibits dimerization (67). Binding affinity measurements
can be used to simulate the fractional concentration of PKR contained within a complex
containing one RNA and two PKR molecules, denoted as the RP2 species. The RNA
concentration dependence of the simulated RP2 species distributions mirror the bell-shaped
activation curves with maxima at approximately equal RNA concentrations (63). These
observations have led to a simple model where the role of RNA is to serve as a scaffold to
facilitate kinase domain dimerization. Because of the strong correlation between RP2 and
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activation we typically characterize PKR activators by their ability to mediate PKR
oligomerization and will be a predominant theme in the studies presented here.

Figure 1.4 Dimerization model for activation. A theoretical bell-shaped activation curve is
shown on the bottom generated by a titration of activating RNA against a fixed concentration of
PKR. The width of the stylized arrows which follow the path of the curve are meant to represent
the relative concentrations of RP2 (green) and RP (red) species.
1.5 Interaction with complex RNAs
Perfect duplex RNAs have served as a model to establish the basic rules which govern
RNA mediated activation of PKR. However, the RNAs which PKR interacts with in vivo rarely
contain 30 bp of uninterrupted duplex RNA. Instead, their structures are punctuated by features
such as stem-loops, bulges, internal loops, single-stranded regions, and more complex tertiary
interactions (68) (Fig. 1.5). These structural elements can positively and negatively regulate
PKR activity and, in some cases, do not adhere to the rubric for duplex lattice length. The
structural features which differentiate activating RNAs from those which function as inhibitors
10

remain largely undefined. It has become apparent that a rigorous examination is required to
characterize the effects of various RNA folded conformations on PKR activation. The effect of
bent duplex structures introduced by mismatched base pairs has been extensively investigated.
PKR is able to straighten the duplex (69) although activation is reduced and activation potency
is determined by the geometry of the kinked structure (70). These types of investigations which
analyze simple RNA features must be extended to develop a catalog which describes how
combinations of basic RNA structural building blocks affect PKR activity.
Several mRNAs activate PKR for regulatory purposes and some utilize complex
structures which function effectively as noncanonical stimulatory elements. PKR is involved in a
negative feedback loop which regulates production of interferon-γ during the interferonmediated antiviral response. Interferon-γ mRNA attenuates its own translation by PKR
activation, providing a method to regulate both PKR levels and interferon production within the
infected cell (71). Activation is dependent on a pseudoknot formed within the mRNA 5′ UTR
which mimics an extended duplex by coaxial stacking interactions with the neighboring stems
(4, 6). TNF-α induces PKR gene expression and a positive feedback loop has been proposed
which upregulates PKR (71). Splicing of TNF-α mRNA is dependent on activation of PKR by a
17 bp stem-loop found within its 3′ UTR (72, 73). Duplex RNA has not been detected during
infection from negative sense RNA viruses such as influenza yet cells lacking PKR are deficient
in viral defense (74, 74, 75). The activating component during influenza infection is postulated to
be a ~15 bp duplex panhandle formed by the complementary 5′ and 3′ termini of the segmented
genomic RNA (74, 74, 76).
In vitro selection experiments have identified a unique class of RNA activators which
contain a 16 bp duplex stem and flanking 5′ and 3′ single-stranded RNA tails (ss-dsRNAs, Fig.
1.5A) (77). Activation has been shown to require a 5′-triphosphate (5′-ppp) and minimal ssRNA
regions of 9 nucleotides on the 5′ tail and 10 nucleotides on the 3′ end (77, 78). A shorter 5′-ppp
dependent construct has also been described which contains two stems 5 and 4 bp in length
11

flanked by a 13 nt 5′ tail (ssRNA-47, Fig. 1.5A) (78). A 5′-triphosphate is a molecular pattern
unique to viral transcripts and provides a mechanism to recognize foreign RNA within the
cytoplasm (79). Thus, 5′-ppp dependence aligns with the role of PKR in antiviral defense (80).
Short stem-loop regions flanked by ssRNA are common in many of RNAs previously discussed
and this likely represents a physiologically relevant activation motif. Indeed, a class of small
nucleolar RNAs have recently been identified which activate PKR in response to metabolic
stress (7). Some exhibit 5′-ppp dependence and can loosely be categorized as ss-dsRNAs
based on minimal regions of extended duplex (SNORD113, Fig. 1.5A). The duplex regions of
the ss-dsRNAs are too short to mediate activation of PKR alone and the function of the singlestranded regions is unknown. There is evidence that ss-dsRNA- and dsRNA-mediated
activation are mechanistically different. Duplex RNAs do not require a 5′-ppp to activate PKR
(78). Incorporation of nucleoside modifications leads to nonequivalent effects in dsRNA versus
ss-dsRNA activation (81, 82). These effects suggest single-stranded regions may engage a
different region of PKR.
Viruses have evolved elaborate mechanisms to inhibit PKR during infection (83, 83).
Adenovirus and Epstein-Barr viruses produce large quantities RNAs named VAI and EBER,
respectively, which bind PKR tightly but do not activate thereby sequestering PKR during
infection (83, 83). We have shown that magnesium modulates PKR-VAI binding stoichiometry
and that at physiological magnesium concentrations only a single PKR binds (84). However,
PKR is able to bind the isolated constituent domains of VAI (85). In the context of full length VAI,
steric hindrance is believed to prevent binding of multiple PKR molecules which prevents
activation (85). Both VAI and EBER are relatively large RNAs which contain many of the
stimulatory structural features present in the smaller activating RNAs shown in Figure 1.5A. The
mechanism by which VAI confers an inhibitory phenotype remains unclear.
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Figure 1.5 Activating and inhibiting RNA ligands. Blue lines represent tertiary interactions.
(A) Activating RNAs. RNAs which exhibit 5′-ppp dependence are indicated by a green cap on
their 5′ terminus. (B) PKR inhibitors. RNA folds are adapted from the following references: IFN-γ
5′ UTR: (4), TNF-α 3′ UTR: (72), ssRNA-47 (78), ss-dsRNA (9,11) (77), SNORD113 (7), VAI
(86), EBER (87).
1.6 Alternative PKR activators
The canonical PKR activator contains long stretches of duplex RNA derived either from
the viral genome itself or produced as a replicative intermediate during the viral life cycle (1, 88).
Alternative activators have also been identified and pose intriguing questions regarding their
mechanism of activation. PKR is activated by a variety of polyanionic molecules including
heparin, chondroitin sulfate, dextran sulfate, and poly(L-glutamine) (89). Heparin is the best
characterized polyanionic activator (90). The heparin binding pocket has been mapped to a
basic cleft within the kinase domain located between helix αC and the C-lobe (91). Heparin
polymers as short as hexasaccharides activate PKR to produce a bell-shape activation profile
13

implying heparin mediates activation by acting as a scaffold for the assembly of PKR molecules
(90, 91). However, this mechanism is not compatible with analytical ultracentrifugation studies
which indicate a sequential assembly of an activating complex which consists of two PKR and
two heparin molecules (91). In this model heparin binds to PKR to form a 1:1 complex which
allosterically enhances the intrinsic PKR dimerization affinity to promote formation of the
activating 2:2 complex. Dilution of PKR monomers onto heparin molecules is not expected to
produce the observed inhibitory effect. PKR activated by dsRNA can phosphorylate catalytically
inactive PKR yet heparin-activated PKR cannot perform the same reaction (90). These results
imply heparin and RNA mediated activation are fundamentally different and produce different
forms of activated PKR.
A protein activator, PACT, has also been identified (92). Like PKR, PACT contains two
tandem N-terminal dsRBDs at its N-terminus. A third domain at the C-terminus belongs to a
class of dsRBDs which resemble the dsRBD in sequence yet lack key residues necessary for
RNA interaction (93). This third domain constitutes the PKR activating component of PACT (94,
95). PACT activates PKR in response to a variety of stress stimuli including serum withdrawal,
H2O2, arsenite, and peroxide (96). The stress response signal is mediated by phosphorylation of
residues within domain 3 which increases PKR binding affinity and activation potency (97). The
domain 3 interaction site has been mapped to an acidic loop within the N-lobe of the kinase
domain (98). The same study detected an interaction between dsRBD2 from PKR and a peptide
containing the loop sequence. A mechanism for PACT activation has been proposed where
PACT-domain 3 and PKR-dsRBD2 both interact with the same site on the N-lobe. The PKRdsRBD2 is autoinhibitory whereas the PACT-domain 3 interaction is stimulatory (98). Note,
however, that another study mapped the PKR-dsRBD2 autoinhibitory interaction to a region
within the C-terminal lobe (55).
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1.7 Objectives
The work presented in this thesis includes several studies of the mechanism of
activation of PKR. In Chapter 3 an ss-dsRNA is designed using ss-dsRNA (9,11) (Fig. 1.4A) as
a template. The parental ss-dsRNA contains 15 nt 5′- and 3′-tails and a 15 bp stem-loop capped
with a tetraloop. What follows is a rigorous examination of the structural features required for
activation. Each tail and the stem are systematically truncated in 5 nt or bp increments. The
effects of truncation are characterized by PKR binding affinity measurements and activation
assays. The analysis is guided by our previous investigation which characterized the length
dependence of duplex regions by similar methodologies (63). In that study we found a strong
correlation between RNA binding affinity and stoichiometry and activation potency where
activation required formation of an RP2 complex and activation potency was proportional to the
relative amount of RP2. Under the conditions we have examined, all of the ss-dsRNAs produce
the RP2 species yet not all activate. In cases where the tails are drastically reduced or
eliminated we observe a reduction in the maximal population of RP2 which correlates with the
inability to activate. However, this correlation is lost with some RNAs with intermediate tail
lengths. The results imply that PKR directly engages single-stranded regions and that this
interaction can produce a stimulatory effect. The potency of activation may be dictated by
specific conformational requirements which are only partially determined by tail length.
The results from Chapter 3 are expanded in Chapter 4 where we investigate the ability of
PKR to interact with single-stranded nucleic acids. We find that two regions on PKR can
independently interact with a variety of nucleic acids: the dsRBD and a basic region lying Nterminal to the kinase domain. An isolated kinase domain construct containing the basic region
is weakly activated by single-stranded RNA. However, a kinase domain construct lacking the
basic region is not activated. We propose a model in which a bivalent interaction between the
dsRBD and the kinase domain gives rise to stronger affinity between PKR and RNAs containing
single-stranded regions. In some cases this can produce a stimulatory effect.
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Chapter 5 reports a new atomic resolution crystal structure of the kinase domain. The
objective of the structural analysis was to gain insight into the nucleic acid binding mechanism
of the basic region. Diffraction quality crystals were obtained of a kinase domain construct
containing the basic region. Unfortunately, the basic region is unresolved in the structure.
However, we observe a unique conformation of the activation segment which has profound
implications for the PKR activation mechanism. PKR forms alternating back-to-back and frontto-front interfaces in the crystal. In the front-to-front interface activation segments are
exchanged between reciprocal protomers suggestive of a trans-autophosphorylation complex.
Finally, Chapter 6 investigates two proteins reported to interact with PKR and elicit
opposite effects on enzymatic activity. Influenza viruses express the NS1 protein during
infection (99) and it has been reported that NS1 interacts with PKR to prevent activation (100102). PACT is an endogenous protein which activates PKR in response to stress (96). Both
PACT and NS1 are proposed to modulate activity by controlling an autoinhibitory interaction in
PKR between the dsRBD and kinase domain. PACT disrupts the interaction to promote
activation (98) while NS1 stabilizes the autoinhibited state (101). However, the assays which
have characterized these interactions are primarily co-immunoprecipitation or yeast two-hybrid
assays performed in cell lysates which do not assess the oligomeric state of the complex or
whether additional components are involved in the interaction (92, 95, 96, 100, 101). We have
purified NS1 and PACT and analyzed their interaction with PKR by sedimentation velocity
analytical ultracentrifugation.
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Chapter 2: Materials and Methods
2.1 Buffers
All buffers were made from reagent grade chemicals with deionized, distilled water (MiliQ, Millipore, MA). Buffers were filter sterilized (0.22 µm) and autoclaved prior to use. Table 2.1
reports the buffer names, components, and their experimental purpose.
Table 2.1 Buffers.
Name

Components

Purpose

AU75

75 mM HEPES (pH 7.5), 75 mM NaCl, 0.1 mM
EDTA, 0.1 mM TCEP

General / Binding

AU200

75 mM HEPES (pH 7.5), 200 mM NaCl, 0.1 mM
EDTA, 0.1 mM TCEP

General / Binding

AU75 / Mg2+

75 mM HEPES (pH 7.5), 75 mM NaCl, 5 mM
MgCl2, 0.1 mM EDTA, 0.1 mM TCEP

Activation

AU200 / Mg2+

75 mM HEPES (pH 7.5), 200 mM NaCl, 5 mM
MgCl2, 0.1 mM EDTA, 0.1 mM TCEP

Activation

20 mM HEPES (pH 7.5), 50 mM KCl, 5 mM
MgCl2, 0.1 mM TCEP

Activation

P50
AU75 / EDTA
CD

75 mM HEPES (pH 7.5), 75 mM NaCl, 10 mM
EDTA, 0.1 mM TCEP
50 mM NaH2PO4 (pH = 7.0)

Crosslinking
Circular Dichroism

Melt 1

10 mM NaPO4 (pH 7.0), 0.1 mM EDTA

Thermal denaturation

Melt 2

20 mM cacodylic acid (pH 7.5), 75 mM NaCl,
0.1 mM EDTA +/- 5 mM MgCl2

Thermal denaturation

Hep-A

20 mM HEPES (pH 7.5), 50 mM NaCl, 0.1 mM
EDTA, 10% glycerol, 10 mM BME

PKR purification

Hep-B

20 mM HEPES (pH 7.5), 1.2 M NaCl, 0.1 mM
EDTA, 10% glycerol, 10 mM BME

PKR purification

HA1

40 mM KH2PO4 (pH 7.0), 10 mM BME

PKR purification

HA2

400 mM KH2PO4 (pH 7.0), 10 mM BME

PKR purification
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Table 2.1 continued Buffers.
Name

Components

Purpose

p20-A0

20 mM Bicine (pH 8.65), 5% glycerol, 1 mM
EDTA, 10 mM BME

dsRBD purification

p20-A

20 mM Bicine (pH 8.65), 50 mM NaCl, 5%
glycerol, 1 mM EDTA, 10 mM BME

dsRBD purification

p20-B

20 mM Bicine (pH 8.65), 1 M NaCl, 5% glycerol,
1 mM EDTA, 10 mM BME

dsRBD purification

PACT-Lysis

20 mM HEPES (pH 7.5), 50 mM NaCl, 0.1 mM
EDTA, 10% glycerol, 10 mM BME

Full length PACT
purification

PACT-Solubilization

20 mM MES (pH 6.0), 4 M Urea, 500 mM NaCl,
30 mM Imidazole, 10% glycerol, 10 mM BME

Full length PACT
purification

PACT-Refolding

20 mM MES (pH 6.0), 500 mM NaCl, 30 mM
Imidazole, 10% glycerol, 10 mM BME

Full length PACT
purification

PACT-Elution

20 mM MES (pH 6.0), 500 mM NaCl, 500 mM
Imidazole, 10% glycerol, 10 mM BME

Full length PACT
purification

D3-Lysis

20 mM HEPES (pH=7.5), 200 mM NaCl, 20 mM
imidazole, 10% glycerol

PACT domain 3
purification

D3-Elution

20mM HEPES (pH=7.5), 200mM NaCl, 500mM
imidazole, 10% glycerol, 20 mM BME

PACT domain 3
purification

NS1-Lysis

50 mM Tris (pH=8.0), 75 mM NaCl, 30 mM
imidazole, 10 mM BME

NS1 purification

NS1-Elution

50 mM Tris (pH=8.0), 75 mM NaCl, 500 mM
imidazole, 10 mM BME

NS1 purification

2.2 Protein purification: PKR
Unphosphorylated PKR was expressed and purified using previously established
protocols (35, 91). PKR was expressed in BL21 Rosetta 2 (pLysS) (Novagen) cells from a pET11a vector (Novagen) under control of the lac operon. Cells were grown in lysogeny broth (LB)
media in a shaking incubator at 37 °C at 250 rpm until optical density reached 0.7 OD. The
culture was cold-shocked by incubation on ice for ~15 minutes and protein expression was
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induced by addition of 1 mM IPTG. Protein expression was allowed to proceed for 5 hours at
RT. Cell pellets were stored at -80 °C until use. Pellets were lysed in buffer Hep-A containing
protease inhibitor cocktail (Sigma) by sonication and clarified by centrifugation. The supernatant
was applied to a heparin Sepharose column (GE Healthcare) equilibrated in Hep-A and eluted
by a salt gradient with Hep-B. Fractions containing PKR elute at ~500 mM NaCl and are
combined and diluted 1:1 with HA1 buffer. The sample is then applied to a hydroxyapatite
column (HA, CHT ceramic hydroxyapatite; Bio-Rad) equilibrated in 40% HA-2 buffer. PKR is
eluted from the column by a 40-100% gradient of HA-2 and elutes at ~220 mM potassium
phosphate. Fractions were concentrated and either stored at -80 °C or applied to size exclusion
chromatography.
PKR kinase domain constructs were created by inserting a TEV protease cleavage site
(ENLYFQ↓G/S) upstream of the desired N-terminus. The 185- and 229-Kinase domain
constructs contain an extra glycine as the N-terminus. The 242-kinase utilizes the wild-type
serine to complete the P1′ portion of the protease site. Proteins were treated with TEV protease
following elution from the heparin Sepharose column overnight at 4 °C. TEV protease was either
obtained from a commercial supplier (AcTEV protease; Thermo Fisher Scientific) or was
produced in our laboratory (103). The cleavage reaction was purified on the hydroxyapatite
column. Chromatography was slightly modified from protocol for full length PKR. The column
was equilibrated in HA-1 buffer and protein was eluted by a gradient from 0-100% HA-2. The
kinase domain typically eluted at ~200 mM potassium phosphate and was well separated from
the N-terminal dsRBD portion of the cleaved protein which eluted at ~100 mM potassium
phosphate. Fractions were concentrated and either stored at -80 °C or applied to size exclusion
chromatography.
The dsRBD (residues 1-184) was expressed and purified as previously described (104).
The dsRBD was expressed with the same expression system as full length PKR except that
protein expression was allowed to proceed overnight at 37 °C. The cells were lysed in buffer
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p20-A in the presence of 0.1 mg/ml lysozyme by sonication. 0.2% w/v polyethylenimine was
added to eliminate contaminating nucleic acids from the preparation and the lysate was clarified
by centrifugation. The supernatant was loaded onto a SP Sepharose Fast Flow column (GE
Healthcare) equilibrated in buffer p20-A and eluted with salt by a 0-50% linear gradient with
p20-B. Fractions containing the dsRBD were pooled and diluted with buffer p20-A0 to lower the
salt concentration and loaded onto a heparin Sepharose column equilibrated in buffer p20-A.
Another linear salt gradient from 0-50% p20-B was used to elute the dsRBD. Fractions were
concentrated and either stored at -80 °C or applied to size exclusion chromatography.
Immediately prior to use, all proteins were further purified by a final size exclusion
chromatography step on Superdex 75 or 200 HiLoad 16/60 columns (GE Healthcare) into the
experimentally appropriate buffer, typically AU75.
2.3 Protein Purification: PACT
PACT was expressed in BL21 Rosetta 2 (pLysS) (Novagen) cells from a pET-15b vector
(Novagen) under control of the lac operon. Cells were grown in LB media in a shaking incubator
at 37 °C and 250 rpm until optical density reached 0.7 OD. Protein expression was induced by
addition of IPTG to 1 mM and allowed to proceed for 4 hours at 37 °C. Cells are pelleted by
centrifugation at 5,000 x g for 10 min and stored at -80 °C until use. The protein is expressed
into the insoluble fraction of the E. coli lysate. Modifications made to the expression and
purification protocols including cold-shock, lower expression temperature and time, lysis by
French press, and different lysis buffers failed to yield soluble protein. Cells were resuspended
in PACT-lysis buffer, lysed by sonication, and pelleted by centrifugation at 22,000 x g for 20 min.
The pellet was resuspended in PACT-lysis buffer and submitted to another round of sonication
and centrifugation. The final pellet was solubilized in PACT-solubilization buffer which contains
4 M urea. PACT contains a hexahistidine (His) tag at its N-terminus and was purified by Ni2+NTA chromatography. The solubilized pellet was loaded onto a pre-packed column of Ni2+-NTA
agarose beads at a flow rate of 0.5 ml/min. PACT was refolded while bound to the column by
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running a decreasing urea gradient into refolding buffer at a flow rate of 0.5 ml/min. Urea
depletion was monitored by conductivity and confirmed by measuring the refractive index of the
solution. PACT was eluted from the column with a 100 mL gradient into PACT-elution buffer
(500 mM imidazole) at a flow rate of 0.5 ml/min. Figure 2.1 shows SDS-PAGE analyses of the
purification steps for full length PACT and a construct of domain 3 (D3). A thrombin protease
site separates the wild-type PACT sequence from the His-tag. The His-tag was cleaved
overnight at 4 °C using thrombin-agarose beads (Thrombin CleanCleave Kit, Sigma) following
the manufacturer’s instructions. The sample was passed over the Ni2+-NTA resin to collect
uncleaved protein and the cleaved his-tag. The flow through was submitted to size exclusion
chromatography on a Superdex 200 HiLoad 16/60 columns (GE Healthcare) into the
experimentally appropriate buffer. Phosphomimetic mutations (S246D and S287D) were
introduced by standard PCR techniques and the proteins were purified by the same protocol.
An isolated PACT domain 3 (D3) construct was created by deletion mutagenesis of the
parental pET-15b-PACT plasmid. A PACT dsRBD1+2 was also created but the protein has only
been characterized by a solubility test on a small scale induction. D3 also contains an Nterminal His-tag separated by a thrombin protease site. D3 was expressed in BL21 Rosetta 2
(pLysS) (Novagen) cells. Cells were grown at 37 °C at 250 rpm until OD reached 0.7 and
induced by addition of IPTG to 1 mM. Expression was allowed to proceed for 5 hours. Cells
were pelleted by centrifugation at 5,000 x g for 10 min and stored at -80 °C until use. The cells
were resuspended in D3-lysis buffer and lysed by sonication. The lysate was clarified by
centrifugation at 22,000 x g for 20 min and applied to prepacked Ni2+-Sepharose column
(HisTrap HP, GE Healthcare) at 1 ml/min. D3 was eluted from the column at 1 ml/min by a 100
ml gradient into D3 elution buffer (500 mM imidazole). D3 elutes with a peak at 250 mM
imidazole. The His-tag was cleaved by the same protocol as used for full length PACT. The
protein was purified by a final size exclusion chromatography step with a Superdex 75 10/300
GL column (GE Healthcare).
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Figure 2.1 PACT purification. (A) Full length PACT. (B) Domain 3. Fractions collected from
chromatography are indicated in mL. For fractions collected from the nickel column (NTA) the
fractionation volume begins with the elution gradient. For size exclusion chromatography
(Superdex 75 and 200) the fractionation volume begins with sample injection.
2.4 Protein Purification: NS1
The NS1 effector domain (NS1-ED) was derived from H1N1 influenza A/Puerto
Rico/8/1934 and encodes residues 74-230 with an N-terminal His-tag. The protein was
expressed in BL21 Rosetta 2 (pLysS) (Novagen) cells from a pET-15b vector (Novagen) under
control of the lac operon. Cells were grown at 37 °C at 250 rpm until OD reached 0.7 and
induced by addition of IPTG to 1 mM. Expression was allowed to proceed for overnight. Cells
were pelleted by centrifugation at 5,000 x g for 10 min and stored at -80 °C until use. The cells
were resuspended in NS1-lysis buffer and lysed by sonication. The lysate was clarified by
centrifugation at 22,000 x g for 20 min and applied to prepacked Ni2+-Sepharose column
(HisTrap HP, GE Healthcare) at 1 ml/min. NS1 was eluted from the column at 1 ml/min by a 100
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ml gradient into NS1-elution buffer (500 mM imidazole). The protein was purified by a final size
exclusion chromatography step with a Superdex 75 10/300 GL column (GE Healthcare).
2.5 Nucleic acid synthesis and purification
ss-dsRNAs were typically produced by in vitro transcription off a plasmid template using
conditions established by Gurevich and reported in Table 2.2 (105). Templates coding for the
target RNA sequences were created by PCR and inserted into the plasmid between the T7
promoter site and a 3′-ribozyme. Plasmids carrying the desired RNA sequence were purified
and linearized as previously described (106). T7 polymerase has a tendency to prematurely fall
off the template or add non-coded nucleotides to the 3′-end of the transcript leading to 3′-end
heterogeneity (107, 108). To produce RNAs with homogeneous 3′-ends the hepatitis delta virus
(HDV) ribozyme was included at the 3′-end of the transcript. The ribozyme cleaves immediately
5′ to its own sequence to release the desired RNA transcript (106, 109). Efficient transcription
using T7 polymerase requires that the transcript begins with two guanosine residues (107).
Therefore, to create the 3′-strands used to make 15-15-15-∆T which begin with either 5′AAGU…-3′ (3′-blunt) or 5′-UCCG…-3′ (3′-UCCG), the hammerhead ribozyme was included at
the 5′-end of the transcript. The hammerhead sequence was engineered so that cleavage would
occur immediately 5′ to the desired RNA sequence (106). Synthetic oligoribonucleotides were
obtained from GE Dharmacon (15-15-15, U30, Het30, 5′-blunt, 5′-UCCG, 3′-blunt, 3′-UCCG,
ds30, ds40), TriLink Biotechnologies, Inc. (5-15-10, ppp-Het30), or IDT, Inc. (dT30, dHet30).
RNA obtained from Dharmacon was deprotected according to the manufacturer′s protocol prior
to use. All RNAs were purified by denaturing 8 M urea PAGE followed by electroelution using an
Elutrap device (Schleicher and Schuell, NH). Samples were ethanol precipitated from the
electroeluter and typically resuspended in AU75 for use. ss-dsRNAs were annealed by heating
~2 µM of RNA in AU75 at 90°C for 5 min followed by snap cooling. Figure 2.3 shows ureaPAGE analysis of several transcription reactions with the purified RNA shown in two of the gels.

23

Table 2.2 Transcription conditions.
Component

Concentration in reaction

HEPES-KOH, pH 7.5

200 mM

MgCl2

28 mM

Spermidine

2 mM

Dithiothreitol (DTT)

40 mM

NTP mix (ATP, GTP, CTP, UTP)

6 mM (each)

DNA template

100 µg/ml

Murine RNase inhibitor (NEB M0314S)

40 units/ml

T7 RNA polymerase

~0.7 µM

Figure 2.2 RNA transcription reactions. Predominant species are labeled. In the two gels on
the right the final purified product is included in the second lane.
2.6 Determination of ε260
Nucleic acid absorbance is largely dependent on structural conformation due to a
hypochromic effect on nucleotide absorbance induced by base stacking and pairing interactions
(110). Nearest neighbor calculations are accurate for predicting single-stranded extinction
coefficients but fail to accurately predict extinction coefficients for nucleic acids with complex
folds. In these cases, the extinction coefficient must be experimentally determined either by
measuring the hyperchromicity induced by thermal denaturation, by tedious analysis of
phosphorous content in a sample, or by hydrolysis of the nucleic acid into its component
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nucleotides. We employed the latter method to determine the extinction coefficient of ssdsRNAs at 260 nm (ε260). The extinction coefficient was estimated by nucleotide composition
and the sample was folded at 2 µM by the snap-cooling previously discussed. The absorbance
of the sample was measured and the sample was enzymatically hydrolyzed with 1 U
RiboShredder RNase Blend (Epicentre). Figure 2.4 shows a time course for the hydrolysis of
10-15-10. The hyperchromic effect from hydrolysis plateaus around 80 minutes. Reactions were
left overnight to ensure complete hydrolysis. At a minimum, samples were prepared in triplicate.
Values for ε260 of the folded RNA were back calculated from the hydrolyzed solution using the
known extinction coefficients of the component nucleotides (111). Extinction coefficients are
reported in Appendix 1.

Figure 2.3 Time course for ε260 quantification by enzymatic hydrolysis.
2.7 Enzymatic treatment of RNAs
RNAs produced by in vitro transcription contain a 5′-ppp and ribozyme cleavage leaves a
2′,3′-cyclic phosphate (112). The dependence of the 5′-triphosphate on PKR activation was
tested by dephosphorylation of the RNAs with calf intestinal alkaline phosphatase (CIP). RNAs
containing a 5′-OH were generated by incubating 100 µL of 2 µM in vitro transcribed RNA with
10 U CIP (New England BioLabs, MA) in 50 mM Tris pH 7.9, 100 mM NaCl, 10 mM MgCl2, 1
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mM DTT at 37°C for 1 hour. The 2′,3′-cyclic phosphate was selectively removed with T4
polynucleotide kinase (T4 PNK, New England BioLabs, MA). T4 PNK is typically used to
phosphorylate the 5′-end of nucleic acids yet the enzyme contains a phosphatase domain which
is specific for phosphates on the 3′-terminus (113, 114). The phosphatase activity can be
promoted by modifying the reaction conditions from those recommended for kinase activity
(109). The cyclic phosphate was removed by incubating 2 µM RNA with 10 U T4 PNK in 100
mM MES (pH 5.85), 300 mM NaCl, 10 mM MgCl2, 10 mM BME at RT for 3 hours. A reduction in
electrophoretic mobility in a denaturing polyacrylamide gel confirmed phosphate removal
(Figure 3.8D).
RNAs were 5′-labeled with

32

P for enzymatic structure probing and crosslinking studies.

Transcripts were first dephosphorylated with calf intestinal alkaline phosphatase (CIP, New
England BioLabs) to remove the 5′-triphosphate and phosphorylated with [γ-32P]ATP (Perkin
Elmer) by T4 polynucleotide kinase (T4 PNK, New England BioLabs). The labeling reaction was
performed by incubating 1 µM RNA with 50 U T4 PNK in 70 mM Tris-HCl pH 7.6, 10 mM MgCl2,
5 mM DTT, and 4 µCi [γ-32P]ATP (Perkin Elmer, MA) at 32 °C for 20 min.
RNAs were typically purified after any enzymatic treatment by phenol-chloroform
extraction followed by ethanol precipitation and refolded prior to use.
2.8 Enzymatic structure probing
Enzymatic structure probing assays were conducted by incubating 2 µg 5′-32P labeled
RNA with varying concentrations of RNases T1, V1, or A (Ambion) and 4 µg yeast RNA in 10
mM Tris pH 7.0, 100 mM KCl, 10 mM MgCl2 at room temperature for 15 min. An alkaline
hydrolysis ladder was produced by incubating 5′-32P labeled RNA and yeast RNA in 50 mM
sodium carbonate pH 9.2, 1 mM EDTA at 95 °C for 2, 5, or 15 minutes. The RNase T1
sequencing ladder was produced by first incubating 5′-32P labeled RNA and yeast RNA in 20
mM sodium citrate (pH 5.0), 1 mM EDTA, 7 M urea at 50 °C for 5 minutes. Either 1 or 0.1 U of
RNase T1 was then added and incubated for 15 minutes at RT. The cleavage reactions were
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stopped by ethanol precipitation and resolved by 12% TBE-Urea PAGE. The gel was dried and
exposed to a phosphor screen then scanned with a Typhoon phosphorimager.
2.9 Activation assays
PKR autophosphorylation was monitored by incorporation of

32

P from [γ-32P]ATP

(Perkin-Elmer). Samples contained a fixed concentration of PKR and a variable concentration of
activator. Reactions were typically performed with 100 nM PKR in AU75 / Mg2+ buffer at 32 °C.
Activation assays with PACT were performed with 200 nM PKR in P50 buffer. Samples were
equilibrated at the experimentally appropriate temperature for 10 minutes prior to initiating the
reaction. Reactions containing ssRNA and PACT were prepared on ice. Phosphorylation
reactions were initiated by addition of ATP to a final concentration of 0.4 mM containing 0.125
(ss-dsRNAs / PACT) or 0.25 (ssRNA) µCi/µL [γ-32P]ATP. Reactions were quenched with sample
loading buffer after 20 min and resolved on SDS-PAGE. The gel was then dried and exposed to
a phosphor screen followed by quantification on a Typhoon phosphorimager (GE Healthcare,
NJ). For ss-dsRNAs, each gel contained an autophosphorylation reaction performed with ppp15-15-15 at 100 nM and a 40mer dsRNA (ds40) at 50 nM. Activation plots were normalized to
the ppp-15-15-15 control and ds40 served as an internal standard. In assays with ssRNAs, low
molecular weight heparin (4-6 kDa) (Sigma-Aldrich) is included as a positive control. In assays
with PACT ds40 is the positive control.
2.10 Analytical ultracentrifugation
Sedimentation velocity analytical ultracentrifugation experiments were performed in a
Beckman Coulter XL-I analytical ultracentrifuge. Table 2.3 lists the rotor speed, optical system,
temperature, and buffer used for the experiments. Samples only containing protein were
monitored by the interference optical system. RNA binding was monitored by the absorbance
optical system set to 260 nm. Sapphire windows were used with the interference optical system
and quartz windows were equipped for absorbance. Initial data analysis was performed using
the time derivative method (115) as implemented in DCDT+, version 2.3.2 (116) to obtain g^(s*)
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distributions. While not usually shown, the data were also analyzed by the c(s*) method to
assess homogeneity and RNA degradation (117). Sample heterogeneity is sometimes more
apparent by c(s*) analysis due to the higher resolution afforded by deconvolution of the
diffusional broadening assuming a single frictional coefficient, f/f0. Distributions were typically
normalized by area for presentation. Binding affinities and stoichiometries were extracted by
global fits of multiple data sets to the Lamm equation incorporating different association models
using SEDANAL, version 6.01 (118). Confidence intervals were obtained using the F-statistic to
define a statistically significant increase in the variance upon adjusting each parameter from its
best-fit value. Correction of sedimentation coefficients to standard conditions was performed
using Equation 1.

s20,w = sT ,b

(1- ur )
(1- ur )

20,w

hT ,b
h20,w

(1)

T ,b

where the subscript 20,w refers to the parameter measured at 20ºC in pure water, the subscript
T,b refers to the parameter measured at temperature T in buffer, s is the sedimentation
coefficient,

u

is the partial specific volume, ρ is the buffer density and η is the buffer viscosity.

Frictional ratios (f/f0) for RNAs and RNA-PKR complexes were calculated using Equation 2.

(

)
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where NA is Avogadro′s number and M is the molecular weight. For ssRNA interactions, it was
not possible to fit for the sedimentation coefficients of some of the RNA-protein complexes due
to cross-correlation with the binding constants. These parameters were fixed at physically
reasonably values based on our experience that RNA complexes with PKR have frictional ratios
(f/f0) near 1.5 (62, 63, 119). Buffer densities, viscosities, and protein partial specific volumes
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were calculated using SEDNTERP, version 2011120 (120). RNA partial specific volumes were
fixed at 0.55 mL g-1 (121).
Table 2.3 Experimental parameters for analytical ultracentrifugation.
Rotor Speed
Optical
Project
Buffer
(rpm)
System

Temperature
(°C)

ss-dsRNAs

AU75 / AU200

40,000

Absorbance

20

ssRNAs

AU75

50,000

Absorbance

20

ssRNAs:PKR constructs

AU75

50,000

Interference

20

Full length PACT

AU200

50,000

Interference

4

PACT-D3

AU200 / P50

50,000

Interference

20

NS1

AU200

45,000 / 50,000

Interference

20

2.11 Thermal denaturation analysis of RNAs
Thermal denaturation experiments were performed on an Agilent Cary 300 UV-Vis
spectrophotometer. Data were collected by monitoring the absorbance change at 260 nm at a
heating rate of 0.5 °C/min. Absorbance readings were collected every 0.5 °C. ss-dsRNAs and
ssRNAs were characterized in 10 mM NaPO4 (pH 7.0) with 0.1 mM EDTA. Thermal
denaturation experiments were also conducted to determine whether Mg2+ induces secondary
structure in the single-stranded tails of ss-dsRNAs by comparing thermal denaturation of 15-1515 and 0-15-0 in the presence and absence of Mg2+. Those data were collected in 20 mM
cacodylic acid (pH 7.5), 75 mM NaCl, 0.1 mM EDTA +/- 5 mM MgCl2. The initial absorbance of
each sample was ~0.5 OD. The first derivative of the melting curves was calculated in
Kaleidagraph, version 4.5.0 (Synergy Software). The derivative curves were smoothed by
boxcar averaging over a 5 °C window. Melting points (Tm values) were determined by a
Gaussian fit to the derivative curves.
2.12 Small angle X-ray scattering
Small angle X-ray scattering (SAXS) data were collected in AU75 buffer at 20 °C on a
Nanostar instrument (Bruker). RNA data were collected as 4, 1 hour frames and the buffer for
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background subtraction was collected as 15, 1 hour frames. The sample to detector distance
was 67.4 cm and the wavelength was 1.54 Å. Data were reduced with the Bruker SAXS
software. All scans overlaid indicating the absence of radiation induced damage in the samples
and were averaged for analysis. Data were analyzed with the ATSAS software package (122).
Values for Rg and Io were determined by Guinier analysis of the low q region of the data where
Rg•q < 1.25. Distance distributions functions (p(r)) were calculated in GNOM (123). The
maximum scattering vector (Dmax) was determined by increasing the maximum distance of the
p(r) distribution until it asymptotically approached zero. For 0-15-0, simulated scattering data
were generated from a modified NMR structure (PDB: 2L2K) computed with CRYSOL (124).
2.13 UV crosslinking
Crosslinking reactions were carried out using RNAs containing 4-thiouridine generated
by replacing UTP with 4-Thio-UTP (TriLink Biotechnologies, Inc.) in the transcription reactions.
RNAs were labeled at 5′-end with
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P to monitor crosslinked complexes. Spurious

autophosphorylation of PKR during the crosslinking reaction due to [γ-32P]ATP contamination
from the labeling reaction would complicate interpretation of the results. Therefore, we took
extraordinary steps to eliminate free [γ-32P]ATP. The RNA was purified by phenol-chloroform
extraction followed by ethanol precipitation. The RNA pellet was resuspended in AU75 buffer
containing 10 mM EDTA and submitted to a series of buffer exchange steps by iterative dilution
and concentration in a 10,000 MWCO centrifugal filter (Millipore). Crosslinking was performed in
AU75 buffer containing 10 mM EDTA. Samples contained 0.5 µM RNA and 1 µM protein in 15
µL. For the dsRBD construct, an additional sample was prepared containing 0.5 µM RNA and
10 µM protein. Samples were incubated on ice 15 minutes prior to UV exposure. An 8 watt
ultraviolet lamp (UVP; model 3UV-38) was used to irradiate the samples at 365 nm at a distance
of 5 cm for 10 minutes on ice. Samples containing a TEV cleavage site were treated with TEV
AcTEV protease (Thermo Fisher Scientific) by combining 5 µL of the crosslinking reaction with
0.5 µL protease and incubating at 32 °C for one hour. Crosslinking reactions were resolved by
30

SDS-PAGE. Gels were fixed in 7.5% acetic acid and stained with SYPRO Orange
(ThermoFisher) to visualize the location of protein within the gel. Gels were then dried and
exposed to a phosphor screen followed by imaging and quantification on a Typhoon
phosphorimager (GE Healthcare).
2.14 Chemical crosslinking
The interaction between PACT and PKR was probed by chemical crosslinking using
disuccinimidyl suberate (DSS). Samples were prepared in P50 buffer with 10 mM PKR and a
titration of PACT. Crosslinking reactions were initiated by addition of DSS to 10-fold molar
excess of the protein concentration. The reaction was allowed to proceed for 30 minutes at RT
and quenched by addition of 50 mM Tris-Cl. Crosslinked products were resolved by SDS-PAGE
in a 4-12% acrylamide tris-glycine gel and visualized by Coomassie Blue staining.
2.15 Circular dichroism
CD spectra of RNA:PKR mixtures or of refolded full length PACT were measured with an
Applied Photophysics Pi Star-180 spectrapolarimeter. The RNA:PKR mixtures were collected
using 2 mm path length cuvettes in AU75 buffer at 20 °C. For each sample, 5 wavelength scans
were collected and averaged. Scans were collected between 200 and 340 nm with a 1 nm step,
2 nm bandpass, and time-perpoint averaging of 2 s. Samples contained 5 µM RNA and the
protein was manually added from a concentrated stock. Dilution effects were corrected for by
concurrent addition of the appropriate RNA stock. Contribution from the protein to the spectra at
wavelengths >240 nm was minimal. Both buffer only and protein only spectra were subtracted
from the RNA:PKR mixtures.
Spectra of full length PACT were collected from 170 to 270 nm in 1 mm path length
cuvettes in 50 mM NaH2PO4 (pH = 7.0) at 15 °C. The slits were set to 2 nm and the data were
collected with a 1 nm step and time-perpoint averaging of 12.5 s. The spectrum presented in
Figure 6.4A is the average of two measurements.
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2.16 Limited proteolysis
Full length PACT(his) was incubated at 0.67 mg/ml with various ratios of PACT/trypsin
for one hour at 4 °C in AU200 buffer. A 3 hour incubation was also performed and yielded the
same digestion pattern. Reactions were quenched by addition of SDS loading buffer and heated
for 5 min at 90 °C. Digestion products were resolved by SDS-PAGE in a 4-14% acrylamide trisglycine gel. Peptides were visualized by Coomassie Blue staining.
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Chapter 3: ss-dsRNAs
3.1 Introduction
A novel family of RNA activators of PKR has been described that contain a 16 bp
imperfect duplex stem capped by a variable length loop with flanking ssRNA regions on the 5′and 3′-ends (ss-dsRNAs) (77, 78). The presence of a 5′-triphosphate (5′-ppp) and minimal
ssRNA tails of 9 nt on the 5′- and 10 nt on the 3′-side are crucial to PKR activation. Activation is
also observed for longer (≥ 47 nt) ssRNAs containing short (5 bp) stems. The duplex regions in
all of these RNAs are too short to mediate PKR activation alone and the mechanism by which
the 5′-ppp and ssRNA regions elicit activation is not known. A 5′-ppp is an important structural
feature for activation of RIG-I (125, 126), an intracellular sensor of foreign RNAs. The 5′-ppp
binding site lies within a positively charged pocket at the C-terminus of RIG-I (127-130).
However, sites for ssRNA or triphosphate binding have not been identified in PKR (131).
Here, we characterize the structural features of ss-dsRNAs that contribute to PKR
binding and activation. We have designed a model ss-dsRNA PKR activator containing two
single stranded tails of 15 nt and a 15 bp stem capped with a tetraloop (15-15-15) and made
systematic truncations and modifications to the tail, stem, and loop regions. Our studies confirm
that stem-loops containing flanking ssRNA regions function as PKR activators. However, we
obtain disparate results regarding the dependence of the 5′-ppp for activation. Synthetic RNAs
containing either a 5′-OH or 5′-ppp do not activate PKR. However, RNAs created by in vitro
transcription (IVT) activate PKR in both 5′-OH and 5′-ppp forms. The chemical difference(s)
between synthetic and IVT RNA which leads to opposing regulation of PKR activity is unclear.
The investigation into the role of the tetraloop is marred by the use of synthetic oligonucleotides
to create some constructs and a critical control experiment in which ligation of RNAs containing
a broken tetraloop does not restore activation. Systematic truncation of the 5′- and 3′- ssRNA
arms generally causes a decrease in binding affinity and activation potency. ss-dsRNAs lacking
either 5′- or 3′- arm bind weakly and do not activate. However, activity and tail length is not
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correlated with binding for ss-dsRNAs with intermediate affinities. These data support a model
where ss-dsRNA induced PKR dimerization is required but not sufficient to activate the kinase.
Results
3.2 Characterization of ss-dsRNAs
We have designed a series of ss-dsRNAs to characterize the length dependence of
ssRNA tails and stem-loop region and the contribution of the 5′-triphosphate to the binding
energetics and activation of PKR. Truncations were made to a model ss-dsRNA with a 15 bp
duplex stem capped by a stable UCCG tetraloop (132) flanked by 15 nt single stranded tails
(Fig. 3.1A). The sequences of the ssRNA tails have been designed to prevent formation of
unwanted secondary structure. Tail truncation constructs were designed by deletion of
nucleotides immediately flanking the stem. Additional mutations within the single stranded
regions were required in some cases to disrupt formation of alternative secondary structures.
The sequences are deposited in Appendix 1. Analysis of the sequences using MFOLD (133)
indicate the absence of alternative folded conformations (data not shown). Enzymatic structure
probing experiments confirm the predicted secondary structure of the model 15-15-15 ssdsRNA (Fig. 3.1A,B). Thermal denaturation measurements indicate a single cooperative
transition associated with unfolding of the stem region (Fig. 3.1C). RNAs with 15 bp duplex
regions exhibit a single cooperative melting transition between 72 – 75 °C. The Tm decreases to
66 °C when the duplex is reduced to 10 bp in 15-10-15. Importantly, we do not detect additional
cooperative unfolding transitions indicating the absence of alternative folded conformations
within the tail regions. The monotonically increasing baseline prior to the cooperative unfolding
of the duplexes is due to decreased stacking interactions within the tails. Thus, the tails do no
adopt unwanted secondary structure. Self-complementary RNA hairpins have the potential to
dimerize, which can complicate analysis of their interactions with PKR (134, 135).
Sedimentation velocity analysis indicates that all of the ss-dsRNAs are homogeneous and
monomeric (Appendix 2). Small angle X-ray scattering (SAXS) provides further evidence for the
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appropriately folded structures (Fig. 3.1D-G). SAXS analysis was performed on the parental
model construct, 15-15-15, a construct lacking tails, 0-15-0, and a construct lacking the
tetraloop capping the stem, 15-15-15-∆T. All constructs contain a 5′-ppp and 15-15-15-∆T was
created by hybridizing synthetic oligonucleotides. Transformation of the data into real space,
represented as a weighted distribution of interatomic distances, P(r), provides information on the
general shape of the molecules in solution (Fig. 3.1G). As expected for an RNA duplex, the
distributions exhibit characteristic features of rod shaped molecules (136). The curves have a
maxima at ~20 Å which corresponds to the cross sectional diameter of an A-form helix. For 015-0, the maximum interatomic distance (Dmax) is determined by the distance from the base of
the stem to the top of the tetraloop (expected distance = ~55 Å). For a 15 bp duplex capped by
a tetraloop the expected distance is ~55 Å and 0-15-0 has a fitted Dmax of 60 Å. Scattering data
for 0-15-0 are validated by theoretical scattering data calculated using Crysol (124) from the
solution structure of a 15 bp stem-loop RNA (PDB: 2L2J). In 15-15-15 and 15-15-15-∆T, the
tails increase Dmax to ~100 Å.
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Figure 3.1 Structural analysis of ss-dsRNAs. (A) Predicted secondary structure of 15-15-15
and enzymatic cleavage sites for RNases T1 (red), V1 (cyan) and A (green). (B) Enzymatic
cleavage products of 15-15-15 resolved by urea-PAGE. (C) Thermal denaturation analysis of
ss-dsRNAs. The top panel shows the absorbance melting curves, vertically adjusted to 0 OD at
20 °C. The first derivative of the melting curves is shown in the bottom panel. Tm values were
determined by a Gaussian fit to the derivative curves. (D-G) SAXS analysis of ss-dsRNAs.
Scattering data (points) and the p(r) fit (solid red line) for 0-15-0 (D), 15-15-15 (E), and 15-1515-∆T (F). Guinier analyses with calculated Rg are shown in the insets. The scattering profile for
a 15 bp stem loop was calculated from PDB: 2L2J using Crysol (124) and is shown as a dashed
teal curve in (A). The predicted Rg from the Crysol simulation is 17.3 Å. (G) p(r) distributions
calculated by an indirect Fourier transform of the data using GNOM (137).
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3.3 Effect of tail deletions on binding
The PKR binding stoichiometries and affinities of the ss-dsRNAs were measured using a
sedimentation velocity analytical ultracentrifugation method (138). Initial experiments were
performed in a buffer containing 200 mM NaCl (AU200) to correlate with our previous PKR-RNA
binding measurements (63, 84, 134).

The data were first analyzed by the time derivative

method (115, 116) to determine the qualitative behavior of the system and to define the correct
association model to use for subsequent global analysis (138). As shown in Figure 3.2A, the
peak of the g^(s*) distribution for ppp-15-15-15 shifts to the right from ~3 S to ~5 S when PKR
binds due to formation of a protein-RNA complex with a higher sedimentation coefficient. The
shift is saturated upon addition of six equivalents of PKR. Assuming a 1:1 binding stoichiometry,
a sedimentation coefficient of ~5 S corresponds to a frictional ratio f/f 0 ~1.5 (Appendix 2), which
is in the range that we typically observe for PKR-RNA complexes (138).

Thus, the

sedimentation data are consistent with binding of a single PKR to ppp-15-15-15 in AU200.
PKR dissociation constants were obtained by globally fitting the sedimentation velocity
data using SEDANAL (118). We obtain an excellent fit of the ppp-15-15-15 data to a 1:1
binding model with Kd = 360 nM and a low RMS deviation of 0.00587, which is on the order of
the noise level of the absorbance optics (Table 3.1). Hydrodynamic calculations indicate that
each of tail deletion RNAs also binds a single PKR in AU200 (Appendix 2). Deletion of the 5′-tail
has a negligible effect on Kd whereas deletion of the 3′-tail or both tails decreases binding affinity
by about three-fold (Table 3.1).
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Figure 3.2 Sedimentation velocity analysis of PKR binding to ppp-15-15-15. Normalized
g^(s*) distributions obtained in (A) 200 mM NaCl (AU200 buffer) or (B) 75 mM NaCl (AU75
buffer). Samples contain 0.7 µM 15-15-15 and the indicated equivalence ratio of PKR. Fitted
sedimentation coefficients for the RNA, 1:1 species (RP), and 2:1 species (RP2) obtained from
the 75 mM NaCl dataset are indicated by vertical lines across both distributions. (C) Global
analysis of the sedimentation difference curves. The fit corresponds to the 75 mM NaCl data
shown in panel B. Scans were subtracted in pairs to remove time-invariant background and fit to
a sequential 2:1 binding model using SEDANAL (118). The top panels show the data (points)
and the fitting results (continuous lines) using the parameters presented in Table 3.2 and
Appendix 2. The bottom panels show residuals. Only every other difference curve is shown for
clarity. A similar analysis was used for the 200 mM NaCl data although the data were fit to a 1:1
binding model. Measurements were performed at 20 °C and 40,000 rpm using absorbance
detection at 260 nm.
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Table 3.1 PKR binding to tail deletion constructs measured in AU200.
RNA

Kd (nM)

RMSDa

ppp-15-15-15

360 (304, 420)

0.00587

ppp-15-15-0

1240 (1169,1319)

0.00483

ppp-0-15-15

449 (409, 491)

0.00652

ppp-0-15-0

935 (840, 1042)

0.00607

Parameters obtained by global nonlinear least square analysis of sedimentation velocity experiments.
The values in parentheses represent the 95% joint confidence intervals obtained using the F-statistic.
a
Root mean square deviation in absorbance units.

3.4 Enzymatic effect of tail deletion
Activation of PKR by ss-dsRNAs was assayed by measuring PKR autophosphorylation
in AU200. Deletion of either of the flanking ssRNA tails abolishes the ability to activate (Fig.
3.3). At the PKR concentration used in the assay, the maximum level of activation occurs at 1
µM and PKR is inhibited at higher RNA concentrations, giving rise to a bell shaped curve similar
to activation by simple dsRNAs (Fig. 3.3B). Our previous analysis of a truncation series of
dsRNAs revealed a correlation between the ability to activate PKR autophosphorylation and the
binding of two or more monomers in AU200 (62, 63). Thus, it is noteworthy that ppp-15-15-15
functions as a potent activator without detectable formation of a 2:1 species in 200 mM NaCl.
The bell shape activation curve suggests that like duplex RNAs, ss-dsRNAs activate PKR by
facilitating dimerization of PKR on the RNA. The amount of 2:1 species populated may be below
the detection limits for the sedimentation velocity analysis.
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Figure 3.3 Activation of PKR by tail deletion constructs in 200 mM NaCl. Experiments
were performed in AU200 buffer plus 5 mM MgCl2 at 32 °C. Each reaction contains 200 nM
PKR, 400 µM ATP, 2 µCi γ-32P-ATP and the indicated amount of RNA. The reaction was
allowed to proceed for 20 min before quenching with SDS loading buffer and products were
resolved on 12% denaturing SDS-PAGE. The incorporation of 32P into PKR was measured by
phosphorimager analysis. (A) ppp-15-15-15 and ppp-0-15-0 (top), ppp-15-15-0 and ppp-0-1515 (bottom). (B) Quantitation of gels shown in panel (A). PKR activation level is plotted as a
function of RNA concentrations. ppp-15-15-15 (black), ppp-15-15-0 (blue), ppp-0-15-15 (red),
ppp-0-15-0 (green).
3.5 Measurements in 75 mM NaCl
The affinity of PKR binding to dsRNA is strongly dependent on monovalent ion
concentration (15, 139) and the stoichiometries can increase upon decreasing [NaCl] from 200
to 75 mM (62, 63). Figure 3.2B shows the normalized g^(s*) distributions of a PKR titration
against ppp-15-15-15 in 75 mM NaCl (AU75 buffer) directly beneath the distributions obtained in
200 mM NaCl (AU200). Addition of a large molar excess of PKR increases the sedimentation
coefficient to ~8 S whereas the maximal sedimentation coefficient in 200 mM NaCl is only ~5 S
(Appendix 2). A sedimentation coefficient of 8 S is larger than expected for a 1:1 complex (RP)
of PKR and ppp-15-15-15 but is consistent with formation of a 2:1 complex (RP2). Reducing the
NaCl concentration to 75 mM also induces a large increase in the maximum sedimentation
coefficient for PKR binding to the nonactivating RNAs ppp-0-15-15, ppp-15-15-0, and ppp-0-150 (Appendix 2). Again, the limiting sedimentation coefficients of the protein-RNA complexes
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indicate that two PKR monomers also bind to these RNAs under these conditions. Despite the
ability to bind two PKR monomers, the tail deletion constructs are deficient in enzymatic
activation measured at 75 mM NaCl (Figure 3.5).

Thus, the binding stoichiometries alone

cannot explain the difference in PKR activation among these ss-dsRNAs.
Global analysis reveals significant differences in the PKR binding affinities for the activating
and non-activating ss-dsRNAs measured in AU75. PKR binds strongly to ppp-15-15-15 with Kd1
and Kd2 lying in the low and mid nanomolar region, respectively (Table 3.2). Deletion of the 3′tail increases Kd1 by about 6-fold and Kd2 by about 3-fold. Deletion of the 5′-tail results in a 30fold increase in Kd1 and a 2.5-fold increase in Kd2. The largest penalty is observed when both
tails are deleted.
For a panel of dsRNAs of increasing length, the rate of PKR autophosphorylation is
proportional to the maximum population of PKR that is contained in RNA complexes containing
two PKR monomers, denoted RP2 (62, 63). Table 3.2 shows the maximum percentage of RP2
for the ss-dsRNAs calculated using the experimentally determined dissociation constants. The
activating ppp-15-15-15 RNA produces a maximum of about 13% RP2 and the nonactivating tail
deletion constructs induce about half as much.
Table 3.2 PKR binding to tail deletion constructs measured in AU75.
RNA

Kd1 (nM)

Kd2 (nM)

Maximum % RP2a

RMSDb

ppp-15-15-15

4 (2, 6)

294 (252, 343)

12.9

0.00821

ppp-15-15-0

26 (20, 34)

928 (782, 1108)

4.9

0.00667

ppp-0-15-15

128 (96, 170)

746 (568, 1003)

5.9

0.00620

ppp-0-15-0

138 (105, 178)

1662 (1311, 2131)

2.8

0.00906

Parameters obtained by global nonlinear least square analysis of sedimentation velocity experiments.
The values in parentheses represent the 95% joint confidence intervals obtained using the F-statistic.
a
The maximum population of the RNA-PKR2 species calculated from Kd1 and Kd2 at the concentration of
PKR used in activation assays (100 nM).
b
Root mean square deviation in absorbance units.
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3.6 Magnesium effects
Further analysis of the ss-dsRNA structure-activity relationships was carried out in
75 mM NaCl so that correlations could be made between the population of the RP2 species
and activation potency. Magnesium is required for kinase activity and is present in
autophosphorylation assays at 5 mM. However, addition of 5 mM MgCl2 to the buffer
containing 75 mM NaCl causes a significant decrease in binding affinity which complicates
measurement of the second dissociation constant (Table 3.3). We performed experiments to
examine the effect of magnesium on ss-dsRNA structure and PKR affinity. Divalent ions can
diffusely interact with the phosphate backbone or site specifically bind to facilitate RNA
folding (140). PKR affinity to dsRNAs is not regulated by divalent ion (15) but the interaction
of PKR with a large, complex RNA, Adenovirus VAI, is modulated by Mg2+ (84). Shielding of
the phosphate backbone by diffuse interaction is expected to cause a similar decrease in
PKR binding affinity for both RNAs. We asked whether the interaction of PKR with ssdsRNAs is affected by Mg2+ by comparing binding affinities in AU75 and AU60 / 5 Mg
buffers, where the increase in ionic strength conferred by the addition of 5 mM Mg2+ to AU75
is compensated for by reducing the NaCl concentration to 60 mM. For both ppp-15-15-15
and ppp-0-15-0, which lacks single stranded tails, the binding affinities decrease strongly in
AU60 / 5 Mg (Table 3.3). This observation is consistent with previous studies indicating that
Mg2+ is ~100-fold more efficient at charge screening of RNAs compared to monovalent
cations (141, 142). As indicated by a similar reduction in the maximum RP2 for the two
RNAs, there are no specific Mg2+ effects conferred by the single stranded tails. Furthermore,
thermal denaturation measurements indicate that Mg2+ does not induce formation of
additional secondary structure in ss-dsRNAs (Figure 3.4). In the absence of Mg2+, 15-15-15
exhibits a monotonic increase in absorbance followed by cooperative unfolding of the duplex
region at ~85 °C. The presence of Mg2+ does not induce additional unfolding transitions for
15-15-15 but simply shifts the duplex unfolding to higher temperature. Additionally,
enzymatic structure probing experiments (Figure 3.1) were performed in the presence of 10
mM MgCl2 and indicate the absence of folded regions within the ssRNA tails although the
entire tail region is not resolved on the gel.
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Table 3.3 Effect of Mg2+ on PKR binding.
RNA

Buffer

Kd1 (nM)

Kd2 (nM)

Maximum
% RP2

Relative
RMSDb
RP2a

ppp-15-15-15

AU75

4

294

12.9

-

0.0082

ppp-15-15-15

AU60 / 5 Mgc

21

2,104

2.3

18

0.0101

ppp-15-15-15

AU75 / 5 Mgd

42

3,704

1.3

10

0.0108

ppp-0-15-0

AU75

138

1,662

2.8

-

0.0090

ppp-0-15-0

AU60 / 5 Mgc

331

11,627

0.4

14

0.0110

ppp-0-15-0

AU75 / 5 Mgd

267

13,918

0.4

14

0.0880

Parameters obtained by global nonlinear least square analysis of sedimentation velocity experiments.
a
Maximum % RP2 relative to AU75 (in percent).
b
Root mean square deviation in absorbance units
c
20 mM HEPES pH 7.5, 60 mM NaCl, 5 mM MgCl2, 0.1 mM EDTA, 0.1 mM TCEP.
d
20 mM HEPES pH 7.5, 75 mM NaCl, 5 mM MgCl2, 0.1 mM EDTA, 0.1 mM TCEP.

Figure 3.4 Thermal denaturation analysis in the presence of Mg2+. (A) Absorbance melting
curves. Thermal denaturation was analyzed by monitoring the absorbance change at 260 nm at
a heating rate of 0.5 °C/min. Data were collected every 0.5 °C. The measurements were
conducted in 20 mM cacodylic acid (pH 7.5), 75 mM NaCl, 0.1 mM EDTA +/- 5 mM MgCl2. The
absorbance of each sample was 0.5 OD. (B) First derivative of the melting curves. The
derivative curves were smoothed by boxcar averaging over a 5°C window.
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3.7 Effect of tail truncations.
We further examined the contribution of each single-stranded tail to binding affinity and
activation by creating a series of ss-dsRNAs with 5 nt incremental symmetric and asymmetric
truncations of the tails. The portfolio of ss-dsRNAs was designed to resolve the minimum length
requirements for activation and test whether the 5′- and 3′-tails are equivalent in their
contribution to affinity and activation. Measurements were obtained in AU75 to investigate
whether ss-dsRNAs exhibit a similar correlation between %RP2 and activation potency as we
have previously observed with duplex RNAs (62, 63). Figure 3.5 shows the RNA concentration
dependence of activation for all of the tail truncation constructs. Panels C and D show the
effects of a series of 5 nt incremental truncations made to either 5′ or 3′ tail while maintaining
the 15 nt opposing tail length. Some RNAs exhibit a bell shape activation profile while other
activation profiles show a monotonic increase with RNA. The absence of a maximum in the
activation profile is correlated with weaker binding (vide infra). Activity measurements at ssdsRNA concentrations greater than 1.5 µM are precluded by potential dimerization of the selfcomplementary sequences. Truncation of either tail leads to a gradual decrease in activation
potency indicating a direct relationship between tail length and stimulation of enzymatic activity.
Truncations made to the 5′ tail have a slightly greater effect on PKR activation than those made
to the 3′ tail. In particular, ppp-15-15-5 retains its ability to activate PKR where little or no
activation is detected for ppp-5-15-15.
Figure 3.5B shows the percentage of PKR molecules contained in the RP2 species
plotted as a function of RNA concentration for the 3′-tail truncation series. The distributions
mirror the trend in the activation plot (Fig. 3.5C). Binding affinity, and maximum %RP2, decrease
in parallel with activation potency as the 3′-tail is reduced in 5 nt increments (Table 3.4).
However, the correlation does not hold for the 5′ tail truncation series (Fig. 3.5D). ppp-10-15-15
exhibits weaker PKR binding than the full-length ss-dsRNA, removal of an addition 5 nt from the
5′-tail results in enhanced affinity such that the ppp-5-15-15 has a maximal %RP2 close to ppp44

15-15-15. Despite the similar population of the RP2 species, ppp-15-15-15 is a potent activator
whereas ppp-5-15-15 fails to activate, indicating that these parameters are not well correlated
for all ss-dsRNAs.
The next series of truncations were made to both tails. Activation plots are grouped
according to the symmetry of the truncations. Asymmetric truncation (Fig. 3.5E) to produce ppp5-15-10 shifts the maximum to slightly higher RNA concentration whereas ppp-10-15-5 shows
weaker activation. The effects of symmetric truncation (Fig. 3.5F) of both tails are more
dramatic:

deletion to 10 nt or less essentially abolishes activation. Within the asymmetric

truncation group the relative binding affinity and activation potency are somewhat correlated:
ppp-5-15-10 populates a higher percentage of RP2 and is a more potent activator than ppp-1015-5 (Table 3.4). The correlation is less clear for the symmetric constructs. PKR binding to ppp10-15-10 is only slightly reduced relative to the parent ppp-15-15-15 yet it does not activate.
Curiously, addition of three nucleotides to create 13-15-10 restores stimulatory properties (Fig.
3.5G).
Table 3.4 PKR binding to tail truncation constructs measured in AU75.
RNA

Kd1 (nM)

Kd2 (nM)

Maximum % RP2a

RMSDb

ppp-15-15-15

4 (2, 6)

294 (252, 343)

12.9

0.00821

ppp-10-15-15

30 (21, 41)

685 (581, 812)

6.4

0.00859

ppp-5-15-15

31 (22, 43)

272 (225, 329)

13.7

0.00870

ppp-15-15-10

4 (2, 6)

483 (418, 557)

8.6

0.00579

ppp-15-15-5

20 (13, 28)

647 (558, 752)

6.7

0.00782

ppp-13-15-10

93 (64, 133)

601 (475, 776)

7.2

0.00655

ppp-13-15-5

95 (67, 136)

358 (273, 472)

11.1

0.00697

ppp-5-15-10

49 (38, 62)

520 (440, 617)

8.1

0.00645

ppp-10-15-5

30 (21, 41)

1062 (885, 1280)

4.3

0.00679

ppp-10-15-10

22 (11, 37)

400 (323, 498)

10.1

0.00821

ppp-5-15-5

67 (43, 99)

838 (650, 1094)

5.3

0.00848

Parameters obtained by global nonlinear least square analysis of sedimentation velocity experiments.
The values in parentheses represent the 95% joint confidence intervals obtained using the F-statistic.
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a

The maximum population of the RNA-PKR2 species calculated from Kd1 and Kd2 at the concentration of
PKR used in activation assays (100 nM).
b
Root mean square deviation in absorbance units.

Figure 3.5 Activation of PKR by tail truncation constructs in 75 mM NaCl. (A)
Phosphorimages for one of the three experiments quantified in panels C-F. Experiments were
performed in AU75 buffer plus 5 mM MgCl2 at 32 °C. Activation is monitored by incorporation of
32
P. Each reaction contains 100 nM PKR, 400 µM ATP, 2 µCi γ-32P-ATP, and the indicated
amount of RNA. (B) Simulated distribution of RP2 species. Kd measurements presented in
Tables 3.2 and 3.4 were used to solve for the percentage of PKR molecules contained in the
RP2 species as a function of RNA concentration. PKR concentration was held at 100 nM. The
maximum %RP2 for each distribution is indicated on the graph. Distributions produced in Igor
Pro (Wavemetrics Inc.). (C-F) Quantification of 32P incorporation. The signals quantified by
phosphorimager analysis were normalized to the 32P incorporation in control samples containing
100 nM 15-15-15 (lane 4 in panel A). Error bars represent the standard deviation of three
experiments. (C) 3′ tail truncations. (D) 5′ tail truncations. (E) Asymmetric truncations to both
tails. (F) Symmetric truncations to both tails. (G) Activation by 13-15-10 and 13-15-5. The
standard for activation, 15-15-15, was not included in these assays. The data are plotted as raw
counts.
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3.8 Effect of stem truncations
The effects of decreasing the length of the duplex stem were investigated by creating
ppp-15-10-15 and ppp-15-5-15. PKR is potently activated by ppp-15-10-15 with a maximum
level about equal to the control ss-dsRNA (Fig. 3.6). Further reduction of the stem to 5 bp
abolishes RNA-induced autophosphorylation. In the case of the stem deletions, the binding
affinities correlate with activation. For the 10 bp stem construct, Kd1 is increased somewhat but
Kd2 is essentially unchanged, resulting in a similar %RP2. For the 5 bp construct, both Kd values
are significantly increased, consistent with the loss of measureable activation.
Table 3.5 PKR binding to stem truncation constructs measured in AU75.
RNA

Kd1 (nM)

Kd2 (nM)

Maximum % RP2

RMSDa

ppp-15-15-15

4 (2, 6)

294 (252, 343)

12.9

0.00821

ppp-15-10-15

72 (44, 115)

303 (201, 458)

12.6

0.0103

ppp-15-5-15

118 (93, 150)

853 (673, 1103)

5.3

0.00667

ppp-0-5-0

5402 (4929, 5896)

-

-

0.00460

Parameters obtained by global nonlinear least square analysis of sedimentation velocity experiments.
The values in parentheses represent the 95% joint confidence intervals obtained using the F-statistic.
a
Root mean square deviation in absorbance units.

Figure 3.6 Activation of PKR by stem truncation constructs in 75 mM NaCl. (A)
Phosphorimage for the data quantified in panel B. Experiments performed as described in
Figure 3.5 (B) Quantification of 32P incorporation. The signals quantified by phosphorimager
analysis were normalized to the 32P-incorporation in control samples containing 100 nM 15-1515 (lane 4 in panel A). Error bars represent the standard deviation of three experiments.
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3.9 0-5-0: A 5 bp stem loop
The dsRBD binding footprint is ~15 bp (143) so it is surprising that 15-5-15
accommodates multiple PKRs with relatively high affinity. To gain insight into the contribution of
the single stranded regions to affinity and stoichiometry we prepared a 5 bp stem loop construct
lacking the flanking tails (0-5-0). Analysis of PKR binding was complicated by the propensity of
the construct to dimerize. Decreasing the RNA refolding and assay concentration minimized the
relative population of the dimeric species. However, at the concentrations required for
absorbance detected sedimentation velocity, a significant population of the dimeric species
persisted (~10 %). The g^(s*) distributions for 0-5-0, PKR mixtures are shown in Figure 3.7A
with 15-5-15 in 3.7B for comparison. The distributions are plotted on the same x-axis scale to
highlight the difference in binding stoichiometries. Only one PKR binds 0-5-0 to shift the
distribution to a maximal sedimentation coefficient of ~4 S whereas distributions containing 155-15 are shifted to a limiting sedimentation coefficient of ~6.5 S due to sequential binding of two
PKR molecules. Depletion of the RNA peak upon PKR addition provides a qualitative
assessment of the relative binding affinities. Freely sedimenting 15-5-15 is depleted by addition
of 1.5 equivalents of PKR however 0-5-0 requires ~10 equivalents to achieve similar reduction.
This behavior is reflected in the fitted dissociation constant reported in Table 3.5. Due to the
contaminating dimer the 0-5-0 affinities should be interpreted with some trepidation. The fitting
procedure cannot differentiate whether PKR binds the monomeric or dimeric form of the RNA
and parameters for the monomeric form were used in the fit. Regardless of which form PKR
interacts with the data provide further evidence for single stranded interactions. In the context of
a 15 bp duplex the single stranded regions confer increased affinity (15-15-15 and 0-15-0, Table
3.2). Yet when appended to a 5 bp duplex the single-stranded regions provide additional binding
sites resulting in both increased affinity and stoichiometry.
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Figure 3.7 Contribution of single stranded regions to PKR binding a 5 bp duplex. g^(s*)
distributions normalized by area are shown for (A) 0-5-0 and (B) 15-5-15. The sequence and
predicted secondary structure of the RNA constructs are shown in each panel. The 0-5-0 data
were obtained with a rotor speed of 50,000 rpm whereas the 15-5-15 data were obtained at
40,000 rpm. Higher rotor speed leads to decreased diffusional broadening making the 0-5-0
distributions narrower. The 0-5-0 data were fit to an association model in SEDANAL where a
single PKR binds. The resulting parameters are reported in the Table 3.5 and in Appendix 2.
3.10 Interaction of dsRBD with ss-dsRNAs
Tail truncation leads to decreased binding affinity and reduced activation potency even
though PKR lacks a defined ssRNA binding motif. We performed binding experiments with a
domain construct of the dsRBD (residues 1-184) to investigate whether this is the region on
PKR which interacts with ssRNA. Binding affinities were determined for 15-15-15 and 0-15-0
and reported with the corresponding measurements obtained for the full length protein in Table
3.6. Unlike the full length protein, our measurements detect a weak, third binding event in the
mixture of the dsRBD and 15-15-15 resulting in the RP3 species. Steric occlusion by the linker
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and kinase domain may prevent the interactions which facilitate RP3 formation in the context of
the full length protein. Alternatively, the RNA may interact with regions outside the dsRBD so
that the full length protein occupies a larger footprint than the isolated dsRBD construct
preventing formation of the RP3 species.
Similar to the full length protein, the dsRBD binds to 15-15-15 with higher affinity than 015-0 indicating that the dsRBD interacts with single stranded regions. However, the increase in
affinity for 15-15-15 is not nearly as dramatic as is seen in the full length protein. The relative
affinities of the first binding event provide evidence that the single stranded regions also engage
PKR outside of the dsRBD. The values of Kd1 for full length PKR binding 0-15-0 and dsRBD
binding to both 15-15-15 and 0-15-0 are all similar. However, Kd1 for interaction of full length
PKR with 15-15-15 interaction is ~28-fold tighter indicated a significant contribution of the
single-stranded regions. These observations are corroborated in Chapter 4 where an RNA
binding region is identified near the N-terminus of the kinase domain.
Table 3.6 dsRBD and full length PKR binding to 15-15-15 and 0-15-0 measured in AU75.
Protein

RNA

Kd1 (nM)

Kd2 (nM)

Kd3 (nM)

RMSDa

Full length

ppp-15-15-15

4 (2, 6)

294 (252, 343)

-

0.00821

Full length

ppp-0-15-0

-

0.00906

dsRBD

ppp-15-15-15

111 (76, 160)

190 (121, 279)

dsRBD

ppp-0-15-0

218 (155, 300)

1097 (961, 1249)

138 (105, 178) 1662 (1311, 2131)

2784 (2102, 3930) 0.00358
-

0.00493

Parameters obtained by global nonlinear least square analysis of sedimentation velocity experiments.
The values in parentheses represent the 95% joint confidence intervals obtained using the F-statistic.
a
Root mean square deviation in absorbance units.

3.11 5′-Triphosphate
It has been reported that a 5′-triphosphate (5′-ppp) is crucial for activation of PKR by
canonical ss-dsRNAs as well as ssRNAs containing short duplexes (78, 131). Host RNAs are
typically capped at their 5′-end prior to export into the cytoplasm while most viral RNAs contain
a 5′-ppp. Thus, the 5′-ppp is an important motif which provides the host cell with a structural
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element to discriminate between self and non-self RNA (79). Because of the critical role
ascribed to the 5′-ppp in the context of ss-dsRNAs and the function of PKR in the innate
immunity pathway (80), we have investigated the contribution of 5′-ppp to PKR binding and
activation. The series of experiments which emerged from some preliminary measurements are
separated for organizational purposes into three sections: 3.11 5′-Triphosphate, 3.12 Synthetic
RNA, and 3.13 Tetraloop. However, each section is inherently linked and briefly summarized
here so that the reader can be mindful of the results. Our experiments indicate that
dephosphorylation of in vitro transcribed (IVT) ss-dsRNAs does not inhibit PKR stimulation.
Curiously, synthetic versions of ss-dsRNAs containing either a 5′-ppp or 5′-OH do not activate
PKR. This surprising and alarming result was not revealed until an important control experiment
was performed while investigating the role of the tetraloop. ss-dsRNAs lacking a tetraloop were
created by annealing two synthetic RNAs and do not activate PKR. However, ligation of the loop
does not restore activation. The corresponding ∆-tetraloop constructs were created by in vitro
transcription and exhibit the same phenotype as their synthetic counterparts. The constructs fail
to activate and cannot be rescued by ligation. In summary, RNAs which should be chemically
identical exhibit different stimulatory effects which are dependent on the method of production.
Only ss-dsRNAs produced in their entirety by in vitro transcription activate PKR. The
experiments described in the following sections seek to establish protocols for complete 5′dephosphorylation and identify the chemical differences between IVT and synthetic RNA.
RNAs transcribed by T7 RNA polymerase contain a 5′-triphosphate. Constructs were
converted to the 5′-OH form by dephosphorylation with calf intestinal alkaline phosphatase
(CIP). Dephosphorylation of ppp-15-15-15 and ppp-5-15-10 by treatment CIP has no significant
effect on the extent of PKR activation (Fig. 3.8A). Several experiments verify that the 5′-ppp is
removed by the phosphatase. ppp-15-15-15 and ppp-5-15-10 cannot be labeled with a 5′-32P by
treatment with T4 polynucleotide kinase and [-32P]ATP because of the presence of a 5′-ppp,
but the corresponding dephosphorylated RNAs are substrates (Fig. 3.8B). Additionally, an ss51

dsRNA labeled during in vitro transcription in the presence of [-32P]GTP displays complete
removal of the 5′-ppp after phosphatase treatment (Fig. 3.8C), indicating that the activity of the
5′-OH RNAs is not due to the presence of residual triphosphate-containing RNA. RNAs used in
this study are produced by transcription off a template that encodes the HDV ribozyme at the 3′end of the transcript. The ribozyme is included to circumvent the problem of 3′-end
heterogeneity which can plague RNA production using standard run-off transcription techniques
(108). Cleavage results in a 2′-3′-cyclic phosphate (144) and we postulated that it may
compensate for the absence of the 5′-triphosphate. RNAs are treated with CIP to
dephosphorylate the 5′-end yet the activity of CIP on 2′-3′-cyclic phosphates is unknown. T4
polynucleotide kinase (PNK) possesses a phosphatase domain specifically evolved to liberate
2′-3′-cyclic phosphates (113, 145). The phosphatase activity can be promoted by altering the
reaction conditions and dephosphorylation can be monitored by a slight mobility shift in a urea
PAGE gel (109). We subjected 15-15-15 to sequential treatments with T4 PNK then CIP to
dephosphorylate both 5′- and 3′-termini. PNK treatment results in a slight retardation of
migration in a urea PAGE gel (Fig. 3.8D). Consistent with other reports, subsequent
dephosphorylation of the 5′ end with CIP results in faster migration in urea PAGE (Fig 3.8D, Fig.
3.10B) (146, 147). The relative migration differences indicate that the enzymatic treatments are
resulting in the expected activities and the complete shift of the bands provides evidence that
the reactions are complete. Neither treatment results in a loss of PKR stimulation (Fig. 3.8E).
Finally, MALDI-ToF mass spectrometry analysis provides further evidence that CIP treatment
results in homogenous dephosphorylation of both ppp-15-15-15 (Fig. 3.8G) and ppp-5-15-10
(Fig. 3.8F). CIP treated RNAs exhibit a mass decrease of 300-315 Da consistent with the
removal of both 5′-ppp and 2′-3′ cyclic phosphate (predicted change of 300 Da). These control
experiments indicate that activation by enzymatically dephosphorylated ss-dsRNAs is not due to
a residual population of 5′-ppp.
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Removal of the 5′-ppp does affect PKR binding affinity (Table 3.7). Kd1 increases about
10-fold and Kd2 increase slightly. However, the maximum %RP2 does not change substantially
and the binding parameters remain in the range of ss-dsRNAs that activate, such as ppp-15-155 and ppp-5-15-10.
Table 3.7 PKR binding to in vitro transcribed and synthetic HO-15-15-15 measured in AU75.
RNA

Kd1 (nM)

Kd2 (nM)

Maximum % RP2

RMSDa

IVT ppp-15-15-15

4 (2, 6)

294 (252, 343)

12.9

0.00821

IVT HO-15-15-15

36 (26, 49)

411 (357, 473)

9.9

0.00861

Synthetic HO-15-15-15

28 (21, 37)

481 (421, 551)

8.7

0.00754

Parameters obtained by global nonlinear least square analysis of sedimentation velocity experiments.
The values in parentheses represent the 95% joint confidence intervals obtained using the F-statistic.
a
Root mean square deviation in absorbance units.
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Figure 3.8 Activation by ss-dsRNAs does not require a 5′-triphosphate. (A) Activation by
5′-ppp and 5′-OH ss-dsRNAs. 5′-OH RNAs were prepared by treatment with CIP. Samples
contain 300 nM RNA. Autophosphorylation activity is indicated under the gel as a percentage
normalized to activation by ppp-15-15-15. (B) Assay for dephosphorylation by 5′-32P labeling by
T4 PNK. RNAs containing a 5′-OH are substrates for T4 PNK whereas 5′-ppp prevents
phosphorylation. (C) A ppp-18-15-15 RNA containing a 32P at the 5′-γ-phosphate was
incubated with Antarctic phosphatase at 37 °C. Aliquots were removed at time points as
indicated in the figure and quenched with denaturing gel loading buffer and resolved by 10%
TBE-Urea PAGE. The gel was exposed to a phosphor screen and scanned on a Typhoon
phosphoimager. Removal of the 5′-ppp is complete at 30 min. γ32P-labeled 18-15-15 was made
by in vitro transcription in the presence of γ-32P GTP. RNAs dephosphorylated by Antarctic
phosphatase activates PKR. (D) Sequential enzymatic treatment of 15-15-15 visualized by a
slight mobility change by 12% TBE-Urea PAGE. (E) Activation by the enzymatically treated 1515-15 shown in (D). In the mock reactions, 15-15-15 was submitted to the enzymatic reaction
conditions but enzyme was not added. Autophosphorylation activity is indicated under the gel
as a percentage normalized to the initial RNA sample labeled as ‘Standard’. (F) MALDI-ToF
analysis of dephosphorylation of ppp-15-15-15. RNAs. (G) MALDI-ToF analysis of
dephosphorylation of ppp-5-15-10. ppp-15-15-15 exhibits a mass loss of 300 Da and ppp-5-1510 exhibits a mass loss of 315 Da. The predicted mass loss is 300 Da (removal of the 5′-ppp
and the 2′-3′-cylic phosphate resulting from HDV ribozyme cleavage).
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3.12 Synthetic RNA
Chemical oligonucleotide synthesis provides a mechanism to produce RNAs of defined
sequence devoid of terminal phosphates. We obtained synthetic RNAs to directly test 5′triphosphate dependence after initial dephosphorylation reactions failed to deactivate ssdsRNAs produced by IVT. Synthetic versions of two potently activating RNAs, 15-15-15 and 515-10, were acquired from two different commercial entities. 15-15-15 was supplied by
Dharmacon and 5-15-10 was obtained from Integrated DNA Technologies. Both RNAs contain a
5′-OH. Binding affinity measurements detect a similar reduction in affinity for synthetic HO-1515-15 as was observed for IVT HO-15-15-15 supporting the idea that PKR recognizes the 5′ppp (Table 3.7). Despite similar binding behavior, the two forms of 5′-OH RNA differ in their
stimulatory properties. As shown in Figure 3.9A the synthetic forms of both 15-15-15 and 5-1510 fail to activate while the IVT versions potently stimulate PKR in the same assay.
Furthermore, synthetic HO-15-15-15 inhibits activation by IVT ppp-15-15-15 (Fig. 3.9B). The
inhibition potency provides additional evidence that activation by 5′-OH IVT RNA is not due to
residual 5′-ppp. In a mixture containing equal concentrations of synthetic and IVT 15-15-15, the
activity is reduced by ~37 % (Fig. 3.9B). Dephosphorylation reactions induce no reduction in
activity (Fig. 3.8A) implying the reactions are very inefficient or that synthetic and IVT HO-15-1515 are not chemically equivalent. Finally, we have used enzymatic ligation to create synthetic
15-15-15 capped by a 5′-ppp yet this RNA also does not activate PKR. This evidence suggests
there are unidentified chemical differences between RNA produced by in vitro transcription and
chemical synthesis.
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Figure 3.9 Activation assays with synthetic RNA. (A) Activation by synthetic 5-15-10 and 1515-15. IVT versions are positive controls at 100 nM. (B) Inhibition of IVT ppp-15-15-15 by
synthetic 15-15-15. Samples contain 100 nM PKR and 100 nM IVT ppp-15-15-15 with a titration
of synthetic 15-15-15. Dashed lines indicate where blank lanes were cropped out of the gel.
Band intensity is quantified in the plot below the phosphorimage. Activation is expressed as a
percentage of the band intensity measured for the sample containing only IVT ppp-15-15-15
(lane 3).
Synthetic RNAs are available from a variety of commercial suppliers which typically
employ nucleoside phosphoramidite chemistry to build oligonucleotides. Synthesis reactions
vary depending on the commercial entity but all utilize a general organic synthesis protocol
which relies on selective deprotection to coordinate the appropriate coupling reactions between
nucleoside monomers and the oligonucleotide chain. The reaction scheme employed by
Dharmacon is summarized below (148, 149). The outline is meant to illustrate the complexity of
the procedure to support the hypothesis that chemical impurities can contaminate the synthetic
preparation and interfere with PKR activation. Oligonucleotide chains are assembled on a solid
phase support in the 3′- to 5′-direction. The building blocks are nucleoside phosphoramidites
which contain chemically protected functional groups to prevent undesired reactions. The
synthesis cycle involves addition of the desired nucleoside phosphoramidite and an activator
which catalyzes the coupling reaction between the newly added nucleoside and free 5′-OH on
the anchored oligonucleotide chain. Unreacted 5′-OH termini are chemically protected from
subsequent coupling steps via a reaction which yields a 5′-acetyl. Nucleosides successfully
coupled to the oligonucleotide contain a 5′-O-silyl ether which is converted to a 5′-OH for
subsequent coupling reactions in a reaction catalyzed by fluoride (triethylamine trihydrofluoride).
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The cycle is repeated until the desired chain length is achieved. Following synthesis, exocyclic
amines present on nucleotide bases are deprotected and the oligonucleotide is released from
the solid phase support. Dharmacon provides RNA in a form where the 2′-OH is chemically
protected (2′-ACE, 2′-O-bis(2-hydroxyethoxy)methyl orthoester) and is deprotected by the
customer with a mildly acidic aqueous solution. Production of synthetic RNA free of chemical
impurities is dependent on the use of pure ribonucleoside phosphoramidite building blocks and
complete deprotection of the appropriate functional groups during every phase of the synthesis
cycle. Mild reaction conditions are utilized to prohibit formation of undesired chemical adducts.
However, numerous impurities have been identified in chemically synthesized oligonucleotides.
These include shorter sequences resulting from incomplete chain elongation (150-152), various
protecting groups remaining from synthesis (150-152), depurinated bases (152), the presence
of 5-methylcytosine presumably from impure nucleoside phosphoramidite precursors (153), and
branched chain oligonucleotides where chain elongation occurs off a deprotected nucleobase
exocyclic amine (154, 155). PKR is sensitive to nucleoside modifications although the effects
manifest in the RNA stimulatory properties rather than binding affinity (82). This is potentially in
agreement with our observations where the synthetic and IVT forms bind with comparable
affinities yet exhibit different stimulatory phenotypes.
Analysis of RNA size and shape fails to identify any significant differences between the
IVT and synthetic forms. Urea-PAGE analysis of the 2′-ACE-protected form of 15-15-15
provided by Dharmacon indicates that nucleoside modifications can be detected by gel
migration differences. RNA containing the 2′-protecting group (2′-ACE) migrates faster through
the gel than RNA in the 2′-OH form (Fig. 3.10A). Presumably the increased electronegative
charge imparted by the protecting group causes faster migration through the gel. However, the
dephosphorylated IVT versions of both 15-15-15 and 5-15-10 run at the same position as their
synthetic equivalents in urea-PAGE (Fig. 3.8D and Fig. 3.10B). Hydrodynamic analysis 15-1515 by sedimentation velocity analytical ultracentrifugation detects slight variation between the
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synthetic and IVT forms (Fig. 3.10C). The sedimentation coefficient of synthetic HO-15-15-15 is
slightly lower than the IVT forms indicating either the synthetic form has a smaller molecular
weight or folds into a slightly more extended structure. Both IVT and synthetic forms of 15-15-15
produce similar digestion patterns from enzymatic structure probing experiments (not shown)
indicating cleavage is not affected by chemical impurities which may be present on the RNA.

Figure 3.10 Analysis of synthetic RNA. (A) 10% TBE-Urea PAGE analysis of protected (2′ACE) and deprotected (2′-OH) forms of 15-15-15. Note that the deprotected RNA was analyzed
directly after the deprotection reaction. RNAs are purified before use by urea PAGE to eliminate
the impurities that are present on the gel. (B) 12% TBE-Urea PAGE analysis of 5-15-10. An in
vitro transcription reaction is shown along with purified ppp-5-15-10 and dephosphorylated IVT
HO-5-15-10. The dephosphorylated RNA co-migrates with synthetic HO-5-15-10. (C)
Sedimentation velocity analysis of 15-15-15. c(s*) distributions for IVT ppp-15-15-15, IVT HO15-15-15, and synthetic HO-15-15-15 are shown. Best fit sedimentation coefficients obtained by
fitting the time difference curves to an ideal species model in SEDANAL are shown in the plot.
Conventional binding assays and analytical ultracentrifugation measurements can
determine how many PKRs are bound to an RNA but do not directly assay dimerization via the
kinase domain interface. Therefore, we recently developed a sensitive homo-FRET anisotropy
assay to directly probe PKR kinase domain dimerization on RNAs (65). Activating duplex RNAs
containing ≥30 bp bind two PKRs and induce dimerization detected by depolarization of
fluorophore

emission

using

steady-state

anisotropy

measurements.

However,

some

nonactivating RNAs that also produce a high population of the RP2 species, as detected by
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analytical ultracentrifugation, either fail to induce dimerization or produce an alternative, inactive
dimer configuration. This behavior may rationalize the failure of synthetic RNA to induce
activation despite populating a similar amount of the RP2 species as IVT RNA (Table 3.7).
Figure 3.11 shows the anisotropy change upon addition of either IVT ppp-15-15-15 or synthetic
HO-15-15-15. The amplitude is the same for both RNAs although the IVT form achieves its
maxima at slightly lower RNA concentrations. By all measurements synthetic HO-15-15-15
should activate to a similar extent as IVT ppp-15-15-15. Both RNAs populate a similar amount
of RP2 species as measured by analytical ultracentrifugation and both induce kinase domain
dimerization to a similar extent. The nature of the chemical differences between IVT and
synthetic RNA forms remains elusive.

Figure 3.11 Analysis of kinase domain dimerization on 15-15-15 measured by homo-FRET
anisotropy. Alexa Fluor 488 is conjugated to p-azidophenylalanine which was incorporated at
position 261. Dimerization is detected by a change in anisotropy induced by depolarization of
homo-FRET emission (65). Samples contain 200 nM PKR and a titration of RNA. The assay
was performed in AU75 buffer at 20 °C. Both IVT 5′-ppp and synthetic 5′-OH 15-15-15 induce a
similar anisotropy change.
3.13 Tetraloop
There are 256 unique nucleotide combinations for tetraloop sequences yet detailed
analysis of 16S ribosomal RNA (156) and bacteriophage T4 mRNA (157) has revealed a biased
frequency toward certain nucleotide arrangements which can be categorized as 5′-UNCG-3′ or
5′-GNRA-3′ tetraloops (N = any nucleotide; R = purine). The bias is thermodynamic in origin and
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can be attributed to the stability conferred by noncanonical base pair interactions between
nucleotides in positions 1 and 4, 2′-OH hydrogen bonds, and base stacking (158). Structural
differences between UNCG and GNRA tetraloops arise from variations in sugar puckering and
glycosidic bond orientation primarily within nucleotides in positions 2 and 3 (159). These
nucleotides pucker out into the solvent to facilitate bending of the RNA backbone and present
an additional surface not present within duplex regions to stabilize protein interaction. Five
structures are available for dsRBDs bound to stem-loop RNAs and in four of the structures the
α1 helix interacts with nucleotides projecting from the loop, thereby orienting dsRBD binding
(Fig. 3.11A). In Rnt1p RNaseIII and ADAR2, the positioning of the dsRBD is believed to play a
functional role by orientating the catalytic domains for specific modification of the RNA substrate
(24, 25). There are some reports indicating that loops modulate PKR binding although the
functional relevance is unclear (26-28). Given that the dsRBD binding footprint is ~15 bp (143) it
is likely that PKR interacts with tetraloop residues during complex formation with ss-dsRNAs
containing shorter duplex regions. To test this interaction the tetraloop within the parental 15-1515 ss-dsRNA was altered. Figure 3.11B shows schematic representations of the constructs and
the nomenclature adopted to describe them. Tetraloop variations include changes to loop
sequence (GAAA and UUUU), deletion of the tetraloop (∆T), and broken loops with the tetraloop
sequence projecting from 5′-, 3′-, or both strands (5′-UCCG, 3′-UCCG, 5′/3′-UCCG).
The original 15-15-15 sequence contains a UNCG type tetraloop (5′-UCCG-3′). Versions
of 15-15-15 were made which contain the loop sequence 5′-GAAA-3′ or 5′-UUUU-3′ and
characterized by PKR binding affinity and activation measurements. The UUUU tetraloop is
expected to exhibit a greater degree of conformational flexibility (160, 161) due to the minimal
contribution of uridines to base stacking interactions (162). The constructs were created by in
vitro transcription. Perturbations to the loop sequence have a minimal effect on PKR binding
(Table 3.8) and activation (Fig. 3.11C).
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Figure 3.12 Characterization of the tetraloop. (A) dsRBD interactions with tetraloops. Rnt1p
RNase III dsRBD1 is shown on the left (1T4L) (47) and ADAR2 dsRBD1 on the right (2L3C)
(17). The nucleotide which puckers out of the tetraloop and contacts helix α1 is shown in red.
The length of the stem and tetraloop sequence is indicated underneath the structure. (B)
Schematic representation of constructs designed to probe the tetraloop. Coloring scheme is
maintained throughout the figure. (C) Activation assays. Constructs containing a broken loop
created by in vitro transcription (IVT) are assayed in the bottom gel. The data are quantified in
the plot beneath the gels. Data are normalized to the wild-type 15-15-15 construct labeled as
‘UCCG’ in each gel. (D) Inhibition of IVT ppp-15-15-15 by synthetic ∆T. (E) g^(s*) distributions
normalized by area comparing PKR interaction with 5′-UCCG (top) and 3′-UCCG (bottom).
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Constructs lacking or containing a broken loop were created by hybridizing two synthetic
oligonucleotides to mimic the loop containing 15-15-15. These constructs were analyzed prior to
recognition that the full-length synthetic ss-dsRNAs do not activate PKR. Constructs
corresponding to 5′-UCCG and ∆T were created by IVT; however, purity and yield from
purification were insufficient for detailed analysis. The material was used for activation assays
but binding experiments were not performed. Figure 3.11C shows the activity assays performed
with all the synthetic and IVT constructs. The synthetic constructs do not mediate activation
which is not surprising given the analysis of full-length synthetic constructs presented in the
previous section. Note, however, that the synthetic constructs analyzed here contain a 5′-ppp
whereas the full-length constructs contain a 5′-OH. Like the full-length synthetic constructs ∆T
inhibits activation mediated by IVT ppp-15-15-15 (Fig. 3.12D). The constructs created by IVT
also do not activate however a control ligation experiment presented below necessitates
cautionary interpretation of this result.
The binding affinity measurements are reported in Table 3.8. Deletion of the tetraloop
from 15-15-15 (∆T) reduces affinity of the first binding event by ~15-fold and decreases the
second by ~2-fold indicating that the loop contributes to complex formation. Constructs
containing a broken tetraloop exhibit drastically different binding behavior dependent on which
strand the loop sequence is placed on. A comparison of the g^(s*) distributions is shown in
Figure 3.12E. A construct containing the loop sequence on the 5′-strand (5′-UCCG) exhibits
similar binding behavior as the canonical 15-15-15 where two PKR monomers sequentially bind
to produce an RP2 species at ~8 S. The binding affinities are decreased, indicating PKR prefers
a folded structure at the top of the stem (Table 3.8). When the loop sequence protrudes from
the 3′-strand (3′-UCCG), mixtures containing a molar excess of PKR produce a larger species
which sediments at ~11 S. An appropriate model to describe the 3′-UCCG data was not
attained. Both the 5′-UCCG and 3′-UCCG constructs have nearly identical distributions for
mixtures containing 0.5, 1, and 1.5 equivalents of PKR. A cooperative transition appears to
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occur upon addition of 2 equivalents potentially indicating that the second PKR mediates a
structural alteration within the RNA which permits formation of higher order complexes. One
possibility is that PKR stabilizes an interaction analogous to kissing loop complexes (68) which
dimerizes the RNA via the broken tetraloop at the top of the stem. However, it is unclear why a
similar complex would not form with the 5′-UCCG construct. Equally puzzling is why a complex
of this nature, or any complex which mediates higher-order assembly of multiple PKR
molecules, does not stimulate activation. In the PKR mediated RNA dimerization scenario,
coaxial stacking of nucleotides at the top of the stem would form a 34 bp duplex interrupted by a
two nucleotide bulge in the center. Perfect duplexes 30 bp in length formed by hybridization of
synthetic oligonucleotides activate PKR (63).
Table 3.8 Effect of loop on PKR binding affinity measured in AU75 buffer.
Loop sequence

Kd1 (nM)

Kd2 (nM)

Maximum % RP2

RMSDa

UCCG

4 (2, 6)

294 (252, 343)

12.9

0.00821

GAAA

17 (12, 22)

345 (324, 366)

11.4

0.00753

UUUU

35 (28, 44)

319 (300, 339)

12.1

0.00798

∆Tb

68 (58, 81)

611 (579, 644)

7.1

0.00842

5′-UCCGb

112 (96, 131)

583 (548, 619)

7.4

0.00896

3′-UCCGb

NDc

NDc

-

-

Parameters obtained by global nonlinear least square analysis of sedimentation velocity experiments.
The values in parentheses represent the 95% joint confidence intervals obtained using the F-statistic.
Sedimentation coefficients are fixed to best fit values for UCCG: s (RP) = 4.88 S; s (RP2) = 8.02.
a
Root mean square deviation in absorbance units.
b
Denotes constructs created by hybridization of synthetic oligonucleotides. All RNAs contain a 5′-ppp.
c
An appropriate model to describe this interaction was not attained. Refer to Fig. 3.12E for g^(s*)
distributions.

Constructs corresponding to ∆T and 5′-UCCG that were created by IVT do not activate
PKR (Fig. 3.12C) suggesting that the loop is a critical element which mediates activation.
However, an essential control experiment disputes the relevance of this finding. Enzymatic
ligation of synthetic (3.13A) and IVT constructs (3.13D) does not restore PKR activation. The
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full length synthetic constructs previously analyzed contained a 5′-OH. However, the ligated
constructs contain a 5′-ppp. Failure to activate provides further evidence for the chemical
differences between IVT and synthetic forms. Analysis of the ligated RNA by denaturing gel
electrophoresis (3.13A, D) and mass spectrometry (3.13C) indicates that ligation was
successful, although the product was typically contaminated with the constituent single-stranded
RNAs. Purification of the ligated reaction by size exclusion chromatography or denaturing PAGE
did not rescue activation (not shown).

Figure 3.13 Ligation of the tetraloop. (A) Ligation of synthetic constructs. The ligation key
indicates the combination of tetraloop sequences which were ligated in the gel below. (B)
Activation on the ligation reactions shown in (A). (C) MALDI-ToF analysis of ligation #3 (5′UCCG). (D) Ligation of IVT RNA. The 5′-UCCG construct produced by IVT reactions was
ligated (left) and assayed for PKR activation (right)
3.14 Discussion
We have systematically dissected a model ss-dsRNA activator to determine the
contributions of the single-stranded tails, stem-loop, and the 5′-triphosphate to PKR activation
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and binding. The model ss-dsRNA activates PKR autophosphorylation strongly and the
presence of both flanking 5′- and 3′-ssRNA tails are required for activation. When either tail is
truncated, the activation potency drops with tail length and truncation of the 5′-tail is more
deleterious to activation than the 3′-tail. However, the effects of tail truncations are not simply
additive as the lengths of the tails are reduced.

For example, the symmetric construct

containing 10 nt 5′ and 3′ tails does not activate PKR yet ppp13-15-10, ppp13-15-5, ppp-10-155, and ppp-5-15-10 stimulate autophosphorylation. Activation is also sensitive to stem length:
the titration is shifted to higher RNA concentrations for the 10 bp construct and the 5 bp
construct is inactive.
The bell shaped curve for activation by ss-dsRNAs supports a model in which lower
RNA concentrations activate by inducing PKR dimerization and high RNA concentrations
dissociate active, RNA-bound PKR dimers onto separate molecules of dsRNA (61, 67).
However, at high salt (200 mM NaCl), our AUC experiments detect the binding of only one PKR
monomer to both activating and nonactivating RNAs. Possibly, the observed activation is
mediated by very weak binding of a second PKR monomer. At lower salt (75 mM NaCl) ssdsRNAs bind two PKRs. In cases where the binding affinity is strongly reduced, such that the
maximal RP2 <10%, activation is abolished or greatly attenuated. However, is it not possible to
predict activation based on Kd1, Kd2, or maximal % RP2 for the ss-dsRNAs with intermediate
binding affinities: some (e.g., ppp-5-15-15) are inactive and others (e.g., ppp-5-15-10) are quite
active. Thus, a threshold concentration of RP2 is required, but not sufficient, to elicit PKR
autophosphorylation by ss-dsRNA. Potentially, specific sequences in the tail regions may
contribute to the relative activation potencies.
Our results implicate the 5′- and the 3′- ssRNA regions in the mechanism of activation of
PKR by ss-dsRNAs. The presence of 5′- and 3′-tails in ss-dsRNAs enhance PKR binding affinity
suggesting that the tails directly bind to PKR. It has been reported that dsRNA binding domains
do not bind to ssRNA (163, 164) and PKR is not activated by ssRNAs (66, 165). However, our
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analysis of ssRNA interactions (presented in Chapter 4) reveals two regions on PKR which bind
ssRNA with micromolar affinity: the dsRBD and a basic region N-terminal to the kinase domain.
Complex formation with ss-dsRNAs is presumably mediated by the nanomolar affinity of the
dsRBD for duplex regions (104). Auxiliary interactions with single-stranded regions tethered to
the duplex would be promoted by the effect of increased localized concentration (166). An
isolated kinase domain construct containing the basic region is weakly stimulated by ssRNA. In
the context of full length PKR and ss-dsRNAs direct engagement of the basic region by the
single-stranded tails may elicit activation. The lack of correlation between tail length, binding
affinity, and activation potency for constructs with intermediate tail lengths may reflect specific
conformational requirements of the interaction.
There is evidence that the single-stranded regions may contribute to PKR activation in
complex, natural RNAs. In the context of perfect duplex dsRNA, a length of at least 30 bp of
dsRNA is required to activate PKR autophosphorylation (62-64). Interestingly, the length of the
duplex regions in several natural RNA activators of PKR, including HCV IRES (167, 168), TNF
mRNA (72), interferon- mRNA (6), and the 3′-UTR regions of several cytoskeletal muscle
mRNAs (3) are below the 30 bp required for PKR activation. Similarly, influenza B
ribonucleoprotein is a potent PKR activator that contains only a short 14-16 bp “panhandle"
(169). Thus, the single-stranded regions may contribute to PKR activation in these complex
natural RNAs.
It has been reported that a 5′-ppp is crucial for activation of PKR by the canonical ssdsRNAs as well as ssRNAs containing short duplexes (78, 131). In contrast, for RNAs produced
by in vitro transcription, we find that this moiety does not contribute to PKR activation and only
slightly affects binding affinity. RNAs produced by chemical synthesis do not activate in both 5′ppp and 5′-OH forms. We also obtain similar results using a previously described ss-dsRNA
(ss-dsRNA 9,11 see Fig. 1.4A) (77, 78). ss-dsRNA 9,11 activates PKR potently when prepared
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by IVT. However, the synthetic counterpart containing a 5′-OH does not activate.
Dephosphorylation reactions on the IVT preparation does not eradicate PKR activation (C.
Mayo and J.L. Cole, unpublished observations). snoRNAs, which contain short duplexes
interspersed with single-stranded regions, were recently reported to activate PKR. In some case
activation is dependent on a 5′-ppp whereas others are active in 5′-OH and 5′-p states (7),
suggesting that the structural context can modulate the triphosphate dependence. We are
currently investigating the chemical differences between synthetic and IVT RNAs.
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Chapter 4: Interaction with single-stranded nucleic acids
4.1 Introduction
Although the antiviral kinase PKR was originally characterized as a double-stranded
RNA activated enzyme it can be stimulated by RNAs containing limited secondary structure and
alternative structural elements are proposed to modulate activity. Single-stranded regions and a
5′-triphosphate appear to be an important determinant for activation yet PKR lacks defined
binding sites for both. Stimulatory RNAs typically originate from viral infection but several
endogenous RNAs have been identified as PKR activators (3-7). In addition to the canonical
activators containing ≥ 30 bp dsRNA regions, PKR is activated by RNAs that contain limited
secondary structure and include single-stranded regions or tertiary structure. Examples include
a 17 bp stem loop within the 3′-UTR of TNF-α mRNA (72), a pseudoknot within the 5′-UTR of
IFN-γ mRNA (4, 6), siRNAs containing short ssRNA overhangs (170, 171), several snoRNAs
induced under metabolic stress (7), and certain bacterial RNAs (172, 173). Notably, short stemloop RNAs with flanking ssRNA tails (ss-dsRNAs) have been identified as a potent PKR
activation motif (77, 78). Truncations to the ssRNA regions result in decreased binding affinity
and activation potency, and complete deletion of either the 5′- or 3′- flanking tail abolishes
activation (119). Surprisingly, a duplex region as short as 10 nt with 15 nt 5′- and 3′- flanking
tails binds two PKR monomers and functions as an activator. These observations imply that
single-stranded regions can play a role in RNA-mediated activation of PKR.
PKR does not contain a canonical ssRNA binding domain yet there is precedent for
ssRNA interactions with both the dsRBD and kinase domain. Complex formation between
ssRNAs and dsRBDs from other proteins has been reported (174, 175) although in one case
the dsRBD contained a novel C-terminal extension which coordinated a zinc ion as well as an
unusually long β1-β2 loop (175). PKR mutations within the dsRBDs that block dsRNA binding
do not prevent photocrosslinking to an RNA with minimal secondary structure, suggesting that
ssRNA binding may be mediated by other regions of the enzyme (131). Other potential
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interaction sites include a basic region adjacent to the N-terminus of the kinase domain (Fig.
4.1) that is important for kinase function (176) as well as a basic cleft lying on the kinase domain
which mediates heparin activation (91). The cluster of basic residues N-terminal to the canonical
kinase domain boundary was previously implicated in mediated PKR interactions with the
ribosome (177). In addition to dsRNA, PKR can be activated by other polyanions (89) the most
well characterized of which is heparin (90). The coarse structural similarity between ssRNA and
heparin suggests that they could share a similar binding site and activation mechanism.
Activation by heparin does not require the dsRBD (178) and the heparin binding site has been
mapped to multiple nonoverlapping basic sites within the kinase domain (91, 179).

A 5′-

triphosphate (5′-ppp) is reported to be critical for PKR activation by RNAs with limited secondary
structure, including the ss-dsRNA motif (7, 78, 131, 169, 172) (but see (119)). Duplex RNAs
exhibit no triphosphate dependence so it is likely that ssRNA and the 5′-ppp bind to the same
site (78).
Here, we seek to provide insight into the role of ssRNA and the 5′-ppp during enzymatic
activation by identifying the regions on PKR that interact with free ssRNA and the contribution of
the 5′-ppp on binding. We demonstrate that ssRNAs can bind to PKR at both the dsRBD and
the basic region with micromolar affinities and can induce activation of the isolated kinase
domain. Photocrosslinking measurements demonstrate that that the basic region interacts with
RNA in the context of full length PKR. We propose that bivalent interactions with the double
stranded RNA binding domain and the basic region underlie the ability of RNAs containing
limited structure to activate PKR by enhancing binding affinity and thereby increasing the
population of productive complexes containing two PKRs bound to a single RNA. Our data
support a model where PKR activation by RNAs is regulated in vivo by interaction with both
duplex and single-stranded regions.
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Results
Based on the critical contribution of single-stranded regions to the binding and activation
of PKR by ss-dsRNAs, we have investigated the interactions of PKR with isolated ssRNAs.
Domain constructs, depicted in Figure 4.1, are used to localize the ssRNA binding site on the
full length protein. The Results section begins with an analysis of the individual components
used in the interaction studies. While somewhat tangential to the present study, a previously
unappreciated role for the basic region during enzymatic activation is identified.

Figure 4.1 PKR domain schematic. (A) PKR domain organization. Canonical domain
boundary positions are indicated above each domain. (B) Linker sequence alignment. The
alignment was generated with ClustalW (180) and prepared in JalView (181). Residues are
colored using the Zappo coloring scheme. (C) PKR domain constructs used in this study. (D)
Nucleic acids used in this study.
4.2 Characterization of protein constructs
This study utilizes a number of protein constructs which have never been created in our
laboratory. Characterization of both their hydrodynamic and catalytic properties were a
necessary prerequisite to analysis of nucleic acid interactions. Notably, active kinase domain
constructs were created by insertion of a TEV protease site into full length PKR which is cleaved
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during the purification procedure to liberate the kinase domain. This circuitous methodology was
required due to low yield of the isolated kinase domain when expressed in E. coli. Presumably
the autocatalytic activities of the kinase domain are deleterious to expression since constructs
containing the inactivating mutation K296R are not problematic (59). Sedimentation velocity
analysis indicates each of the constructs is homogeneous and monomeric up to the highest
concentration assayed in nucleic acid binding measurements (Fig. 4.2A, Table 4.1). The RNAindependent autophosphorylation activities were measured by the protein concentration
dependence on

32

P incorporation and reveal a previously unappreciated contribution of the

basic region to enzymatic activation. Samples were resolved by SDS-PAGE and imaged by
Sypro Orange protein staining and phosphor screen exposure. The protein stain confirms that
equivalent amounts of each construct are added to the appropriate lanes. Relative yields of

32

P

incorporation indicate the basic region contributes to enzymatic activity. The 242-kinase domain
construct lacking the basic region requires ~3-fold higher protein concentrations to achieve
similar levels of phosphorylation activity as the 229-kinase construct (Fig. 4.2D). In full length
constructs deletion of variable lengths of the basic region cause a similar reduction in activity
(Fig. 4.2E). The 229-kinase construct requires ~3-fold more protein than full length PKR to
achieve similar levels of

32

P incorporation (compare D and E). Note however that PKR contains

14 autophosphorylation sites and the full length enzyme contains more phosphorylation sites
per mole than the kinase domain constructs (182). It is likely that this difference contributes to
increased PKR autophosphorylation. In contrast, 229-kinase and 242-kinase contain the same
number of phosphorylation sites so that the differences in the extent of phosphorylation can be
attributed to a difference in intrinsic activity. The contribution of the basic region to activation is
unclear although it is adjacent to the dimer interface and stabilization of the dimer would
presumably lead to enhanced activity.
The full length protein constructs containing TEV cleavage sites provide a method to
map PKR phosphorylation sites with very course resolution. The data indicate that the previous
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assignment of 14 autophosphorylation sites (182) is underestimated. Full length constructs with
a cleavage site located at position 185, 229, or 242 were phosphorylated, cleaved with TEV,
and resolved by SDS-PAGE. The gel was stained with Sypro Orange and exposed to a
phosphor screen. Both images are shown in Figure 4.2F. The N-terminal portion of cleaved
PKR containing the dsRBD stained poorly with Sypro Orange and its position is indicated by a
yellow arrow. Protein fragments resulting from cleavage at positions 185 and 229 can be
resolved in both images yet the N- and C-terminal fragments which arise from 242 cleavage
cannot be resolved in the phosphor image. The relative intensities of the cleavage fragments
indicate that a majority of autophosphorylation sites are located in the linker region between
residues 185 and 229 (Figure 4.2E). When cleaved at position 185 the C-terminal fragment
containing the linker and kinase domain produces ~70% of the measured signal. Cleavage at
position 229 inverses the relative intensities so that the N-terminal fragment which now consists
of the linker and dsRBD contains ~90% of

32

P. Analysis of PKR phosphorylation sites by mass

spectrometry identified 14 sites with 71% coverage of the total sequence (182). Yet the missing
segment of the analysis corresponds primarily to residues 175-233 which is overrepresented in
serine and threonine residues (Fig. 4.1). TEV cleavage of phosphorylated constructs provides
only course resolution of the phosphorylation sites yet indicates the linker is the most heavily
phosphorylated portion of PKR.
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Figure 4.2 Characterization of protein constructs. (A) Sedimentation velocity analysis of
PKR domain constructs. g^(s*) distributions are normalized by area. Protein concentrations:
PKR, 16 µM; kinase domain constructs, 30 µM; dsRBD, 12 µM. Fits reported in Table 4.1. (B-E)
RNA-independent autophosphorylation of PKR constructs. Samples were resolved by SDSPAGE and stained with Sypro Orange to visualize protein and exposed to a phosphor screen to
measure autophosphorylation. Kinase domain constructs are shown in (B). Wild-type PKR and
constructs containing internal deletions are shown in (C). Protein stain is shown on the top and
phosphorimage is shown on the bottom. The marker band, M, in (C) corresponds to BSA (66
kDa). (D, E) Quantitation of 32P incorporation and Sypro stain as a function of protein
concentration. Kinase domain constructs are shown in (D) and full length constructs are shown
in (E). The data are plotted on a log-log scale. 32P data are shown as a solid line and the Sypro
intensities are shown as a dashed line. (F) TEV cleavage of phosphorylated PKR. Two images
of the same gel are shown with Sypro Orange protein stain on the left and phosphorimage on
the right. Molecular weights of the Mark 12 protein ladder are indicated. TEV protease is present
in each lane and runs at ~30 kDa. The position of the cleaved fragment containing the dsRBD is
indicated by a yellow arrow. (G) Quantitation of 185 and 229 cleavage positions. Normalized to
the sum of the intensity of the cleaved fragments.
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Table 4.1 Sedimentation velocity analysis of PKR domain constructs.
Protein

Predicted
Massa

Fitted Mass

s20,w
(Svedbergs)b

RMSDc

dsRBD

20,262

19,797

1.83

0.0061

242-kinase

35,811

32,830

2.89

0.0207

229-kinase

37,436

38,608

2.91

0.0168

185-kinase

41,907

41,626

2.92

0.0221

Full lengthd

62,095

60,774

3.71

0.0211

Parameters obtained by global nonlinear least square analysis of the sedimentation velocity data to a
single ideal species model. Protein concentrations used in the global analysis: dsRBD, 12 µM; kinase
domains, 5, 15, 30 µM; Full length PKR, 16 µM
a
Masses predicted based on amino acid sequence.
b
Sedimentation coefficient corrected to standard conditions (water at 20 °C).
c
Root mean square deviation in fringes.
d
Data from (91)

4.3 Characterization of ssRNAs
Experiments were initially performed with the heteropolymeric synthetic oligonucleotide
used to create the 5′ side of the 15-15-15-∆T construct (Chapter 3). The RNA was available in
both 5′-ppp and 5′-OH forms and was used to probe the contribution of the triphosphate to
binding energetics. At the temperature that binding affinities were measured (20 °C), the
heteropolymeric sequence is predicted to fold into two short duplex regions 2 and 3 bp in length
(133) (Fig. 4.3A). However, the Gibbs free energy of the structure (-4.01 kcal/mol) indicates the
folded form is not stable. Thermal denaturation results in a slight absorbance increase that
could be associated with weak secondary structure formation or unstacking but there is no
transition which can be assigned to cooperative unfolding (Fig. 4.3B). Transient duplex
formation could possibly be further stabilized by PKR binding. To confirm that interactions are
specific for single stranded regions we repeated binding analysis with homopolymers of
uridylate which should exhibit minimal structure due to lack of stacking interactions between
uridines (162). Thermal denaturation of a 30 nt poly-uridylate (U30) verifies the absence of
structure (Fig. 4.3B). The small absorbance decrease can be attributed to thermal expansion of
the solution.
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Figure 4.3 Thermal denaturation analysis of ssRNAs. (A) Predicted secondary structure of
Het30. Secondary structure was computed at 20 °C using MFOLD (133). The free energy of
folding is -4.01 kcal/mol. (B) Absorbance melting curves. Thermal denaturation was analyzed by
monitoring the absorbance change at 260 nm at a heating rate of 0.5 °C/min. The
measurements were conducted in 10 mM NaPO4 (pH 7.0) with 0.1 mM EDTA.
4.4 Analysis of protein:nucleic acid interactions
Protein:nucleic acid interactions were monitored by sedimentation velocity analytical
ultracentrifugation in order to detect transient, lower affinity interactions that may not be reliably
measured in gel shift (183) or filter binding (184) assays. All of the interactions reported in this
chapter are weak and rapidly reversible. Reequilibration of the complexes during sedimentation
results in sedimentation profiles which represent reaction boundaries rather than discrete
species. The shape of the reaction boundaries are a representation of both the sedimenting
particles and association kinetics. In some cases, this behavior led to cross correlation between
the dissociation constants and complex sedimentation coefficients during the fitting procedure
making assignment of the sedimentation coefficients a critical determinant of affinity and
complex stoichiometry. To interpret the data, we chose an approach that would emphasize
comparison of binding affinities for different nucleic acids to different regions of PKR.
Sedimentation coefficients of complexes were fixed so that their frictional coefficient (f/fo) was
1.5 which is typically what we observe for protein:RNA complexes (138). This was often in good
agreement with fitted sedimentation coefficients for systems which exhibited stability during the
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fit. The fitted dissociation constants for all the protein:nucleic acid mixtures reported in this
Chapter are presented together in Table 4.2 so they may be readily compared. The
sedimentation coefficients used in the fits can be found in Appendix 2.
Table 4.2 Sedimentation velocity analysis of PKR constructs binding to RNA.
Protein

Nucleic Acid

Kd1 (µM)

Kd2 (µM)

RMSDa

Full length

U30

3.51 (3.49, 3.52)

39.9 (39.4, 40.5)

0.00662

U15

32.51 (30.27, 34.99)

-

0.00611

ppp-Het30

0.825 (0.761, 0.894)

3.81 (3.49, 4.15)

0.00876

Het30

1.07 (1.01, 1.12)

10.8 (10.1, 11.6)

0.00667

dT30d

5.28 (4.13, 6.28)

>100

0.00875

dHet30d

10.70 (10.15, 11.26)

>100

0.00911

U30

8.42 (7.98, 8.88)

52.3 (47.6, 57.7)

0.00514

ppp-Het30b

5.36 (4.60, 6.31)

9.66 (8.03, 11.6)

0.00810

Het30b

8.21 (7.38, 9.18)

19.4 (16.3, 23.0)

0.00701

dT30d

40.68 (30.99, 55.50)

46.28 (29.95, 72.07)

0.00476

dHet30d

55.25 (53.42, 59.69)

>100

0.00352

185-kinase

U30

31.9 (29.8, 34.2)

68.9 (51.8, 97.5)

0.00452

229-kinase

U30

1.91 (1.79, 2.05)

7.87 (7.16, 8.64)

0.00706

ppp-Het30

NDc

NDc

Het30

NDc

NDc

ds30

3.80 (3.37, 4.33)

3.27 (2.82, 3.77)

0.00457

dT30

2.59 (2.44, 2.76)

16.2 (14.5, 18.2)

0.00630

U30

96.1 (88.1, 106.8)

>100

0.00539

ds30

24.3 (20.7, 29.1)

>100

0.00452

dsRBD

242-kinase

Parameters obtained by global nonlinear least square analysis of the sedimentation velocity data using a
model of sequential binding of two proteins monomers. The values in parentheses represent the 95%
joint confidence intervals obtained using the F-statistic.
a
Root mean square deviation in absorbance units.
b
Good fits required that the sedimentation coefficients for the protein-RNA complexes be allowed to float
to their best-fit values.
c
Not determined. More than two protein monomers bind to the RNA and the data could not be reliably fit
to an association model. Plots of the normalized g^(s*) distributions for these experiments are in Figure
4.9.
d
These fits were obtained from only one PKR:nucleic acid mixture.
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4.5 PKR interaction with ssRNA
Figure 4.4A shows a titration of a model ssRNA, U30, with full length PKR depicted as
an overlay of g^(s*) sedimentation coefficient distribution functions. Addition of PKR results in a
decrease in the amplitude of the peak at 1.5 S associated with free U30 and formation of a peak
at higher sedimentation coefficients due to complex formation. A similar titration against the
heteropolymeric RNA, Het30, is shown in Figure 4.9A. The data are plotted as an overlay of
g^(s*) distributions for Het30 in 5′-ppp and 5′-OH forms. This representation provides qualitative
insight into the contribution of the triphosphate to ssRNA binding energetics which is discussed
subsequently. Comparison of g^(s*) distributions for U30 and Het30 reveals significant
differences in binding behavior. Complex formation with U30 results in a single broad peak
which forms at ~4 S. Addition of 15 equivalents of PKR to Het30 results in a bilobal distribution
with a feature at ~3.6 S corresponding to freely sedimenting PKR and a complex which appears
at ~6 S. Hydrodynamic constraints restrict the maximal sedimentation coefficient for a 1:1
complex to values less than 6.57 S and it is likely the feature at ~6 S corresponds to a
multivalent complex. The time derivative method employed to generate g^(s*) distributions is a
model independent analysis and can be used to guide interpretation of the data. In order to
define the interaction stoichiometry and obtain dissociation constants the sedimentation velocity
profiles were subtracted in pairs to remove systematic noise and the difference curves were fit
to alternative association models. A fit of the U30 binding data to a model where two PKR
monomers sequentially assembly on a single RNA is shown in Figure 4.4B and the affinities are
reported in Table 4.2. Similar to PKR interactions with duplex RNAs, the first PKR binds with the
highest affinity, with a Kd1 = 3.5 µM, and the second binds weaker, Kd2 = 40 µM. PKR binds
about three-fold more strongly to the heteropolymeric ssRNA of the same length with a similar
decrease in affinity for the second PKR (Het30, Table 1). Increased affinity toward Het30 may
reflect weak secondary structure formation by the heteropolymeric sequence (Fig. 4.3A) or
some slight nucleotide identity preferences. PKR gains specificity for dsRNA over other nucleic
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acid conformations via its dsRBD which recognizes the register of 2′-OH groups and
phosphates presented by the A-form geometry of the RNA helix (23). The requirement for
appropriate spatial distribution of 2′-OH is demonstrated by a lack of interaction with dsDNA,
RNA/DNA hybrids, or chimeric RNAs partially substituted with either 2′-deoxy or 2′-OCH3 (15,
65). We asked whether single-stranded nucleic acid interactions exhibit the same specificity by
analyzing the DNA versions of U30 and Het30. PKR binds both dT30 and dHet30. Affinity is
reduced ~1.5-fold for dT30 and ~10-fold for dHet30 relative to their respective RNA forms
indicating the 2′-OH contributes to single-stranded nucleic acid interactions but is not required.
Binding to U30 activates PKR autophosphorylation weakly (Figure 4.4C) to a level about
1.5-fold above the background in the absence of RNA. As in the case of duplex RNAs (67), the
bell-shape activation curve implies that ssRNAs induce PKR dimerization. The low extent of
activation is likely a consequence of the relatively weak binding affinity. Higher ssRNA
concentrations inhibit, consistent with dilution of PKR dimers by the excess nucleic acid.
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Figure 4.4 Interaction of PKR with U30. PKR binding to U30 ssRNA was assayed by
sedimentation velocity analytical ultracentrifugation. Measurements were performed in AU75
buffer at 20 °C and 50,000 rpm using absorbance detection at 260 nm. (A) Titration of U30 with
PKR represented as an overlay of g^(s*) sedimentation coefficient distribution functions. The
samples contained 1 µM U30 (black) and 1 µM U30 plus 0.5 eq. (orange), 1 eq. (blue), 2 eq.
(red), 5 eq. (green), 10 eq. (cyan), and 15 eq. PKR (purple). The decrease in the U30 peak and
appearance of the peak at higher S are due to complex formation. (B) Global analysis of the
time difference curves. Scans within each data set were subtracted in pairs to remove timeinvariant background noise and fit to a sequential 2:1 binding model using SEDANAL (53). The
data are indicated by points and the fit by solid lines. The residuals are plotted as a grayscale
image in the x-y plane at z=0. The best-fit parameters are in Table 1. (C) Activation of PKR by
U30. 500 nM PKR was incubated with variable concentrations of U30 in AU75 buffer with 5 mM
MgCl2 for 20 min at 32 °C. Samples were resolved by SDS-PAGE and 32P-PKR was quantified
with a phosphorimager. The data are normalized to activation of PKR in the absence of
activator.
4.6 PKR interaction with U15
Initial binding measurements with poly-uridylate were performed with a 15 nucleotide
RNA to match the single-stranded length of the model 15-15-15 RNA characterized in Chapter
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3. Figure 4.5 shows two g^(s*) distributions produced from different time intervals from the
experiment. Binding is difficult to assess by g^(s*) analysis because the RNA is small and does
not form a discrete peak in the same scan range that a complex would appear (Fig. 4.5A).
Analysis of scans collected later during the sedimentation process contain only the freely
sedimenting RNA and provide some qualitative insight into binding (Fig. 4.5B). In both plots,
addition of PKR causes a decrease in the feature corresponding to free RNA which is indicative
of complex formation. Indeed, the data fit better to a model which incorporates formation of a
1:1 complex with a weak binding affinity of 33 µM (Table 4.2) than to a model of freely
sedimenting species (not shown). Further characterization of single-stranded interactions in the
context of a homopolymer was performed with U30 to avoid ambiguity associated with weak
interactions.

Figure 4.5 Interaction of PKR with U15. Two g^(s*) plots are shown which correspond to
scans acquired during different time intervals of sedimentation. The plot in (A) was created by
analysis of scans taken starting ~124 minutes after rotor acceleration and ending at ~260
minutes. (B) Corresponds to scans taken from ~303 to ~440 minutes. The data are plotted on
different x-axis scales. Note that the sample of U15 alone contains 2-fold more RNA than the
RNA:PKR mixtures. The samples contained 2 µM U15 (black) and 1 µM U15 plus 1 eq. (blue), 5
eq. (red), and 15 eq. PKR (green). The progressive decrease in the U15 peak with addition of
PKR is indicative of binding.
4.7 Localization of ssRNA binding: the dsRBD
We characterized U30 and Het30 binding to individual PKR domain constructs to define
the region(s) responsible for interaction with ssRNA and the contribution of the 5′-ppp. The
dsRBD (residues 1-184) binds U30 (Fig. 4.6A) and Het30 with affinities slightly reduced relative
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to the holoenzyme (Table 4.2), indicating that ssRNA can also bind to this canonical dsRNA
binding site. Similar to full-length PKR, affinity is greater for the heteropolymer. The dsRBD also
exhibits a preferences for the 2′-OH as affinities are slightly reduced toward DNA versions of the
nucleic acids.
Binding of the dsRBD to dsRNA distorts the helix causing a slight opening of the major
groove and changing the number of bp per helical turn (143). This conformation change can be
exploited to monitor binding of the dsRBD to dsRNA by circular dichroism spectroscopy since
ellipticity near 260 nm is related to the helix winding angle (110). CD spectroscopy has
previously been employed to measure stoichiometries between PKR’s dsRBD and RNA
duplexes of varying lengths (57). Here, we have used the technique to ask whether the dsRBD
induces any structural change detectable by spectroscopy during complex formation with U30.
Figure 4.6 shows the CD spectra resulting from titration of the dsRBD against either U30 (B), a
25 bp dsRNA (C), or 0-15-0 (D). The spectra of each nucleic acid agrees with published reports
with the duplex absorption maxima at ~260 nm (185) and U30 maxima at ~270 nm (186). As
expected, addition of the dsRBD to dsRNA causes an increase of ellipticity at 260 nm. However,
the spectra for U30 remains unchanged upon addition of the dsRBD. Although CD spectroscopy
only probes some of the possible structural changes associated with binding, these
measurements indicate that neither intra or intermolecular base stacking interactions, which
typically accompany protein:ssRNA interactions (187), occur between PKR and U30.
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Figure 4.6 Interaction of dsRBD with U30. (A) g^(s*) distributions normalized by area
depicting the interaction between U30 and the dsRBD. Samples were prepared as a titration of
the dsRBD against 1 µM U30. The dsRBD has a sedimentation coefficient of 1.8 S and begins
to appear as it is added in sufficient quantity for detection. (B-D) Spectroscopic analysis of
dsRBD:RNA interaction by circular dichroism. Samples were prepared as a titration of the
dsRBD against 5 µM of U30 (B), ds25 (C), or 0-15-0 (D). Spectra are an average of 5 scans per
sample with the contribution of buffer and protein subtract. Data were collected in AU75 buffer
at 20 °C.
4.8 Localization of ssRNA binding: the kinase domain
Single-stranded nucleic acids bind the dsRBD yet data indicate that this may not be the
only binding site. The dsRBD binds single-stranded nucleic acids with affinities that are slightly
reduced relative to the holoenzyme. Removal of the single stranded regions from 15-15-15 has
a disproportionate effect on the relative binding affinities for full length PKR and the dsRBD
(Chapter 3, Table 3.5). Affinities are compared for the first binding event (Kd1). Full length PKR
binds 0-15-0 with about 35-fold reduced affinity relative to 15-15-15 but removal of the tails
reduces dsRBD binding by only about two-fold, indicating that the tails predominantly interact
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with regions outside of the dsRBD. In the absence of the tails the two constructs bind about
equally well, confirming that binding to duplex regions is mediated primarily by the dsRBD.
In the human enzyme, the dsRBD is separated from the kinase domain by an ~80
residue unstructured linker. The length of the linker is highly variable among PKR orthologs (Fig.
4.1B). This length variability arises within the N-terminal acidic portion of the linker, but a cluster
of basic residues within the C-terminal portion is conserved. This portion of the linker is
implicated in kinase function (176) and ribosome association (177) and represents a potential
RNA interaction site. Alternatively, the heparin binding site is located on the kinase domain (91,
179) and represents another possible ssRNA binding motif.

We prepared PKR domain

constructs (Fig. 4.1C) to probe the role of the linker, basic region, and isolated kinase domain in
ssRNA binding.
Figure 3 shows titrations of U30 and ds30 RNAs with PKR kinase constructs that contain
(229-kinase) or lack (242-kinase) the basic region. Addition of stoichiometric 229-kinase to U30
causes a decrease in the RNA peak and a shift of the distribution to higher sedimentation
coefficients, indicating that this construct binds to ssRNA. The distribution at the highest protein
concentration is bilobal due to the contribution of free 229-kinase at 2.8 S and a protein:RNA
complex which sediments at 4.7 S. In contrast, addition of the 242-kinase construct lacking the
basic region results in only a minimal decrease in the free RNA peak. The new feature which
appears at 2.8 S is primarily due to absorbance of the free protein. The 229-kinase data fit well
to the sequential 2:1 binding model with Kd1 = 1.9 µM and Kd2 = 7.9 µM. However, the 242kinase binds very weakly (Table 4.2). Thus, the basic region mediates ssRNA binding to the Cterminal portion of PKR. Affinity is substantially reduced when the remainder of the linker is
included in the 185-kinase construct presumably due to the electrostatic effect of the added
negatively charged and polar amino acids (Table 4.2). These measurements may be more
representative of the affinity of the basic region for ssRNAs in the context of full-length PKR.
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Interestingly, 229-kinase also binds a 30 bp dsRNA and the dissociation constants are
similar to those observed with U30. Thus, the basic region interaction is not specific for ssRNA.
Indeed, 229-kinase also binds to a 30 nt ssDNA, dT30, albeit with reduced affinity indicating a
small contribution from the 2′-OH (Table 1).

The 242-kinase and ds30 have similar

sedimentation coefficients (3.2 and 2.8 S, respectively) so that the two species are not resolved
by time derivative analysis. Although the affinity is weak and the 2:1 complex is inadequately
populated to obtain a reliable fit the data are best described by models which account for
complex formation.

Figure 4.7 Interaction of the PKR kinase domain / basic region with RNA. Each panel
shows a titration of RNA with protein depicted as a g^(s*) sedimentation coefficient distribution.
Addition of 229-kinase to U30 or ds30 causes a shift in the distributions to the right, indicating
complex formation. In contrast, 242-kinase induces only a slight decrease in the peak
corresponding to free U30, indicating a very weak interaction. The peak at 2.8 S at higher
protein concentrations is due to free 242-kinase. The sedimentation coefficients of 242-kinase
and ds30 are similar and the increase in the peak amplitude is primarily due to free protein. The
data were fit to a sequential 2:1 binding model to extract the binding parameters displayed in
Table 1.
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Given the strong binding of ssRNA to 229-kinase we asked whether it could mediate
activation. For comparison, we also assayed activation of the 242-kinase construct. The 229kinase is activated by U30 with a bell-shaped activation curve (Fig. 4A and C). As observed for
the full-length enzyme, the maximum extent of activation by ssRNA is fairly weak,
corresponding to about 3-fold over the basal level. Consistent with the lower ssRNA binding
affinity, 242-kinase is not activated by U30.
The heparin binding site is located on the kinase domain and the 242-kinase construct
binds heparin (91). Fig. 4C and D show that both 229- and 242-kinase are activated by heparin,
with the maximum shifted to about 100-fold higher heparin concentration for the 242-kinase.
Although ssRNA and heparin are both flexible polyanions, the basic region is not required for
heparin binding. These data are consistent with a model where ssRNA and heparin bind to
different sites on the kinase. Previously, we localized the heparin binding site to a pocket
adjacent to helix αC (91) that is distinct from the basic region. The shift in the maximum to
higher heparin concentration upon removal of the basic region in 242-kinase may be due to
weaker, nonspecific contribution of the basic region. Consistent with this interpretation, heparin
binds more weakly to 242-kinase than to the full length enzyme (91).
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Figure 4.8 Activation of PKR kinase domain by ssRNA. Autophosphorylation reactions were
carried out with a fixed concentration of protein and titrated with either U30 (A, C) or heparin (B,
D). The basal (RNA-independent) activities of 229- and 242-kinase are much lower than the
full-length enzyme and are different from each other (Fig. 4.2). Thus, the protein concentrations
were adjusted to give approximately equal extents of autophosphorylation in the absence of
RNA: 1.5 µM 229-kinase and 5 µM 242-kinase. Phosphorimager scans of SDS-PAGE gels are
shown in (A) and (B). The quantitation of 32P-incorporation is shown in (C) and (D). The error
bars correspond to the standard deviation from three replicates. In (C), the activation by U30 is
plotted relative to samples containing no activator. In (D), activation by heparin is normalized to
the maximum signal because heparin is a potent activator and quantitation relative to the low
signal in the absence of activator is not accurate. The ~100-fold increase in the heparin
concentration required for maximal activation of the 242-kinase persists when the protein
concentration is reduced to the same concentration used for 229-kinase (1.5 µM).
4.9 Analysis of the 5′-ppp recognition site
Previous reports indicate that a 5′-ppp contributes to PKR activation by certain RNAs
with limited secondary structure (7, 78, 169, 172), yet the 5′-ppp recognition site remains
undefined (131). We probed the effect of this moiety on binding affinity in the context of the
heteropolymer, Het30, and analyzed the domain constructs to localize the 5′-ppp binding
pocket. Figure 4.9 shows the measurements for each protein construct as an overlay of g^(s*)
distributions for Het30 in 5′-ppp and 5′-OH forms. This representation is meant to provide
qualitative insight into the relative contribution of the 5′-ppp to binding affinity toward different
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regions of PKR. In each distribution, samples prepared with equal concentrations of Het30 and
protein exhibit a shift to higher sedimentation coefficients when the RNA is capped with a 5′ppp. Qualitatively, the relative shift between 5′-ppp and 5′-OH forms appears similar for each
protein construct. Sedimentation coefficients for complexes calculated with frictional ratios of 1.5
are indicated along the x-axis of each g^(s*) distribution. This assumption of macromolecular
shape indicates that the dsRBD (Figure 4.9B) and 229-kinase (Figure 4.9C) form complexes
larger than RP2 with Het30. However, fits to models which accommodate a sequential assembly
process to form RP4 produced unreasonable dissociation constants (not shown) indicating the
fitting procedure applied to the other interactions reported in this Chapter could not be used
here. Reasonable fits to the dsRBD data were obtained by allowing the sedimentation
coefficients to float to their best fit values (sRP = 3.55 S, sRP2 = 5.02 S, Appendix 2) in a 2:1
sequential binding model. However, after exhaustive attempts, a model to accurately describe
the 229-kinase association could not be obtained.
In full length PKR, the presence of a 5′-ppp enhances affinity, reducing Kd2 by a factor of
about 3 relative to the 5′-OH RNA (Table 4.2).

A similar magnitude effect of a 5′-ppp is

observed for Het30 binding to the dsRBD. Dissociation constants describing 229-kinase affinity
are unavailable yet the qualitative comparison provided by Figure 4.9 indicates the 5′-ppp
confers a similar increase in affinity as full length PKR and the dsRBD. Thus, the enhancement
of ssRNA binding to PKR by the 5′-ppp is not associated with a distinct binding site, as previous
suggested (131) but is nonspecific and likely attributable to electrostatic interactions.
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Figure 4.9 Triphosphate effects on binding.
Each panel shows an overlay of g^(s*)
distributions normalized by area depicting the
effect of a 5′-ppp on binding affinity to Het30.
Filled circles correspond to the 5′-ppp form and
open circles correspond to 5′-OH. Samples
contain 1 µM Het30 and the indicated
equivalence ratio of protein. For reference
sedimentation coefficients of RNA:protein
complexes calculated with a frictional ratio of
1.5 are indicated along each x-axis. Protein
constructs are depicted as domain schematics
with full length in (A), dsRBD (B), and 229kinase (C).
4.10 Analysis of RNA interaction by crosslinking
Our results indicate that PKR contains two RNA binding loci. The dsRBD and the basic
region interact with single-stranded nucleic acids with comparable affinities. Both regions also
interact with duplex RNA yet the dsRBD binds with ~100-fold tighter affinity with an intrinsic
dissociation constant in the low nanomolar range (104). Complex formation with an RNA
containing both duplex and single-stranded regions is presumably driven by the high affinity
interaction between the duplex and dsRBD. However, the binding affinities do not indicate
where the single-stranded regions interact. The relative binding affinities of full length PKR
versus the dsRBD construct for 15-15-15 and 0-15-15 suggests that single-stranded regions
engage the protein outside the dsRBD (Section 4.7, Table 3.5). We have designed a
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photocrosslinking assay to directly probe the RNA interaction sites on full length PKR. A
schematic of the protocol is provided in Figure 4.10A. 15-15-15 and 0-15-0 were transcribed in
the presence of 4-thiouridine triphosphate (s4U), resulting in incorporation of the modified
nucleotide throughout the RNA, radiolabeled at the 5′-end, and crosslinked to PKR by exposure
to 365 nm light. Reactions were performed with wild-type PKR, kinase and dsRBD domain
constructs, and full length PKR constructs containing a TEV protease cleavage site located at
position 185, 229, or 242. Following crosslinking, samples were cleaved by TEV protease,
separated on SDS-PAGE, and visualized by both phosphorimaging and Sypro Orange protein
staining. Crosslinking of the ss-dsRNAs to wild type PKR is dependent on s4U and the adduct is
not cleaved by TEV protease (Fig. 4.10C lane 3, 4.10D lane 3). The mutants containing TEV
sites are efficiently cleaved by the protease giving two predominant products. The relative
intensities of the cleavage products provides coarse resolution for the RNA crosslinking site
which is further resolved by comparing the fragment intensities produced from the different
protease sites. Distributions of the cleavage pattern were generated by measuring pixel intensity
vertically across the gel (Fig. 4.10E and F). The cleavage distributions are similar for both 1515-15 and 0-15-0. When cleaved at positions 185 or 229 that are N-terminal to the basic region,
most of the

32

P-labeled RNA is associated with the C-terminal kinase domain. Cleavage at

position 242 shifts the distribution so most of the label is attached to the N-terminal fragment
containing the dsRBD and basic region. This switch in band intensity indicates that the basic
region interacts with the ss-dsRNA in the context of full length PKR. The residual crosslinking of
the C-terminal fragment may reflect the weak interactions observed between the 242-kinase
construct and RNA.
Crosslinking of the ss-dsRNA to the isolated domain constructs mirrors the trends
observed with the full-length protein. The kinase domain requires the basic region for
crosslinking to both 15-15-15 and 0-15-0. Crosslinking of ss-dsRNAs to the dsRBD is weak and
requires addition of 10-fold molar excess of protein relative to the other samples to generate a
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similar amount of adduct. An explanation for low crosslinking yields toward the dsRBD is not
readily available however several hypothesis are presented. The low amount of product is not
due to weak binding. The dsRBD binds duplex RNA strongly (intrinsic Kd ~100 nM (104))
whereas the basic region in the context of the 229-kinase binds a 30 bp duplex with only
micromolar affinity (Table 4.2). One possibility is that variations in how the dsRBD and basic
region engage the RNA lead to differences in accessibility for s4U. The mechanism for duplex
RNA recognition by the dsRBD is well established (13). The dsRBD primarily binds the
backbone and makes only a few interactions with the bases all of which occur along the shallow
minor groove (23). The basic region loosely resembles arginine rich motifs (ARMs), short
peptides enriched in basic residues which bind their cognate RNA by inserting into the deep
major groove (188). The reactive sulfur projects into the major groove which may be more
accessible to the binding mode of the basic region. However, these proposed differences in
binding mechanism only provide rationale for lower crosslinking efficiency toward 0-15-0. The
dsRBD also produces less crosslinked product with 15-15-15. Binding affinity may provide the
explanation. The dsRBD preferably binds the duplex region which could preclude the ssRNA
interaction. In this scenario, crosslinking with single-stranded regions occurs only after duplex
binding sites have been saturated.
Sulfur and oxygen have similar electrochemical properties and uridine containing sulfur
in the 4′ position rather than oxygen is expected to make canonical base-pairing interactions
(189). We had hypothesized that s4U incorporated into duplex regions would only crosslink to
its Watson-Crick base pair partner so that crosslinking would specifically map the singlestranded binding site. Yet, we observe crosslinking reactions between 0-15-0 and PKR. Note,
however, that the uridine in position one of the tetraloop is more accessible to solvent than
duplex residues. A sheared base pair interaction with the guanosine in position four orients the
4′ sulfur toward the solvent (190). This residue could be responsible for crosslinking with 0-15-0
but requires mutagenesis to prove. Crosslinking with 15-15-15 is much more efficient than 0-1590

0, indicating the single-stranded regions substantially contribute to the reaction. Because 15-1515 and 0-15-0 were labeled to the same specific activity and the gels were exposed
simultaneously, the crosslinking efficiency can be directly compared. 0-15-0 yields ~10-fold less
complex than 15-15-15 indicating that the single stranded regions enhance crosslinking
efficiency (compare y-axis values, Figure 4.10E and F). Thus, while a background of
crosslinking toward the duplex region exists, it seems that a majority of the complex is formed
from s4U within the single-stranded regions. This assay confirms that the basic region engages
both single- and double-stranded regions in the context of the full length protein.
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Figure 4.10 Crosslinking analysis of PKR binding to ss-dsRNA. (A) Protocol schematic.
TEV cleavage positions are indicated. RNAs are labeled at the 5′-end with 32P. (B) Secondary
structure of the ss-dsRNAs and chemical structure of 4-thiouridine. Modified uridines are
highlighted red in the secondary structure and the modified sulfur is highlighted in red in 4thiouridine. (C) Phosphorimage of 15-15-15 crosslinking. (D) Phosphorimage of 0-15-0
crosslinking. Samples contained 0.5 µM RNA and 1 µM protein. One sample of dsRBD
contained 10 µM protein (labeled 10x). Lanes labeled as (-) s4U contained unmodified ssdsRNA. (E) Quantitation of 15-15-15:protein adducts following TEV cleavage. Distributions
created from panel C lanes 7, 10, and 13. (F) Quantitation of 0-15-0:protein adducts. Created
from lanes 6, 9, and 12 from panel D. (G) Sypro stained gels from panels C and D. (H)
Visualization of crosslink mobility change. WT phosphorylated PKR is run next to the full-length
crosslinked species.
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4.11 ThioU incorporation abolishes activation
Certain nucleoside modifications are deleterious to RNA-stimulated activation of PKR.
Incorporation of 4-thiouridine into a mostly single-stranded RNA reduces PKR activation and
abolishes activation by a perfect duplex (82). Curiously, EMSA demonstrates that the affinity of
the dsRBD for dsRNA is not significantly perturbed by nucleoside modifications suggesting that
kinase domain dimerization may somehow be diminished. Based on these data, we assayed
s4U-modified ppp-15-15-15 for activation and find PKR activation is eliminated (Fig. 4.11). The
implications of this result with respect to the crosslinking data are unclear since the mechanism
of PKR inhibition by nucleoside modification is unknown. Oxygen and sulfur have similar
electrochemical properties yet replacement of the 4′-keto oxygen with sulfur may produce slight
changes to base pair hydrogen bonding and base stacking interactions. Both stabilizing (191)
and destabilizing (192) effects on duplex thermodynamics have been reported and the effects of
s4U incorporation into single-stranded regions are unknown. The previously reported
disproportionate effect of s4U incorporation on activation mediated by unstructured versus
perfect duplex RNA (82) is partially in agreement with our crosslinking analysis. Activating RNAs
which contain less than 30 bp of duplex presumably bind PKR with the duplex:dsRBD
interaction with auxiliary interactions involving the single-stranded regions serving to elicit
stimulatory effects.

Figure 4.11 Activation by s4U 15-15-15. Titration of PKR by s4U modified 15-15-15.
Unmodified 15-15-15 is included as a positive control.
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4.12 Deletion of the basic region
PKR constructs with internal deletions to the basic region have been created to directly
probe its contribution to activation by ss-dsRNAs. One construct contains a deletion of residues
229-241 (∆229-241) to complement the kinase domain constructs and the other contains an
extended deletion from residue 229 to the canonical kinase domain boundary at position 254
(∆229-254) (Figure 4.1C). As shown previously, these deletions decrease PKR autophosphorylation activity as measured by the protein concentration dependence on
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incorporation (Figure 4.2E). Activation by U30, 15-15-15, and a 40 bp duplex were measured for
each construct (Figure 4.12). In the U30 assay, protein concentrations were adjusted based on
the auto-phosphorylation measurements (Figure 4.2E) so that the basal level of phosphorylation
activity would be equal. WT PKR was assayed at 400 nM and the two internal deletion
constructs were assayed at 800 nM. The level of background activity in the absence of activator
is indicated as a dashed line on the graph in Figure 4.12A. Despite the attempt to normalize the
basal activity the wild-type protein is ~3 times more active than the deletion constructs.
Quantitation of the band intensities indicates that the samples containing U30 are more intense
than the corresponding protein alone suggesting U30 activates the internal deletion constructs.
These experiments must be repeated to confirm the results. Measuring weak activation is an
experimentally challenging task. To reduce basal level activity, samples are prepared at low
PKR concentrations. However, within this regime autophosphorylation activity increases
considerably. From 250 to 500 nM PKR autophosphorylation activity, as measured by
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incorporation, increases ~10-fold (Figure 4.2E). Thus, small pipetting errors can produce
substantial changes to the sample activity. For strong activators, such as dsRNA, these effects
are negligible. However, for weak activators such as U30 this may produce false positive
results.
Deletion of the basic region also reduces stimulation by duplex RNAs (Fig. 4.12B) and
15-15-15 (Fig. 4.12C). The reduction in activity indued by duplex RNAs may be related to the
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apparent reduction in enzyme activity measured in the absence of activators (Fig. 4.2). Because
of the effect on activation by duplex regions we cannot make definitive conclusions regarding
the reduced stimulation by 15-15-15 (Fig. 4.12C).

Figure 4.12 Internal deletions of basic region. (A) Activation by U30. Protein concentrations:
400 nM WT, 800 nM ∆229-241, and 800 nM ∆229-254. Heparin (average MW = 5,000 Da) at 3
µM was a positive control. The dashed line on the graph indicates the level of protein
phosphorylation in the absence of activator. (B) Activation by 40 bp duplex (ds40). (C)
Activation by 15-15-15. For each trial data are normalized to the activation of the WT protein by
0.3 µM 15-15-15. In both B and C protein concentration of each construct was 200 nM. All of the
phosphorimages consist of two merged gels. The site of merger is indicated by a dashed line.
4.13 Discussion
This study provides the first direct evidence that PKR binds to and is activated by singlestranded RNAs and rationalizes previous reports (78, 119, 172) that single-stranded regions
present in structured RNAs contribute to PKR interactions.

The relatively weak binding of

ssRNAs to PKR and the modest activation indicates that isolated single-stranded RNAs are
unlikely to form a stable complex with PKR or to promote significant activation in vivo. However,
these interactions provide a rationale for the contribution of single-stranded regions to PKR
binding and activation in the context of structured RNAs. Invariably, potent RNA activators of
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PKR possess some secondary and tertiary structure (193). Some of these RNAs lack the
minimum 30 bp of duplex required to support PKR activation by simple dsRNAs but can form
extended double stranded regions by coaxial stacking of shorter helices (4) or by dimerization of
self-complementary stem loops (134, 135). Other RNA activators contain a single duplex as
short as 10 - 15 bp (77, 119) or two hairpins of 5 and 4 bp (78), implying a substantial
interaction of PKR with the unstructured regions. The crosslinking results demonstrate that both
the dsRBD and the basic region-kinase domain interact with RNAs containing structured and
unstructured regions. Despite the presence of these two RNA binding sites, sedimentation
velocity data for full length PKR binding to ssRNAs and ss-dsRNAs only fit to a model where
two monomers sequentially assemble onto a single RNA. The data do not fit well to models
which incorporate binding of multiple RNA ligands to a single protein. The ~80 residue region
separating the dsRBD and the basic region (Figure 4.1) is intrinsically disordered and PKR
adopts multiple conformations in solution (38, 60).

NMR data indicate that dsRBD2 can

transiently interact with the kinase domain (54, 55) suggesting a model in which PKR exists in
an equilibrium between open and closed states (59). In the closed conformation, the dsRBD
and basic region/kinase domain would be in close proximity and capable of binding to a single
RNA.
The protein:RNA binding behavior is similar to our observations for duplex interactions
and follows the expected trend for interaction with a ligand possessing multiple identical binding
sites (194). The reported binding affinities are macroscopic measurements influenced by the
ensemble of binding conformations. Sequential binding of multiple proteins becomes weaker
due to statistical effects (195). Previously, we have applied a binding model which
accommodates the statistical effects associated with multiple proteins to an RNA duplex lattice
to extract the intrinsic (microscopic) binding affinity for the dsRBD to dsRNA (104). It is unclear
whether similar methodology could be applied to determine the intrinsic binding affinity for
single-stranded RNA.
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The weak dependence of binding affinity on a 5′-ppp is consistent with the absence of a
distinct binding site for this moiety in PKR. A 5′-ppp also increases the affinity in the context of a
ss-dsRNA containing a 15 bp stem and 15 nt 5′- and 3′-tails (15-15-15) but it is not required to
detect kinase activation (Chapter 3, (119)). A 5′-ppp may play a role in PKR activation by RNAs
with limited secondary structure (7, 78, 169, 172) by increasing binding affinity and thereby
increasing the maximum population of active PKR dimers. However, a 5′-ppp is not absolutely
required for activation of PKR, or the 229-kinase, by unstructured RNAs. Proteins with defined
5′-ppp recognition sites, supported by structural analysis, provide the basis for the expected
contribution of the triphosphate to binding energetics. The canonical cytosolic sensor for RNAs
bearing a 5′-ppp is RIG-I. This protein contains a helicase domain which binds duplex RNA and
a regulatory domain which binds the 5′-ppp (196). For RIG-I, the presence of a 5′-ppp increases
the binding affinity by >100-fold relative to the 5′-OH form, but the enhancement is only 2.4-fold
for the isolated helicase domain (197). The latter is similar in magnitude to PKR and presumably
represents the contribution of nonspecific electrostatic interactions. The antiviral proteins IFIT1
and IFIT5 recognize ssRNAs containing a 5′-ppp via a deep, positively-charged cavity (198,
199).

IFIT5 binds a 5′-ppp ssRNA with nanomolar affinity yet does not form a detectable

complex with ssRNA bearing a 5′-OH (200, 201). The origin of the 5′-ppp effect in RIG-I and
IFITs is attributable to well-defined structural information correlated with a large energetic
contribution to binding affinity. In the absence of similar information in the context of PKR it is
difficult to infer the relevance of the 5′-ppp and the source of experimental differences regarding
the dependence of the 5′-ppp for enzymatic activation (Chapter 3, (119)).
We propose that bivalent interactions underlie the ability of RNAs containing limited
structure to activate PKR by enhancing binding affinity and thereby increasing the population of
productive complexes containing two PKRs bound to a single RNA. In this model, a major
contribution driving complex formation is the well-characterized interaction of duplex regions
with the dsRBD (62, 104).

This interaction is stabilized by adjoining unstructured regions
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binding to the basic region. The bivalent interaction gives rise to strong (Kd ~ 100 nM) binding
even for ss-dsRNAs containing a stem as short as 5 bp. In addition to enhancing binding, the
bivalent interactions may serve to orient the kinase domains to increase the propensity for the
formation of active dimers (65).
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Chapter 5: Structural analysis of the kinase domain
Authors Note: I would like to acknowledge the contribution of Dr. Heidi Erlandsen to the
findings reported in this chapter. Without her expertise in the analysis of X-ray diffraction data
and unbridled excitement for science we would not have obtained the atomic resolution models
presented here. I crystallized the PKR kinase domain and Heidi solved the structure. Also note
that the structural models presented here are still being refined.
5.1 Introduction
The experiments described in Chapter 4 have identified the basic region N-terminal to
the canonical kinase domain boundary as an RNA binding site which binds single-stranded and
duplex nucleic acids with micromolar affinity. The data indicate that the basic region mediates
very weak activation by ssRNA and may also play a role during activation by more complex
RNAs. Additional stimulatory properties attributed to the basic region include activation by
heparin and activation induced by self-association. The basic region is proximally located in
primary sequence to the region which forms the back-to-back dimer interface (29). This dimeric
configuration is critical for PKR activation (39) suggesting the basic region may produce its
stimulatory effects by facilitating complex formation. SAXS analysis of full length PKR
demonstrates that the region lying between the dsRBD and kinase domain is intrinsically
disordered (60). This is corroborated by structure prediction of the linker region (residues 170260) using the Phyre2 web server (202). However, the basic region is predicted to fold into a
helix (Fig. 5.1). Models were also built from 30 residue blocks iterated over a 10 residue step
size and support the prediction using the full length linker sequence. Note, however, that while
the Phyre2 web server relies on homology modeling, homologs for the basic region were not
identified. Instead, the models were built primarily by the PSIPRED algorithm (203) which is
utilized for secondary structure prediction during the Phyre2 protocol. The length of the linker is
variable among PKR orthologs yet the basic region remains relatively conserved supporting a
role for PKR function (see Chapter 4, Fig 4.1). These observations have provided the impetus
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for structural analysis of the kinase domain construct containing the basic region (229-kinase).
Here, we describe the process of protein crystallization and the atomic models we have
obtained by X-ray diffraction. Unfortunately, the basic region is unresolved in the current
structures yet we observe a unique assembly of PKR molecules which has profound
implications for the mechanism of PKR autophosphorylation.

Figure 5.1 Structure prediction of the linker. Structures were predicted using the Phyre2
web server (202). The large model in green was generated using the entire linker sequence
(residues 170-260). Residues which may contribute to RNA binding are indicated as sticks with
Cα atoms are shown as spheres. The smaller models were generated from 30 residue
segments of the linker as indicated. The same residues are shown as sticks but their identity is
not annotated. N- and C-termini are indicated as blue and red spheres, respectively.
Structures of the kinase domain have previously been solved by X-ray diffraction yet the
constructs used for structure determination lacked the basic region and contained mutations. In
two structures, the kinase domain begins at residue 258 and is phosphorylated on threonine
446, representing the active form. The kinase domain was crystallized as a complex with eIF2α
in the presence (PDB code: 2A19) and absence (PDB code: 2A1A) of AMP-PNP (29). Mutations
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were introduced to facilitate protein expression and crystallization including H412N, C551A, and
a 13 residue deletion of residues 338-350. Another study reports the structure of a kinase
domain beginning at residue 254 containing the inactivating mutation K296R (PDB code: 3UIU)
(30). In all the structures a similar back-to-back dimer is formed mediated by the N-terminal lobe
of the kinase. A face-to-face dimer interface is also reported in the 3UIU structure along a 2-fold
crystallographic symmetry axis so that alternating back-to-back and face-to-face interfaces
contribute to the crystalline lattice.
In many eukaryotic kinases the transition from an inactive to active state is controlled by
activation loop phosphorylation and conformational changes in the αC helix. A network of
interactions stabilize catalytic residues in the active site, αC helix orientation, and a disordered
to ordered transition of the activation loop. PKR belongs to the ‘RD’ kinase family which contain
an invariant arginine neighboring a catalytic aspartate (44). The aspartate plays a critical role in
catalysis by accepting a proton from the substrate hydroxyl (31). In the active state, the
phosphorylated moiety in the activation loop interacts with the conserved ‘RD’ arginine to
position the aspartate for phosphoryl transfer. The interaction also stabilizes the inherently
disordered activation loop, making the active site accessible to substrate. In PKR, the
conformational states of the activation loop and αC helix are linked by additional anchoring
interactions between the phosphorylated moiety and basic residues emanating from the helix.
Correct positioning of the αC helix is critical for catalysis as exemplified by the myriad of
conformational arrangements associated with the kinase on/off switching mechanism. In the
active orientation, a conserved salt bridge is formed between an αC helix glutamate (E308 in
PKR) and lysine (K296 in PKR) residue from the N-lobe which stabilizes ATP phosphates for
catalysis. Additionally, a hydrophobic spine is completed in the active orientation which
improves catalytic efficiency by reducing conformational dynamics (204). Kinases in an inactive
conformation are typically characterized by rotations or translations of the αC helix which disrupt
these key interactions. In PKR, the back-to-back interface is partially formed by the αC helix
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providing a mechanism coupling dimerization to the catalytic state of the enzyme. It is likely that
dimerization controls αC helix orientation rather than activation loop phosphorylation since the
helix adopts a similar conformation in both phosphorylated (2A19, 2A1A) and unphosphorylated
(3UIU) structures. A structure of the monomeric PKR kinase domain is unavailable but the
structural rearrangements which occur upon dimerization may be inferred from structural
homologs. Ire1 (205) and the Pkn kinase family (206-209) form a similar back-to-back dimer. In
their monomeric structures, distortions to the αC helix break the key interactions addressed
above (40). In PKR, the functional importance of the interface is demonstrated by mutagenesis
of key interfacial residues which results in both decreased autophosphorylation and
phosphorylation of eIF2α (39). Out of the 374 identified ‘RD’ kinases, 167 require activation loop
phosphorylation for full catalytic activity and 94, including PKR, have no upstream kinase (33).
These kinases must phosphorylate their own activation loop either through a cis or trans
mechanism. The back-to-back arrangement adopted by the PKR kinase domains disqualifies
trans-autophosphorylation

within

the

dimer.

Instead,

dimerization

may

promote

cis-

phosphorylation or dimers may phosphorylate other dimers or monomers in trans. Experiments
designed to resolve between these scenarios have relied primarily analyzing whether PKR
molecules containing inactivating mutations are phosphorylated by wild-type PKR. Data
supporting both cis (34) and trans (35-38) mechanisms have been reported.
Here, we report a structural model for a putative PKR kinase domain transautophosphorylation complex solved by X-ray diffraction. We have obtained two structures of
the kinase domain from crystals grown under different conditions and into different space
groups. Back-to-back and front-to-front interfaces similar to those which have previously been
reported (29, 30) are present in the crystals. However, a unique front-to-front configuration is
also observed involving activation segments which are exchanged between reciprocal
protomers. Functional analyses to investigate the complex have not yet been performed
although the significance of the structure is interpreted from structural homologs. Similar kinase
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domain complexes have been reported and are interpreted to represent a mechanism for trans
activation segment phosphorylation (33). Our structure shares many of the conserved features
of activation segment exchange. Additionally, proteins which form functionally important backto-back dimer arrangements analogous to PKR have subsequently been shown to form
additional interfaces suggestive of a similar requirement for trans-autophosphorylation. The
back-to-back Ire1 interface mediates assembly of a larger oligomer which includes an interface
in which an activation loops interdigitate into neighboring protomers (210). A face-to-face Ire1
structure has also been reported (211). PknB has been crystallized in both back-to-back (206,
208) and face-to-face (212) orientations and a structural model for activation is proposed which
resembles the complex observed in our asymmetric unit (212). Thus, although the functional
analyses which typically accompany a crystallographic report are not included, evidence from
the literature provides precedent for the structures reported here.
Results and Discussion
5.2 Crystallization and optimization
Both 229-kinase and 242-kinase were initially screened using reagents supplied by
Hampton Research. In total, 192 reagents have been tested (Crystal Screen; HR2-110, Index;
HR2-144, and PEG/Ion Screen; HR2-126) yielding three excellent hits and two promising leads.
Proteins were concentrated, passed through a 0.02 µm syringe filter, and diluted to 10 mg/ml
(~285 µM) in a solution consisting of 20 mM HEPES (pH 7.5), 75 mM NaCl, 0.1 mM EDTA, and
0.1 mM TCEP. Samples were mixed in a 1:1 ratio (either 1 µL + 1 µL or 2 µL + 2 µL) with
crystallization solution and screened by hanging drop vapor diffusion at 20 °C. The first solution
to yield crystals was composed of 0.1 M HEPES (pH 7.5), 2 % v/v polyethylene glycol 400
(PEG-400), and 2.0 M ammonium sulfate. Proteins crystallized into a shower of microcrystals
with a plate like appearance over ~ 5 days (Fig. 5.2A). A grid search strategy was employed to
optimize the solution pH and reagent concentrations to produce larger crystals suitable for
analysis by X-ray diffraction. Changes to pH and ammonium sulfate concentration did not yield
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better results than the initial condition yet increasing PEG-400 concentration to 6-7 % v/v
produced much larger crystals. Like the initial hit, crystals were numerous throughout the drop
indicating that crystal nucleation was occurring too frequently effectively reducing free protein
concentration for further growth. Therefore additional elements of optimization included
approaches designed to reduce the rate of crystal nucleation by decreasing the speed of
equilibration between crystal drop and well solution. These included growth at 4 °C and
crystallization by sitting drop vapor diffusion yet neither method improved crystal size.
Increasing protein concentration was also ineffective since only the number of protein crystals
within the drop was amplified rather than their size. Changes to the mixing ratio between protein
and crystallization solution proved most effective to obtaining less crystals of larger size within
each drop. This approach has the advantage of sampling both protein concentration and the
equilibration path along the crystallographic phase transition in a single experiment. The optimal
crystallization condition was identified as a drop prepared by mixing of 3 µL 10 mg/ml protein
with 1 µL crystallization solution consisting of 0.1 M HEPES (pH 7.5), 6-7 % v/v PEG-400, and
2.0 M ammonium sulfate and equilibrated over ~5 days by hanging drop or sitting drop vapor
diffusion at 20 °C. Crystal production has focused on the 229-kinase although 242-kinase
behaves similarly in trials. We have also obtained crystals of the kinase in complex with the ATP
analog adenosine-5′-(β,γ-imido)triphosphate (AMP-PNP) and magnesium using the conditions
described above. 10 mM of each ligand was added to 10 mg/ml protein solution and allowed to
equilibrate for 15 minutes prior to crystallization. A change in crystal morphology provided
evidence that ligands were incorporated (Fig. 5.2A) which was subsequently confirmed during
structure determination. Curiously, the terminal phosphate from AMP-PNP is hydrolyzed and
bound proximal to the active site.
Screening has identified additional conditions including a similar condition to that listed
above consisting of 0.05-0.15 M Bis-Tris (pH 5.5) and 2.0 M ammonium sulfate which yielded a
crystal used to solve one of the structures reported here. A very promising initial hit has also
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been obtained from a solution of 0.1 M HEPES (pH 7.0), 5% v/v Tacsimate, and 10% w/v
polyethylene glycol monomethyl ether 5,000 (Fig. 5.2). Optimization trials similar to those
reported above are currently underway.

Figure 5.2 Crystal growth conditions and optimization. (A) Optimization of the initial crystal
hit. The size of protein crystals grown in the original condition was increased by changing the
mixing ratio between protein and precipitant solutions and by increasing the concentration of
PEG-400. Crystals grown in the presence of AMP-PNP and MgCl2 have a more cubic
appearance than the apo form. Structure two, reported below, was solved from crystals shown
in the bottom drop. (B) An additional condition has been identified which yields oval shaped
crystals but has not yet been optimized.
5.3 Data Collection and analysis
X-ray diffraction data were initially collected on our home source but the crystals
diffracted poorly with the highest resolution shell typically occurring at ~6 Å. High quality data
were obtained from the more intense X-rays generated by synchrotron radiation sources. To
date, we have collected high quality diffraction data from several crystals grown under different
conditions and have solved 2 structures. All structures are obtained from crystals of 229-kinase.
Data were processed and scaled using iMosflm in the CCP4i2 suite (213). Phases were solved
by molecular replacement in CCP4i2 with the PHASER module (214) using the phosphorylated,
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AMP-PNP-bound PKR kinase domain as the search model (molecule B, 2A19). Rebuilding was
performed in COOT and refinement using Refmac5 in CCP4i2 (215). The first structure was
obtained from a crystal grown in a 1:3 molar ratio of heparin (dp8) to protein, 0.1 M Bis-Tris pH
5.5, and 2.0 M AmSO4. The crystal was cryoprotected using a 30 s - 2 min soak in high
concentration of Na-malonate (between 1.5 - 1.7 M final concentration) and frozen in liquid
nitrogen for transportation to the synchrotron. The crystal diffracted to approximately 3.1 Å and
a complete dataset was collected at the NSLS-II FMX beam line at NSLS-II. The structure was
solved using one monomer of the 2A19 PKR structure, with one molecule in the asymmetric unit
and the following unit cell parameters: a = 92.69 Å, b = 92.69 Å, c = 123.33 Å, α, β = 90°, γ =
120°, and space group P 61 2 2. The crystal used to solve the second structure was grown in
0.1 M HEPES (pH 7.5), 2.0 M ammonium sulfate, and 6 % PEG-400 and the protein was
complexed with AMP-PNP and Mg2+. Crystals were cryoprotected in 2 M LiSO4 for several
weeks, frozen in liquid nitrogen for transportation to the synchrotron, and a dataset was
collected at SSRL beamline 14-1. The crystals diffracted to 2.6 Å. Three protein chains
comprise the asymmetric unit and the unit cell parameters are: a = 106.48 Å, b = 159.60 Å, c =
172.99 Å, α, β, γ = 90°, and space group C 2 2 21. Figures were made in PyMOL (The PyMOL
Molecular Graphics System, Schrödinger, LLC).
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Table 5.1 Crystallographic data collection and refinement statistics.
Structure 1
Data Collection
Beam line
Wavelength (Å)
Space group
Unit cell dimensions
a, b, c (Å)
α, β, γ (°)
Resolution (Å)
Molecules/ASU
Rmeas
I/σI
Completeness (%)
Refinement
Rwork/Rfree (%)
Reflections Unique / Free
r.m.s deviations from ideal
Bonds (Å)
Angles (°)
B-factor analysis
Molecule A (Å2)
Molecule B (Å2)
Molecule C (Å2)
Model
Nonhydrogen atoms
Water molecules
Metals
Ligands

Structure 2

FMX, NSLS-II
0.9790
P 61 2 2

14-1, SSRL
0.9795
C 2 2 21

92.69 92.69 123.33
90, 90, 120
123.33-3.10(3.10-3.181)
1
0.268 (0.070)
9.1 (3.2)
100 (100)

106.48, 159.60, 172.99
90, 90, 90
172.99-2.6 (2.6-2.667)
3
0.098 (0.034)
9.4 (0.8)
97.1 (98.1)

25.9 / 34.7 (38.3 / 38.6)
5801 / 296 (410 / 16)

20.9 / 27.3 (39.9/40.5)
42,089 / 2245 (3,154 / 157)

0.0108
1.560

0.013
1.774

89.8
-

78.8
86.8
92.6

2046
-

6480
52
1 Mg2+
ADP, 1 PO4, 7 SO4

Values corresponding to the highest-resolution shell are indicated in parentheses

5.4 Comparison of structures one and two
Both structures of the kinase domain exhibit similar interactions in the crystalline lattice
but contain different numbers of protein chains in the asymmetric unit. Figure 5.3 shows the
arrangement of molecules in the lattice with the asymmetric units (ASU) labeled. In the first
structure, one molecule occupies the asymmetric unit and a filamentous assembly is formed by
alternating face-to-face and back-to-back interfaces so that two unique interfaces are formed
between each protomer. Each front-to-front interface is stabilized by activation segment
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exchange interactions. Structure two has a similar assembly except that three protein chains
comprise the asymmetric unit. Each protomer is in complex with AMP-phosphoramidate (AMPPN), a magnesium ion, and what is presumed to be the hydrolyzed phosphate. The protein
chains within the asymmetric unit are assigned a label A, B, and C. Unlike structure one,
activation loops do not swap in one face-to-face interface (C:C). Consequently, there are three
unique interfaces in the filament: front-to-front with activation segment exchange (IF1, A:B),
back-to-back (IF2, B:C and A:A), and front-to-front without exchange (IF3, C:C). Analysis of the
interfaces was guided by PDBePISA (216) and calculated parameters are reported in Table 5.3.
Note that the back-to-back interface formed by interactions between molecules B and C is
nearly identical to the A:A interface which bridges asymmetric units. Additional interactions
occur within the crystal between neighboring C-lobes but have a low buried surface area and
are presumably an artifact of crystal packing. Structure 2 is the subject of further discussion
since the dataset used to generate the structure is generally of better quality than structure 1. In
particular, the higher resolution allows for more accurate modeling of the activation segment
exchange region. It should be noted, however, that crystals used to generate each dataset were
grown in slightly different solutions and structure one was grown in the absence of ligands. The
molecules are arranged by different space groups (Table 5.1) each belonging to a different
crystal family. Thus, activation segment exchange is likely not an artifact of crystal growth
conditions or crystal packing arrangements and is not induced by AMP-PNP or magnesium.
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Figure 5.3 Comparison of structures one and two. A surface representation of the filament
formed within the crystalline lattice is shown on the top with cartoon representations of four
protein chains on the bottom. Structure 1 is shown in (A) and structure 2 is shown in (B). One
protein chain occupies the asymmetric unit (ASU) in structure 1. Three protein chains comprise
the ASU in structure 2 and are labeled A, B, and C. In structure 2, AMP-PN and a phosphate
are shown as ball and stick representations and magnesium is shown as a grey sphere. Unique
interfaces (IF) are indicated in the cartoon representation of each structure.
5.5 Architecture of the kinase domain
The features of the kinase structure are annotated onto molecule C in Figure 5.4. Note
that with the exception of the exchanged region, the structural deviations between monomers
are minimal (Table 5.2, Fig. 5.5). Each monomer adopts the typical kinase domain architecture
with a smaller N-lobe (olive) and larger C-lobe (cyan) connected by a flexible hinge. The protein
is bound by AMP-phosphoramidate, a phosphate, and a magnesium ion in the ATP binding
pocket between the two lobes. The N-lobe begins with a short noncanonical α-helix, α0, which
contains residues forming a critical salt-bridge in the back-to-back interface, R262 and D266
(Fig. 5.6). The lobe is composed primarily of a five stranded antiparallel β sheet (β1-β5) and the
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crucial αC helix. A short hinge connects the N- and C-lobes and forms the back of the ATP
binding pocket. The structural elements of the larger C-lobe include eight α helices (αD-αJ), two
antiparallel β sheets (β7-β8 and β6-β9), and the activation segment. PKR and other eIF2α
kinases contain a slightly elongated αG helix which is also displaced from the canonical position
occupied in other kinases (29, 217, 218). The helix forms the docking site for eIF2α (29) thus, it
is noteworthy that it occupies that same position in the absence of a binding partner (Fig. 5.4
and 5.5). In eukaryotic kinases, the activation segment is typically defined as the region
between two tripeptide motifs DFG and APE (SPE in PKR) and is colored red in Figure 5.4 (32).
An important step in the structural analyses presented below is to establish that the catalytic
machinery within the active site is appropriately oriented for phosphoryl transfer. One signature
of the active kinase conformation is the short β6-β9 β sheet, stabilized by two hydrogen bonds,
immediately C-terminal to the DFG motif (32). The absence of this β sheet leads to a
destabilizing effect on proximal residues within the active site, D432 and D414 (Fig. 5.4).
Segments missing from the structure are indicated by dashed lines and include a large
noncanonical loop between β strands 4 and 5 conserved within the eIF2α kinase family
corresponding to residues 334-356 of PKR. A portion of the activation loop is also missing
presumably due to disorder in its unphosphorylated state. The residues which are missing vary
slightly for each protein chain. Molecule A is missing residues 441-450, B is missing 440-450,
and C is missing 440-443 and residue 449.
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Figure 5.4 Architecture of the kinase domain. A cartoon representation of protomer C is
shown in two orientations. The N- and C-lobes are colored olive and cyan, respectively. The
activation segment is colored red. Secondary features are annotated. Regions missing from the
structure are represented by a dashed line. AMP-PN, a phosphate, and a magnesium ion are
bound in the cleft between the two lobes.
5.6 Comparison to the active conformation
Figure 5.4 shows an alignment of each molecule in the asymmetric unit to the
phosphorylated kinase domain (2A19). Two sets of RMSD values for the alignment of Cα atoms
are reported in Table 5.2. The first set of values is an alignment of the entire protein chain. In
the second set, regions which obviously deviate from the 2A19 structure are omitted: the
activation segment which swings out in protomers A and B and the segment of the activation
loop which has shifted closer to the αC helix in protomer C. When these regions are omitted, the
Cα atoms of each protomer align very well to the phosphorylated, active form of the kinase
domain. The conformational changes to the region surrounding αEF associated with activation
segment exchange are apparent in the alignment. G466 may serve as the flexible hinge
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facilitating the domain swap configuration and will be a target of mutational analysis to probe the
complex in solution.
Table 5.2 Alignment of Cα atoms to phosphorylated PKR kinase domain (2A19).
Region aligned

Entire

With omissions

Protein Chain

# Atoms aligned

RMSD

A

252

4.528

B

252

4.728

C

257

1.297

A

237

0.699

B

237

0.745

C

250

0.782

Superposition of active site residues with the phosphorylated 2A19 structure provides
evidence that each protomer is in a form that is competent for phosphoryl transfer. An enlarged
view of the aligned active site is shown in Figure 5.5B. Note that the active site residues in 2A19
make many of the conserved interactions with AMP-PNP and magnesium which are
characteristic of the active kinase conformation (49). Residues critical for catalysis are rendered
as sticks. AMP-PNP and the magnesium ions are from the 2A19 structure and bind at the
conserved positions. However, the γ-phosphate is not correctly oriented for phosphoryl transfer.
Its catalytically appropriate position is between the two magnesium ions directed toward the
substrate hydroxyl which binds to the left of D414 (219). The magnesium ion binding positions
are designated as I and II. For clarity, only the hydrogen bonding network for 2A19 is shown as
the catalytic residues within each of our protomers occupy the same positions and make the
same interactions. However, only a single magnesium ion is bound in our structure at MgII
(Figure 5.10). The network of hydrogen bond interactions formed by protein residues and
magnesium ions not only orient ATP but also provide a mechanism for charge transfer during
the reaction (31). The only protein residue which directly engages the phosphates is K296 which
stabilizes the α- and β-phosphates. Backbone residues from the G-loop also typically make
phosphate interactions (219) but in 2A19 the loop is too far away. Additional charge
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neutralization and stability is imparted on the phosphates by the coordinated magnesium ions.
MgI is coordinated by D432 and the β-phosphate and is typically also coordinated by the γphosphate. MgII interacts with α-, β-, and γ-phosphates, D432, and the carbonyl oxygen from
N419. The catalytic residue, D414, is stabilized by hydrogen bond interactions with N419 and
K416. K416 interacts with the γ-phosphate and remains bound during all the steps of the
reaction pathway (50). In our structure, the γ-phosphate is hydrolyzed but remains proximally
bound by interactions partly mediated by K416. D414 acts as a catalytic base during phosphoryl
transfer by positioning the substrate hydroxyl for in-line nucleophilic attack on the γphosphorous atom and accepting a proton during the reaction (50).
The catalytic apparatus is linked to helix αC and more distantly to the back-to-back
interface by three pathways. 1) E308 orients K296 with a crucial salt bridge interaction (Fig.
5.4B). 2) R413 coordinates with pT446 and stabilizes the activation loop. This tethering
interaction is a conserved mechanism for activation within the ‘RD’ family of kinases (44). In
PKR, the phosphorylated moiety is further stabilized by K304 and R307 providing a linkage
between the activation loop and helix αC (Fig. 5.4B). 3) A conserved hydrophobic spine called
the R-spine, shown as a surface representation in Figure 5.4B, has a stabilizing effect on a
proximal catalytic residue, D432. The completed spine provides rigidity to the catalytic core and
is typically disrupted in inactive kinase structures (42). In PKR, the spine begins with F433
which burrows into the hydrophobic core of the protein. L312 from helix αC interdigitates into the
spine and Y323 from β4 completes the spine on the back of the protein. Y323 links the R-spine
to the back-to-back interface by engaging in a hydrogen bond triad formed with Y293 and D289
from the interacting partner (Fig. 5.6). In other kinases Y323 is often replaced with a leucine (43)
and in PKR mutation to alanine abolishes activity (39). Above Y323, a hydrophobic pocket
created by residues from helix αC, β4, and β5 provides a docking site for I288 from the
reciprocal protomer (Figure 5.6D). Thus, the active site is intimately linked to both helix αC and
the dimer interface by several allosteric pathways. These stabilizing linkage pathways may
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provide a mechanism for how back-to-back dimerization induces a catalytically competent
conformation within the active site.

Figure 5.5 Comparison to phosphorylated PKR. (A) Alignment of each unique protomer in
our asymmetric unit to the phosphorylated PKR kinase domain (PDB: 2A19). The hinge where
the αEF helix flips out is indicated. A hypothetical path for missing residues in protomer A is
indicated by a dashed line. The phosphorylated threonine (446) in 2A19 is indicated as sticks.
(B) View of the active site. Residues important for catalysis are rendered as sticks with the Cα
carbon shown as a sphere. AMP-PNP, magnesium (grey spheres), and pThr446 (TPO446) are
from 2A19. α-, β-, and γ-phosphates are labeled. Hydrogen bond interactions are denoted as
black dashed lines. The R-spine is shown in surface representation. Green and purple arrows
represent linkage pathways from helix αC to the active site. Note that the phosphate
orientations are slightly distorted. K296 typically does not interact with the α-β bridging oxygen
and the γ-phosphate is not correctly oriented for phosphoryl transfer. The correct position of the
γ-phosphate is between the two magnesium ions for in-line transfer onto the substrate hydroxyl.
Basic residues involved in coordination of the phosphorylated threonine 446 deviate
substantially in the absence of a phosphorylated moiety. These include K304 and R307
emanating from the αC helix and R413 from the canonical HRD motif. However, the absence of
phosphocoordinating interactions does not perturb positioning of the αC helix or residues within
the active site suggesting dimerization may promote the active state. αC is correctly oriented so
that E308 can hydrogen bond to K296, a conserved interaction characteristic of active kinases
(31). Interestingly, in protomer A, a sulfate from the crystallization solution is bound in place of a
phosphorylated moiety. The sulfate is coordinated by K304 and R413. Similar observations
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have been reported for other kinases (220) and it is theorized that anions are coordinated by
phosphate binding pockets which are formed prior to phosphorylation (32).
The glycine rich G-loop is a dynamic element of the kinase structure and its
conformation changes during the catalytic cycle (221). Thus, it is not surprising that this region
is a source of structural deviation between each of our protomers and 2A19. B-factor
measurements support that this is a conformationally dynamic region (Figure 5.5). Structures
containing transition state analogs have revealed how the loop clamps around the active site
during catalysis shielding it from the solvent and helping to position ATP (222-224). In the 2A19
structure, the loop is shifted away from the active site and is not within hydrogen bonding
distance of the phosphate. In protomer A, the backbone carbonyl from G279 is close enough to
make a weak hydrogen bond (3.6 Å) with the β-phosphate.
The B-factors also highlight the stability imparted to helix αG by complex formation with
eIF2α. The 2A19 protomer is bound by eIF2α via this helix and is much less flexible in this
region than the unbound protomers present in our structure. This observation correlates with the
2A19 complex structure in which a back-to-back dimer is in complex with a single eIF2α. The
molecule lacking an eIF2α binding partner is disordered at the eIF2α binding site and
coordinates for αG and αD helices are missing from the structure (29).
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Figure 5.6 B-factor measurements. Cartoon representation of the dynamic features within the
crystal environment. Cα B-factors for each protomer and the phosphorylated 2A19 structure are
indicated as a blue to red spectrum on an absolute scale. The tubular representation is relative
to each protein chain with a wider tube indicating regions with higher B-factors.
5.7 Analysis of interfaces: back-to-back (IF2)
Table 5.3 PISA analysis of interfaces.
Protein
Interface
Description
chains
Front-to-front
IF1
A:B
exchange

Interface
area (Å2)

∆Ga
(kcal/mol)

Hydrogen
bonds

Salt
bridges

1252

-7.0

12

4

IF2

B:C

Back-to-back

863

-5.5

8

6

IF2

A:A

Back-to-back

829

-4.3

8

6

Front-to-front no
810
-6.2
6
2
exchange
a
∆G reflects the thermodynamic gain by buried surface area. Electrostatic contributions are not
included.
IF3

C:C
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The back-to-back interfaces formed between protein chains B and C within the
asymmetric unit and between asymmetric units by two A protomers are nearly identical as
evidenced by alignment and analysis by PDBePISA (IF2, Fig. 5.6A, Table 5.3) (216). The
assembly is essentially identical to the previously reported PKR back-to-back interface (30, 39)
as well as the interface formed by the PKR homologue PERK (217). Several images of the
back-to-back interface formed between protomers B and C are presented in Figure 5.6.
Residues from the α0 helix on the top of the N-lobe contribute to the interface via two bifurcated
salt bridges from between R262 and D266 (Fig. 5.6B). A hydrogen bond triad is formed between
Y323, D289, and Y293 near the αC helix (Fig. 5.6C). Mutagenesis to disrupt these interactions
blocks PKR autophosphorylation capability (39) but does not abolish dimerization (65). The Cterminal portion of the αC helix is stabilized by a hydrogen bond interaction between D316 and
H322 (bottom of Fig. 5.6D). Additional interactions include two hydrogen bonds in the center of
the interface formed between N324 from each protomer involving the side chain amide and
main chain carbonyl (Fig. 5.6C). With the exception of H286, the interface is symmetrical. In one
half of the interface H286 (protomer B, magenta) hydrogen bonds to the main chain carbonyl of
C326 (protomer C, green). In the other half, H286 from protomer C is involved in a water
mediated interaction with R262 (Fig. 5.6B).
Without a structure of the monomeric kinase domain, only assumptions can be made
about the allosteric linkage between the dimer interface and active site conformation. Structural
homologs may provide insight. PknB forms a similar back-to-back dimer and structures are
available in both monomeric (225) and dimeric forms (206, 208). The structures demonstrate
the conformational changes to helix αC associated with dimerization which, as previously
discussed, often regulates the on/off switching mechanism in protein kinases (51). Monomeric
structures of PknB were generated by mutating the residue corresponding to I288 in PKR
(leucine in PknB) to aspartic acid (225) suggesting that I288 is critical to the interface. In both
PKR and PknB, this residue contributes to the dimer by burying into a hydrophobic pocket
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formed between αC, β4, and β5. A surface representation of the pocket is shown in in Figure
5.6D. In Section 5.6 an allosteric pathway was presented which linked the dimer interface to the
active site via the R-spine (Fig. 5.4). The intimate link between dimerization and the active site
can now be fully appreciated with the images of the dimer interface shown in Figure 5.6. The Rspine is completed by Y323 which is right below the hydrophobic pocket and hydrogen bonds to
the residue immediately preceding I288 (D289).

Figure 5.7 Back-to-back interface. (A) Alignment of back-to-back dimers. Both back-to-back
dimers (B:C and A:A) are aligned. Color coding in this Figure is as in Figure 5.3. Residues
contributing to the interface are shown for B:C in (B-D). A top-down view looking down on the Nlobe is shown in (B). In (C) the view is rotated 90° and tilted down slightly. A surface
representation is shown in (D) to illustrate how I288 packs into a hydrophobic pocket formed
between αC, β4, and β5.
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5.8 Analysis of interfaces: front-to-front without exchange (IF3)
The front-to-front interface without activation segment exchange (IF3) is formed between
C protomers across two asymmetric units. The αEF helix from one protomer docks into the cleft
formed between the αEF and αG helices on the reciprocal protomer (Fig. 5.7B). Electrostatic
interactions which stabilize the interface include a salt bridge between D500 at the base of αG
and K521 from the loop connecting αH and αI and a hydrogen bond triad which is formed
between T496 from αG, S461 from αEF, and Q463 immediately following αEF. Perhaps the only
significant contribution from hydrophobic residues is I460 which is buried between αEF helices.
Few electrostatic interactions and little buried surface area (810 Å2) suggests the interface may
be an artifact of crystal packing. However, similar interfaces utilizing the αEF and αG helices
have been reported for trans-autophosphorylation complexes of PAK1 (226) (see Fig. 5.10) and
PknB (212). The interface may also represent a step toward formation of the exchanged
conformation.

Figure 5.8 Front-to-front interface without exchange. (A) Surface representation of the
interface. (B) View of the interface. Residues contributing to the interface are rendered as sticks
and elements of the secondary structure are labeled.
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5.9 Analysis of interfaces: front-to-front with exchange (IF1)
The most provocative interaction within the crystal is the front-to-front interface with
exchanged activation segments formed between protein chains A and B (IF1, Fig. 5.9). As is
typical in domain swapped oligomers, the exchanged portion of each protomer makes the same
interactions in the reciprocal protein chain as in the monomeric form (227). Additional
interactions are gained along the interface formed by the exchanging portions. These new
interactions, which are absent in the monomer, may provide some of the thermodynamic
impetus for formation of the domain swapped structure. Most of the residues participating in the
interaction are shown in Figure 5.9B. In 5.9F, a surface representation of protomer A provides a
helpful visual which illustrates how exchanged αEF arms dock into the reciprocal protomer. The
discussion of the interface will begin by comparing the activation loops in the exchanged
conformation to the monomeric configuration of the activation loop in the 2A19 structure. Panels
C-D show an alignment of 2A19 onto protomer B. Note that in our structure, a portion of the
region presumably involved in exchange, residues 440-450, is unresolved and is indicated by
dashed lines in Figure 5.9C. Moving from N- to C-terminus, the region extended from the
monomeric conformation begins immediately C-terminal to β9, moves through the αEF helix,
and ends at helix αF (Fig. 5.9C). A glycine (G466) N-terminal to helix αF may serve as a flexible
hinge facilitating extension of the activation segment. The interface is formed by docking of αEF
helices into the cleft formed between helices αF, αG, and αI on the opposite protein chain which
is normally occupied by the αEF helix in its monomeric form. Many of the interactions anchoring
the αEF helix into the cleft are the same in monomeric and dimeric forms and some are highly
conserved in kinases. Panels D and E illustrate the interactions which anchor αEF in both the
monomer and dimer. R526 from the loop between αJ and αI anchors the C-terminal portion of
the activation loop by engaging in a salt bridge with E458 at the base of αEF (Fig. 5.9D). This is
a highly conserved interaction and mutation of the corresponding residues in PKA leads to
decreased catalytic efficiency (204). Also, in both monomeric and domain swapped forms, Q459
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stabilizes the HRD motif by a hydrogen bond to the main chain carbonyl of R413 (Fig. 5.9B, not
shown in 2A19 alignment). Additional interactions anchor αEF to αG (Fig. 5.9E). R499 from αG
is positioned proximal to the backbone to make hydrogen bond interactions with main chain
carbonyls of R453, L452, and M455. At the tip of the αEF arm a hydrogen bond triad stabilizes
the final portion of the activation segment which is resolved in our structure. Residues involved
include R453 and Y454 from the activation loop and E460 from αF (Fig. 5.9E). The hydrophobic
character of the tyrosine is highly conserved in kinases and this position is invariably occupied
by a tyrosine, tryptophan, or phenylalanine. In cases where the tyrosine is replaced by
tryptophan or phenylalanine, the glutamate from αF is typically replaced with a hydrophobic
residue as well (32).
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Figure 5.9 Exchanged front-to-front interface. (A) Surface and cartoon representations of the
interface. AMP-PN and phosphate are shown as ball and stick. Magnesium is a grey sphere.
Protomers are identified A and B as in Figure 5.3. (B) Top-down view of the interface.
Interacting residues are rendered as sticks and labeled. Cα atoms are shown as spheres.
Elements of secondary structure are labeled. (C-D) Alignment of the interface with 2A19. A key
is provided left of panel (C). In (C), a hypothetical path for the missing segments of the protein
chain is indicated by a dashed line. Panels (D, E) indicate the interactions that occur in both
dimer and monomeric configuration. Note the interaction between Q459 and main chain
carbonyl of R413 is not included. (F) Surface representation of protomer B with residues
participating in the interaction colored according to the key.
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Electrostatic interactions are gained as αEF helices pass by one another to dock into the
reciprocal protomer. Note that some of these interactions are also associated with a lost
interaction in the monomeric form. For example, in the monomeric structure Y465 hydrogen
bonds to the R413 side chain, providing further stability to the phosphocoordinating site. In the
dimer, Y465 assumes two different conformations dependent on the protein chain. In protomer
B, it is oriented toward the side chain of S462 from protomer A (Fig. 5.8B). On the opposite side
of the interface, Y465 from protomer A is more favorably orientated to participate in a hydrogen
bond interaction with the side chain amine from Q459 in protomer B (right side of Fig. 5.8B).
The only residue to gain an interaction in the dimer configuration is S462 which forms a
symmetrical hydrogen bond interaction in which each side chain hydroxyl interacts with the
reciprocal backbone carbonyl. In the monomer, the S462 side chain interacts with the backbone
of D464 but the main chain carbonyl does not have an interacting partner.
Analysis of the interfaces with PISA indicates the face-to-face dimer with activation
segment exchange has a larger surface area and predicted dimer stability than any other
interface in the crystal (Table 5.3). However, the thermodynamic contribution of this parameter
to complex formation should be interpreted with caution due to the structural changes required
to form the interface. A majority of residues within the C-lobe and αEF arm buried in the dimer
would also be buried in the monomer. Docking of the exchanged portion of the αEF arm
(residues 451-465) into the C-lobe in the monomeric configurations yields a buried surface area
of 616 Å2 and ∆G = -4.2 kcal/mol. Thus, the change in buried surface area between monomeric
and dimeric forms is only 636 Å2. The tip of the N-lobe is also buried in the dimer yet this
surface contributes only 119 Å2 and predicted ∆G of -0.2 kcal/mol. Curiously, despite the
presence of charged amino acids in this region, none are correctly oriented to contribute
electrostatic interactions. The N-lobe interaction surface may be an artifact of crystal packing.
Structural homology with other kinase domain trans-autophosphorylation complexes is
discussed in a subsequent section. Most complexes utilize the general mechanism of
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exchanged αEF helices docking into the reciprocal site on the opposite protomer but differ in
protomer symmetry. Very few are oriented to utilize the N-lobe in the interaction surface and for
those that do, the buried surface area is similarly small. Note that the large loop connecting β4
and β5, comprising residues 334-356, is unresolved in the structure and would be oriented
toward the front-to-front interface. This loop contains an abundance of polar and acidic amino
acids and could electrostatically contribute to the interface. Mass spectrometry has identified
this loop as a region which becomes heavily phosphorylated (182). Although PKR was extracted
from yeast and modification could be due to endogenous kinases rather than PKR
autophosphorylation.
5.10 Comparisons to similar structures
PKR belongs to a family of kinases which require activation loop phosphorylation as an
on/off switching mechanism yet paradoxically have no upstream kinase to activate them in vivo.
For many members of this family, incubation of purified, unphosphorylated enzyme with ATP
and magnesium results in activation loop phosphorylation, demonstrating that a basal level of
autophosphorylation activity persists in the ‘inactive’ state (33). Thus, phosphorylation likely
serves to shift a preexisting equilibrium towards a more activate state. A structure elucidating
how autophosphorylation of a latent kinase may occur in trans by activation loop exchange was
first determined for check point kinase 2 (Chk2) (228). Similar complexes have since been
reported (229-232). These structures adopt a similar conformation as observed in our interface,
utilizing exchange of the αEF helix to bring the activation loop within close proximity of the
catalytic apparatus of the opposing protomer. Figure 5.9 presents a structural comparison
between PKR and two similar activation segment exchange complexes, Chk2 and SLK. An
additional trans-autophosphorylation complex for PAK1 is also included and will be discussed
subsequently. The distances between the catalytic aspartate and the primary and/or secondary
phosphoacceptor sites within the activation loop are indicated in the enhanced view of the active
site presented left of the surface representation. For complexes engaged in activation segment
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exchange (PKR, Chk2, and SLK) the distances range from 6.3 Å in Chk2 to 18.9 Å in SLK. As
shown in the magnified view of the active site, the residues comprising the catalytic machinery
are properly oriented for phosphoryl transfer yet the substrate hydroxyl is too remote in the
crystallographic configuration. These complexes are generally symmetrical and both protomers
could function as either enzyme or substrate. Brownian motion is proposed to transiently orient
the complex for phosphorylation (233). Note that only Ser/Thr kinases are discussed here yet
similar complexes engaged in activation segment exchange have been described for tyrosinespecific kinases as well. These complexes exchange activation segments but do not exchange
the αEF helix. The substrate tyrosine is typically much closer to the catalytic aspartate, however,
the active site is disassembled in each protomer (234).
A unique asymmetrical trans-autophosphorylation complex has also been described for
PAK1 in which only one monomer extends its activation loop into the opposite monomer (226).
The structure can be described as an enzyme-substrate complex. The enzyme accepting the
activation loop contains a bound AMP-PNP and utilizes its own activation loop as the substrate
docking site. N- and C-lobes clamp down on the substrate and the enzyme is poised for
catalysis. This geometry is structurally distinct from the substrate molecule, which is in an open
conformation and free of ligand. A similar asymmetric complex has been reported for PknB,
although the activation loops were less resolved in the structure and both protomers adopted
similar conformations (212). Both complexes bury αEF and αG helices within the interfacial area
similar to the front-to-front dimer formed without activation segment exchange (IF3) in our
crystal. The interfaces reported in both studies are supported by functional analyses correlating
mutagenesis of key interfacial residues with decreased catalytic activity. Interestingly, members
of the Pkn kinase family also form a back-to-back dimer similar to PKR which is essential for
activity (PknB: (206, 208), PknD: (209), PknE: (207)). Thus, PknB forms two essential dimeric
configurations mediated by different regions of the protein. Monomeric structures of PknB are
also available providing the structural basis for dimerization driven allostery of the active site
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(225). In the monomeric state, the N- and C-lobes are shifted relative to each other and the αC
helix is rotated orienting the essential glutamate away from the active site. These structural
insights have coalesced into a mechanistic model for the PknB activation mechanism in which
back-to-back dimerization mediates formation of the active kinase conformation and back-toback dimers phosphorylate other monomers or dimers in trans via the face-to-face interface
(212, 225). The model is structurally analogous to the arrangement of protomers within our
crystal.

Figure 5.10 Kinase trans-autophosphorylation complexes. PDB IDs and literature
references: PKR, to be determined; Chk2, 2CN5 (228); SLK, 2J51 (230); PAK1, 3Q4Z (226).
Note PAK1 contains inactivating mutations K229R and D389N.
5.11 Analysis of ligands bound in the active site
Structure 2, the primary topic of discussion in this Chapter, was co-crystallized with
AMP-PNP yet electron density for the γ-phosphate is missing from the structure. The current
structure is modeled with each protomer bound in its active site by AMP-phosphoramidate
(AMP-PN), a magnesium ion, and a proximal phosphate. The assignment of the AMPphosphoramidate and neighboring phosphate are based solely on the appearance of the
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electron density map. This model predicts that AMP-PNP was hydrolyzed within the crystal and
the terminal phosphate remained proximally bound to the protein. Commercial preparations of
AMP-PNP have been shown to be contaminated with decomposition products of AMP-PNP
(235). Thus, an alternative possibility is that contaminating ADP from the commercially supplied
AMP-PNP preferentially bound to the protein during crystallization. In this scenario, the proximal
phosphate is instead a sulfate obtained from the crystallization solution. The atomic scattering
factors are similar for phosphorous and sulfur (atomic numbers: Z = 15 and 16, respectively) so
that the electron density map alone is insufficient to discern the chemical identity. The analysis
proceeds assuming the ligand assignments are correct however methods which probe the
chemical identity of the molecules contained within the crystal are required.
Figure 5.10 shows the interactions stabilizing the ligands within the active site. Protomer
B is shown with the exchanged portion of protomer A entering on the right. Note that each
protomer within the crystal contains the same bound ligands and, with exception to the glycine
rich G-loop, adopt similar residue conformations. AMP-PN binds in a hydrophobic pocket in the
back of the hinge region between the N- and C-lobes. The pocket is formed primarily by I273,
V281, V294, F368, and F421. Of particular note is F421 which emanates from β7 within the Clobe to stabilize the adenosine ring by pi stacking interactions. Together with V281, V294, and
residues within the C-lobe, F421 forms a hydrophobic spine (C-spine) which regulates
conformational dynamics. The adenosine ring completes the spine linking protein dynamics and
ATP binding (204). The phenyl ring which forms the foundation for ATP binding is unique to
PKR as kinases typically contain a leucine in place of F421 (236). At the back of the binding
pocket, main chain atoms from E367 and C369 within the hinge region make hydrogen bond
interactions with exocyclic and cyclic nitrogens, respectively, of the pyrimidine ring. Interactions
are described moving towards the terminal phosphate. The only interaction stabilizing the ribose
sugar is a hydrogen bond between the 2′-OH and the backbone carbonyl from S418. The αphosphate and the bridging α,β-phosphate oxygen are stabilized by the catalytically important
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K296. Mutation of this residue, even to arginine, disrupts catalysis in most kinases (31). The βphosphate is stabilized via the G-loop by G279. The G-loop is a dynamic element within kinases
and functions during the catalytic cycle by opening and closing to bind and release ATP and
ADP. Structures of eukaryotic Ser/Thr kinases co-crystallized with transition state analogs are
limited but demonstrate how the G-loop closes during catalysis to stabilize the phosphates for
phosphoryl transfer (222-224). The β-phosphate is also stabilized by D432. In our structure, only
a single magnesium ion is bound at the MgII binding site and magnesium site occupancy is
discussed further below. A view of magnesium bound at the MgI site is provided in Figure 5.4
for the 2A19 structure. Magnesium ions bind on opposite faces of the ATP phosphates. MgI is
coordinated by D432 and the β- and γ-phosphates. In our structure, MgII is bound by N419,
D432, the hydrolyzed phosphate, and the α- and β-phosphates. When present, MgII also
coordinates with the terminal phosphate to position it for in-line phosphoryl transfer. The free
phosphate is bound proximal to AMP-PN and interacts with many of the same moieties that it
would in its intact state including MgII and K416. Presumably, water served as a nucleophile to
hydrolyze the terminal phosphate and, in the absence of a true substrate, the phosphate
retained many of its interactions to remain bound. The phosphate is shifted away from the active
site so that it gains an additional coordination from the side chain of S418. In some sense, the
presence of the hydrolyzed phosphate recapitulates some of the observations from PKA. Cocrystallization with ATP, Mg2+, and a dummy substrate peptide whose phosphoacceptor serine
had been mutated to alanine yielded a structure with partially hydrolyzed ATP. The hydrolyzed
phosphate remained bound in a similar position as transition state analogs (237). Relative to the
PKA structure, the phosphate in our structure is shifted ~5 Å away from the active site yet still
interacts with many of the same moieties. Thus, the dummy substrate peptide retained the
hydrolyzed phosphate within the active site.
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Figure 5.11 View of bound ligands. (A) A view of the active site of protomer B is shown
(magenta). The exchanged portion of protomer A is shown in cyan. AMP-PN and the phosphate
are shown in ball and stick representation. Magnesium is shown as a grey sphere. Residues
contributing to the hydrophobic pocket are shown as yellow sticks. Residues contributing
electrostatic interactions are shown as grey sticks with oxygen and nitrogen colored red and
blue, respectively. Hydrogen bonds are drawn liberally as black dashed lines with a 3.2 Å cutoff.
(B) 2-dimensional view of ligand stabilizing interactions. Most of the residues shown in (A) are
flattened into a 2-dimensional interaction map for added clarity. Hydrogen bonds are drawn as
red dashes. A pi stacking interaction between F421 and the adenine ring is shown as two green
circles connected by a dashed line. The hydrophobic surface created by V294 and V281 is
shown as a curved green line.

Hydrolysis of AMP-PNP has previously been observed during co-crystallization as
reported in several publications (238-243) and several unpublished structures deposited on the
PDB (3IED, 4BWP, 4U7O, 5C3Y, 5H9B). Catalysis of the terminal phosphate within free
solution has also been reported by many different types of enzymes including alkaline
phosphatase (244, 245), ATPases (246, 247), a motor domain (248), a calcium pump (240), but
only one kinase, PKA (249). Thus, hydrolysis of the γ-phosphate from AMP-PNP is a relatively
common phenomenon. In some crystallographic studies, acidic crystallization solutions, where
AMP-PNP is unstable, may induce hydrolysis (241-243). The pH of the solution used to grow
our crystals was not acidic (pH = 7.5) and hydrolysis is likely the consequence of enzymatic
action.
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In a structural analysis of PKA, the slow rate of AMP-PNP hydrolysis was exploited
yielding valuable crystallographic snapshots of the phosphoryl transfer mechanism (249).
Crystals were obtained in complex with AMP-PNP and a substrate peptide and two sets of
diffraction data were obtained ~3 and ~5 months after crystal appearance. In the first data set,
the γ-phosphate is partially transferred to the substrate serine and has been fully transferred
after ~5 months. While neither structure represents a transition state per se (only starting end
points of phosphoryl transfer) the structures provide insight into the phosphoryl transfer
mechanism, primarily with respect to the role of magnesium ions. Most kinases utilize two
magnesium ions to catalyze phosphoryl transfer which were historically assigned as the
activating (Mg1) and inhibitory (Mg2) ions. This terminology is misleading and arises from the
observation that high concentrations of magnesium decrease catalytic activity. In fact, ADP
release from the active site, rather than phosphoryl transfer, is the rate-limiting step and is
modulated by magnesium concentration (250). In the 2A19 structure, which is also bound by
intact AMP-PNP, the magnesium ions bind the canonical positions and are labeled as MgI and
MgII in Figure 5.4. In our structure, only MgII is present but it occupies the same position as
MgII from 2A19. This corroborates the observations from the PKA structures where release of
MgI occurred coincident with phosphoryl transfer (249). It is also in agreement with structural
studies on CDK2 which suggest that ADP is released from the active site in complex with MgII
as the rate limiting step during catalysis (251).
5.12 Future directions
The

crystal

structures

reported

here

suggest

that

PKR

forms

a

trans-

autophosphorylation complex during activation. The experiments proposed in this section will
probe whether the complex forms in solution and its role during activation. Additional
crystallographic approaches and their rationale are also described. For additional clarity, the
various experiments are organized in Table 5.4.
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Table 5.4 Future directions.
Approach

Remarks

cis vs. trans

His-tag catalytically inactive PKR (K296R / D414N) and
examine whether it is phosphorylated by WT PKR. Does
any phosphorylation occur (32P)? Is the activation loop
phosphorylated (anti-TPO446 Western)?

S462A

Destabilize domain swap configuration.

G466L

Impede domain swap by reducing flexibility.

N441G

These substitutions promote domain swap. N441 and
D464 H-bond to anchor the N- and C-terminal portions of
the activation segment together.

D464G
R445G
Y454  pAzF / pBpa
T496A / Q463A / S461A
D500A / K521A
Optimization of other
crystallization solutions
Co-crystallization with drug
candidates
Co-crystallization with ssRNA
Co-crystallization with heparin
Co-crystallization with substrate
peptide
Co-crystallization with transition
state analogs
Crystallization of I288D

Crystallization of phospho-PKR

Crystallization of full-length PKR
alone and with dsRNA

Similar to N441:D464, R445 anchors N- and C-terminal
portions of the activation segment by H-bond interactions
to backbone carbonyls.
Directly probe domain swap by crosslinking.
Mutations designed to disrupt the front-to-front interface
without exchange (IF3). May be combined or made
individually.
0.1 M HEPES (pH 7.0), 5 % v/v Tacsimate, 10 % w/v
PEG-MME 5,000 must be optimized.
Structural mechanism of activation by small molecules.
May induce folding within basic domain.
Confirm heparin binding site (91). May also stabilize basic
domain.
Structural information is lacking for how substrate binds in
the active site of PKR.
Limited structural information on mechanism of phosphoryl
transfer. Could stabilize exchanged complex.
The homologous mutation in PknB generated a
monomeric structure (225).
Crystal structure of active PKR is phosphorylated on
threonine 446 (29). Yet other phosphorylation sites are
present within the kinase domain (182, 252). How do these
alternative sites regulate catalytic activity?
Currently only structures of individual domains are
available. Some evidence suggests the dsRBD engages
the kinase in an auto-inhibitory interaction (54). Other
studies indicate PKR exists in a more open conformation
(38, 60). This discrepancy may be resolved by a full length
structure. A complex containing dsRNA would be
invaluable to understanding activation.
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A reexamination of PKR activation by assays which discriminate between cis versus
trans-autophosphorylation mechanisms is required. Both cis (34) and trans (35-38) mechanisms
have been reported. These assays are interpreted by the ability of wild-type PKR to
phosphorylate PKR molecules containing inactivating mutations. The two species are separated
by a tag(s) inserted onto PKR. A His-tag is sufficient to generate separation from wild-type PKR
on an SDS-PAGE gel (36). These experiments will be repeated in our laboratory. Activation will
be probed by both
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P incorporation and Western blots using antibodies specific for

phosphorylated T446 and T451. Additionally, this assay will be combined with the mutations
discussed below in various configurations to provide further insight into the requirements for
autophosphorylation. Note, however, that activation of PKR molecules in solution can be
conceptualized as a multi-step, self-perpetuating activation cascade (61). The slower initial
steps which activate latent kinase molecules may differ from the more efficient subsequent
reactions in which activated PKR molecules phosphorylate latent PKR. A model which
incorporates both cis and trans mechanisms at different steps of the activation pathway may be
required to reconcile with the functional data.
The hypothesis that the exchanged activation segment complex represents a transautophosphorylation complex predicts that disruption of interfacial residues will reduce catalytic
efficiency. However, the mechanism of domain exchange presents a challenging obstacle in
designing mutations to specifically destabilize the strand-exchanged dimer. Inherent to the
domain swapped configuration is restoration of the interactions that would stabilize the domain
within its folded monomeric form within the reciprocal protomer in the dimer. Mutation to
interfacial residues will invariably have an effect on the monomeric conformation, complicating
interpretation of functional analysis. Candidate residues for mutational analysis are limited.
Indeed, the only residue whose interactions are unique to the dimer configuration is S462 which
will be mutated to alanine. Mutagenesis of interfacial residues is a classical approach to
confirming the significance of complexes trapped within crystals. To circumvent the issues
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previously addressed, investigators of domain swapping interactions typically employ an
additional approach that probes the hinge region by mutagenesis (227). In PKR, a flexible
glycine, G466 (see Fig. 5.4A), presumably functions as the hinge to facilitate exchange.
Conceptually, proline is the residue of choice to reduce flexibility. However, proline residues
actually often function as the hinge and facilitate domain swapping by adopting a more
favorable conformation in the exchanged configuration (227). Therefore, bulkier residues will be
introduced to impede exchange. A similar approach was used to confirm activation segment
exchange in SPAK kinase (232). Conversely, mutations will be introduced designed to promote
domain swapping by disrupting interactions which anchor the N- and C-terminal portions of the
activation segment together (N441, R445, and D464, Table 5.4). Mutants containing S462A,
G466L, N441G, D464G, or R445G will test the trans-autophosphorylation complex by functional
analyses for PKR activity. S462A and G466L are expected to decrease activity while stimulatory
effects are anticipated from N441G, R445G, and D464G.
The front-to-front interface without activation segment exchange (IF3) will be probed by
the classical mutagenesis approach. Refer to Figure 5.7 for an image of the interface and Table
5.4 of a list of target residues. The electrostatic interactions which stabilize the interface are
limited and only include a hydrogen bond triad between T496, Q463, and S461 and a salt bridge
between D500 and K521. Similar to other mutations, the effects of mutagenesis will be
screened by functional assays for PKR activity. The functional relevance of the back-to-back
interface is already well established (39). It may be helpful to include mutations which
selectively disrupt the back-to-back interface in the cis- vs. trans-autophosphorylation assays to
provide information on the PKR assembly process. Screening mutational effects by
quantification of oligomeric equilibrium constants is an appealing approach but may not be
applicable to this system. The presence of multiple interfaces and weak oligomerization in
solution complicates the analysis. We have previously measured PKR dimerization by
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sedimentation equilibrium analytical ultracentrifugation to obtain a dissociation constant of ~500
µM (35, 91).
Analysis of the oligomeric configuration of PKR molecules within solution will also be
probed by crosslinking. Classic methodologies combining bifunctional crosslinking agents with
analysis by mass spectrometry are considered. A more elegant approach is afforded by
unnatural amino acid mutagenesis of a tyrosine residue, Y454, which interacts with the
reciprocal protomer at the tip of the αEF arm. Y454 is positioned similarly in the monomer and
the domain swapped configurations and is within hydrogen bonding distance to E480 (see Fig.
5.8E). A method to introduce unnatural amino acids with unique chemistries into proteins is well
established (253) and has been utilized by our laboratory to site-specifically label PKR with
fluorescent probes (65). The system adds an amino acid to the genetic code by co-expression
of an aminoacyl-tRNA synthetase/suppressor tRNA pair which reassign the amber stop codon
(TAG) to encode for the amino acid. Y454 will be replaced with a photoreactive crosslinker,
either p-azido-L-phenylalanine (pAzF) or p-benzoyl-L-phenylalanine (pBpa). Exposure to UV
light activates the amino acids for crosslinking and complexes can be analyzed by SDS-PAGE.
Bands corresponding to dimer confirm activation segment exchange and will be further
validated by mass spectrometry. pAzF is the desirable substitution, generating minimal
structural perturbations by replacing the tyrosine hydroxyl with the reactive azide. However, the
bulkier pBpa has a longer lived excited state and different reaction chemistry (254) and may
produce a crosslinked complex where pAzF fails. The probes will be introduced at other sites
within the protein to probe the back-to-back and front-to-front interfaces and as negative
controls. Note that pBpa has already been introduced at sites to probe the back-to-back
interface. Higher-order oligomers appear on an SDS-PAGE gel and are dependent on pBpa and
UV light confirming the efficacy of this approach (D. Mouser, S. Hesler, and J. Cole,
unpublished results).
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The proposed mechanism for PKR activation is phosphorylation of two threonines within
its activation loop, T446 and T451 (255). T446 is unresolved in our structure but T451 is located
at the tip of the exchanged portion of the αEF helix as the final residue resolved in this region.
The hydroxyl is 8.6 Å from the catalytic aspartate in the reciprocal protomer and structural
rearrangements may mediate formation of a complex to phosphorylate T451 in trans. Similar
rearrangements may orient T446 for phosphorylation yet this is even more speculative given
that it is absent from our structure. Phosphorylation of the residue corresponding to T446 is
conserved in most ‘RD’ kinases and the structural relevance is well established (256). However,
homology does not provide a function for T451 phosphorylation since this residue is not typically
phosphorylated in other kinases. Most Ser/Thr kinases contain a threonine or serine at this
position yet its function is seldom annotated (32). Although, a catalytically function for this
residue has been proposed from structural analyses on PKA (237). Substrate peptide induces a
reorientation of the residue so that it engages in a trigonal bonding interaction with the catalytic
aspartate (D414 in PKR) and neighboring lysine (K416 in PKR). The interaction is proposed to
orient the catalytic aspartate carboxylate for proton abstraction. It is unclear whether
phosphorylation of T451 is compatible with this catalytic mechanism. Note, however, that while
phosphorylation of T451 is often referenced in the literature, evidence for this modification is not
convincing. The prescribed function of T451 as a phosphoacceptor site is deduced from the
correlations between T451A mutations and phosphomimetic mutations, enzymatic activity, and
Western blots with antibodies against phosphorylated T451. However, a catalytic role for T451
would be perturbed by mutation and antibodies may not be specific for T451. Mass
spectrometry has failed to detect phosphorylation of T451 even though T446 is phosphorylated
in the analysis (48, 182). Furthermore, in the structure of the phosphorylated PKR kinase, only
T446 is phosphorylated (29). A reexamination of T451 phosphorylation is necessary prior to its
assignment as a phosphoacceptor site in our putative trans-autophosphorylation complex.
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Finally,

additional

crystallographic

approaches

will

be

pursued.

Additional

crystallographic conditions, such as crystallization by Tacsimate / PEG-MME 5,000 (see Fig.
5.2), require optimization. Another structure exhibiting domain swapping in a front to front
arrangement generated from an additional crystallographic condition and possibly space group
would provide further validity to the structures reported here. The ability to make diffraction
quality crystals brings a valuable technology to the laboratory which synergizes with many other
projects. An ongoing project to identify small molecule activators of PKR (S. Hesler and J. Cole,
unpublished results) would benefit greatly from a facile method to analyze the structural function
of any hits. We have previously characterized heparin mediated activation of PKR and used
mutagenesis to identify a positively charged pocket partially formed by helix αC as the heparin
binding site (91). Although, alternative sites have been proposed (179). A structure of PKR
bound to heparin would resolve the discrepancy and provide valuable mechanistic insight into
how heparin induces activation. The original motivation behind crystallographic analysis of the
229-kinase construct was to obtain structural information on the basic region. Unfortunately,
residues 229-256 are unresolved in our structure. The basic region exhibits cursory
resemblance to arginine rich motifs (ARMs), short stretches enriched in basic residues which
bind RNA (257). One of the most well characterized ARMs is HIV-1 Rev which has been shown
to fold into an alpha helix upon binding its target RNA, RRE (258, 259). Thus, a ligand may be
required to induce folding within the basic region and co-crystallization trials with short ssRNAs
are currently underway. Under the assumption that our structure represents an enzymesubstrate complex, the front-to-front interfaces recapitulate some of the observations from the
PKR-eIF2α complex. In both structures, the substrate for phosphorylation (T446 in PKR and
S51 in eIF2α) and neighboring residues are disordered. A structure containing substrate peptide
bound at the active site is unavailable, necessitating assumptions for how substrate may
interact from homologous kinases where such information is available. Such a complex may
also provide information on the role of T451 during activation. Structural information on the
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Ser/Thr kinase transition state gleaned from co-crystallization with transition state analogs is
limited (222, 223, 260). Dissociative (SN1) and associative (SN2) mechanisms for phosphoryl
transfer have been proposed which differ primarily in the relative distances and bonding
interactions between the β-phosphate, γ-phosphate, and substrate hydroxyl during the transition
state (250). Molecular dynamics simulations indicate a dissociative mechanism is more likely
(50). A structure of PKR containing a transition state analog would provide much needed
information on the nature of phosphoryl transfer but also may stabilize activation loops in the
front-to-front interface in active sites of reciprocal protomers. Finally, a structure of monomeric
PKR would provide valuable structural information on the conformation changes associated with
the assembly of PKR molecules into the activating complex. Structural investigations of the Pkn
family of kinases, which are structural homologous to PKR and form similar interfaces, are a
useful guide (261). A monomeric structure of PknB was produced by mutating residues
contributing to the back-to-back interface. One residue is conserved in PKR, I288, which packs
into a hydrophobic pocket on the back of the αC helix (Fig. 5.6).

137

Chapter 6: Host and viral protein regulators of PKR
6.1 Introduction
The canonical PKR activators are long stretches of duplex RNA. However a protein
activator, PACT, has been identified more recently (92). PACT activates PKR in response to a
variety of cellular stressors to induce apoptosis in the absence of viral infection (96). Similar
observations have been reported for the mouse ortholog, RAX (262). PACT contains two Nterminal dsRBDs homologous to PKR (dsRBD1 and 2) and a dsRBD at the C-terminus that
lacks residues that mediate RNA binding (D3). The model describing PACT-mediated PKR
activation hinges upon the proposed autoinhibitory intramolecular interaction within PKR
between dsRBD2 and the kinase domain (see Section 1.4) as well as the proposed role of the
dsRBDs in mediating protein-protein interactions (54, 55). PKR is stimulated in a concerted
mechanism whereby dsRBD1 and 2 from PACT relieve autoinhibition by engaging dsRBD1 and
2 in PKR and D3 interacts with the kinase domain to promote activation (94, 95). A MBP-D3
fusion construct binds PKR weakly yet is able to potently activate PKR in vitro. However, full
length PACT is required for PKR activation in vivo (95). Phosphorylation of two sites within D3,
S246 and S287, increases PKR affinity and activation potency (97, 263). S246 appears to be
constitutively phosphorylated and S287 phosphorylation transduces the stress response signal.
The upstream activating kinase is unknown (97). Phosphomimetic (SD) mutations functionally
substitute for phosphorylation (97, 263). Deletion mapping and alanine scanning experiments
have identified a region within the N-lobe of the PKR kinase domain corresponding to residues
328-335 which interacts with D3 (98). In NMR experiments, addition of D3 to a labeled peptide
consisting of residues 326-337 from PKR produced chemical shifts, indicating binding. The
same effect occurred upon addition of PKR-dsRBD2, supporting the hypothesis that D3 and
dsRBD2 interact with the same site on the kinase domain (98). Note, however, that an
alternative site within the C-lobe has been proposed to maintain the dsRBD2-kinase
autoinhibitory interaction (55).
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The solution structure of the first dsRBD from PACT has been solved (PDB ID 2DIX;
RIKEN Structural Genomics Initiative) (Fig. 6.1D). PACT is the human homologue to Xlrbpa and
the two proteins share ~67% sequence identity within dsRBD2 (Fig. 6.1C). The crystal structure
of Xlrbpa dsRBD2 in complex with dsRNA is presented in Fig 1.2B. D3 belongs to a class of
motifs categorized as type-B dsRBDs which resemble the canonical dsRBD in sequence yet
lack the residues necessary for dsRNA binding (Fig. 6.1B) (93, 164). To date, the structure of
only a single type-B dsRBD has been solved, dsRBD5 from STAU1 (STAU1-5) (264). The
structure reveals how the domain has retained a group of conserved residues which engage in
hydrophobic packing interactions in the region between α1 and α2 to stabilize the dsRBD αβββα
fold. A sequence alignment between ‘true’ (type-A) and ‘false’ (type-B) dsRBDs which is
relevant to this study is shown in Fig. 6.1B. Domain 3 from PACT and TRBP both contain the
appropriate conserved hydrophobic residues which stabilize the dsRBD fold. Thus, it is likely
that, like STAU1-5, they form the canonical αβββα structure. Based on the sequence alignment
(Fig. 6.1B) the expected positions for the phosphorylated residues within PACT-D3 are
indicated on the structure of PACT-dsRBD1 shown in Figure 6.1D. S246 is expected to replace
a RNA-binding residue in region 1 within helix α1. S287 resides in the β2-β3 loop expected to
be bigger in both PACT-D3 and TRBP.
PKR activation is intricately controlled in vivo by PACT and its functional antipode TRBP
(Tar RNA Binding Protein). TRBP is homologous to PACT in sequence and domain
organization, with tandem dsRBDs at the N-terminus and a type-B dsRBD at the C-terminus
(265). TRBP was originally identified as an endogenous component which enhances HIV
replication (266). This activity has been attributed to sequestration of dsRNA by the dsRBDs
(267). However, subsequent analyses have indicated that TRBP directly interacts with PKR to
inhibit it (268). The proposed interaction mechanism is similar to PACT where the N-terminal
dsRBDs interact with the dsRBDs of PKR. In TRBP, the third domain elicits an inhibitory effect
(269). As shown in Figure 6.1A and C the third domains of TRBP and PACT are highly
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homologous. Thus, the residues which confer the stimulatory phenotype to PACT must be
highly specific. PACT and TRBP both homodimerize and can interact with one another allowing
for precise control of PKR activity within the cell (265, 270). The PACT-TRBP interaction
prevents the stimulatory interaction between PACT and PKR. Phosphorylation of S287 within
PACT in response to stress inhibits the TRBP interaction to promote PKR activation (271, 272).
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Figure 6.1 Structure of PACT. (A) Domain organization. (B) Structure based sequence
alignment of dsRBDs. The protein name is indicated and the number after the hyphen
corresponds to the respective dsRBD within each protein. Values in parenthesis represent the
amino acids shown in the alignment. A combination of resources was used to generate a
sequence alignment. The consensus residues which contribute to RNA binding (cyan) and the
dsRBD fold (green) are adapted from (13). Sequences were first aligned in Clustal Omega
(180). An additional alignment was performed in Pymol for the sequences with associated
structures. The alignment was further manipulated by hand guided by the interpretations of
Gleghorn et. al. (93). The phosphorylated residues within domain 3 of PACT are indicated in
magenta. (C) Pairwise amino acid percent identity matrix for alignment shown in (B). Prepared
by Clustal Omega (180). (D) Structure of PACT dsRBD1 (PDB ID 2DIX). Amino acids are color
coded according to the alignment shown in (B). Cα atoms are shown as spheres. The alignment
suggests PACT-D3 adopts a similar fold. Hypothetical locations for the two phosphorylation
sites in D3 (S246 and S287) are shown in magenta.
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Viruses whose propagation is inhibited by PKR often develop methods to inhibit PKR
activation. Examples include RNAs that irreversibly bind PKR, proteins which inhibit PKR
dimerization, and proteins that act as decoy phosphorylation substrates (9). Influenza encodes a
26 kDa protein, NS1, which is not part of the virion but is expressed during infection. NS1 is a
multifunctional protein which interacts with a variety of host components to promote viral
replication (99). The primary role of NS1 appears to be inhibition of the cellular 3′-end
processing system which results in retention of host mRNAs in the nucleus (273). By
sequestering host mRNA in the nucleus, NS1 increases the amount of viral RNA translated.
NS1 has also been associated with inhibition of PKR. Influenza mutants lacking NS1 are
attenuated in mice yet replication is rescued in mice containing PKR knockouts (274). The
mechanism of PKR inhibition remains controversial. Some studies indicate that NS1 binds and
sequesters viral dsRNA from PKR (275, 276) while others show NS1 binds directly to PKR to
inhibit activation (100-102). NS1 inhibits PKR activation by both dsRNA and PACT (100, 101).
The PKR interaction site has been mapped to residues 123-127 in NS1 (100). The NS1
interaction site on PKR is mapped to the linker region and a mechanism of inhibition has been
proposed where NS1 locks PKR in an auto-inhibited state (101).
NS1 contains a unique N-terminal RNA binding domain and a C-terminal effector domain
(ED) separated by a short ~15 residue linker (Fig. 6.2A) (277). A disordered C-terminal tail has
a strain-specific length up to 33 amino acids and interacts with host components, although its
contribution to virulence is unclear (278). The RNA-binding domain dimerizes to form a sixhelical bundle (279, 280). The structure of the RNA-binding domain in complex with dsRNA
reveals how two long helices lay along the duplex making contacts with the RNA backbone (Fig.
6.2B) (281). The first crystallographic studies of the isolated effector domain (ED) reported
multiple dimeric interfaces (282-284). Biochemical and biophysical analysis of isolated effector
domain constructs support the helix-helix interface shown in Figure 6.3C in which a highly
conserved tryptophan (W187) packs into a hydrophobic pocket on the reciprocal protomer (283,
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285, 286). The isolated ED dimerizes weakly in solution (286) yet several studies indicate that
this activity contributes to cooperative assembly of NS1 molecules onto dsRNA. Cryo-EM
studies have detected tubular filamentous assemblies of NS1 molecules onto long duplex RNAs
(287). Mutation of the invariant interfacial tryptophan decreases RNA binding affinity (285).
Virulence is severely attenuated in influenza viruses expressing a truncated NS1 lacking the ED
yet can be partially rescued by attachment of heterologous dimerization domains (288). The
structures of full length NS1 (287, 289) have led to a mechanistic model which reconciles much
of the crystallographic and functional data. The model proposes that the relative orientations of
the RNA binding domain and the effector domain change to promote different oligomeric
configurations of the effector domain. These changes facilitate the myriad of binding interactions
and functions attributed to NS1 (289). The proposed assembly of NS1 molecules on a dsRNA is
shown in Figure 6.2D.
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Figure 6.2 NS1 domain organization and structure. (A) NS1 domain organization. The
positions of residues implicated in PKR interaction (IMDKN) are indicated in purple. The
conserved tryptophan (W187) which mediates dimerization is also shown in yellow. Color
coding is maintained throughout the figure. (B) Dimer of the RNA-binding domain in complex
with dsRNA. Residues which contribute to the interaction are shown as sticks. For clarity
nucleotide bases are omitted. (PDB: 2ZKO, (281)). (C) Dimeric structure of the effector domain
(PDB: 3D6R, (283)). PKR-binding residues and W187 are shown is sticks. Note that in this
strain of influenza contains a N127R mutation in the PKR binding site. (D) Proposed assembly
of NS1 molecules onto dsRNA. Full length NS1 containing a truncation to the linker region (∆8084) crystallizes as a dimer (PDB: 4OPA, (289). Effector domains dimerize via the interface
shown in (C) across a 2-fold crystallographic symmetry axis. Three asymmetric units are shown
in (D). PKR-binding residues and W187 are shown as spheres. Importantly note that duplex
RNA has been manually added. This model is adapted from references: (285, 289).
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The purpose of this study is to examine the mechanisms by which protein regulators
modulate PKR activity. NS1 and PACT elicit opposite effects yet both are proposed to operate
by controlling the same conformational switch in PKR. PACT interacts with a region in the
kinase domain to break an intramolecular autoinhibitory interaction between PKR-dsRBD2 and
the kinase domain (98). NS1 interacts with the linker region (residues 170-230) to lock PKR into
the autoinhibited conformation (100, 101). However both these mechanisms are incompatible
with evidence which indicates PKR does not adopt the autoinhibited conformation in the latent
state (reviewed in Section 1.4). Heparin and dsRNA both activate PKR by facilitating kinase
domain dimerization (63, 91). Thus it seems likely that PACT activates PKR by promoting
oligomerization or by inducing a similar allosteric effect within the activate site as mediated by
the back-to-back PKR dimer interface. The interactions of PACT and NS1 with PKR have been
assayed primarily by the use of two-hybrid assays and co-immunoprecipitation assays often in
crude or partially purified lysates (92, 95, 96, 100, 101). These assays cannot distinguish the
stoichiometry of the interacting complexes or whether additional components are involved. Here
we apply sedimentation velocity analytical ultracentrifugation using purified protein preparations
to probe these interactions.
Results
6.2 Characterization of NS1 and PKR interaction
We have expressed the effector domain of NS1 encoding residues 74-230 from H1N1
influenza A/Puerto Rico/8/1934 (NS1-ED) containing a N-terminal his-tag. As an initial step
toward analyzing the interaction with PKR we characterized the association state of NS1-ED by
sedimentation velocity in AU200 buffer. In agreement with earlier reports (285, 286) the effector
domain dimerizes in solution (Fig. 6.3A). The time difference curves were fit to a monomerdimer equilibrium model in SEDANAL (118). The Kd obtained from the fit was 7.1 µM (4.47,
9.73) with a monomer s value of 1.80 S (1.78, 1.82) and dimer s value of 2.50 S (2.50, 2.51)
and rmsd of 0.0347. A similar sedimentation velocity protocol was employed to investigate the
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interaction of NS1-ED with PKR. NS1-ED was titrated against PKR up to a 2:1 molar
equivalence ratio. Our analysis does not detect the interaction with PKR which has been
reported in the literature (100, 101). The NS1-ED monomer-dimer equilibrium causes
concentration dependent formation of a complex at 2.50 S. However, a species does not form at
sedimentation coefficient values above ~3.4 S where PKR freely sediments.

Figure 6.3 Characterization of NS1 and PKR. (A) Dimerization of the NS1 effector domain.
Sedimentation velocity was used to monitor the concentration dependence of NS1-ED
oligomerization. Measurements were obtained in AU200 buffer at 20 °C and 55,000 rpm using
interference optics. The data are represented as c(s) distributions which are normalized by area.
Parameters obtained from fitting the data to a monomer-dimer equilibrium model are reported in
the text. (B) Analysis of NS1-ED:PKR interaction. Sedimentation was monitored at 50,000 rpm
in AU200 buffer at 20 °C and 55,000 rpm using interference optics. Samples were prepared at a
fixed concentration of PKR with addition of NS1-ED. Sedimenting species are labeled. The trace
for PKR alone is drawn thinner to show the distributions underneath.
6.3 Characterization of PACT
In agreement with earlier reports (92, 94) full length PACT resides in the insoluble
fraction when expressed in E. coli. Attempts to optimize expression and cell lysis protocols
failed to yield soluble protein. A His-tagged version of PACT was solubilized with 4 M urea and
refolded while bound to Ni2+-NTA resin by running a decreasing gradient of urea. The His-tag
was cleaved prior to most of the assays reported here. The initial set of experiments were
designed to examine the refolded protein (Fig. 6.4). The protein readily aggregates at 20 °C so
most experiments are performed at 4 °C. The circular dichroism spectra indicates the presence
of secondary structure with minima at 208 and 222 nm characteristic alpha helical content (290)
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(Fig. 6.4A). PACT sediments as a strongly associated dimer with a corrected sedimentation
coefficient (s20,w) of 3.8 S (Fig. 6.4B). Misfolded protein are expected to aggregate.
Sedimentation velocity was used analyze the interaction of a 20 bp dsRNA with PACT at 4 °C in
200 mM NaCl (Fig. 6.4C). The distributions shift to a sedimentation coefficient of ~6 S as PACT
is added indicative of complex formation. The data fit well to a model where the PACT
homodimer interacts with the RNA to form a 2:1 complex with a Kd = 94 nM and RMSD =
0.00816 OD. For comparison, full length PKR binds to the same 20 bp dsRNA with an affinity of
300 nM in 200 mM NaCl at 20 °C (62). This result demonstrates that PACT is competent to bind
dsRNA with high affinity and indicate that the refolding protocol was successful. Finally,
resistance to proteolytic digestion by trypsin indicates regions that are protected (Fig. 6.4D). In
the protease titration PACT remains largely intact until addition of a 1:2,500 ratio of
trypsin/PACT. In contrast, a 1:20,000 ratio induces substantial cleavage of PKR within the
unstructured linker region (59). The ~17 kDa intermediate band that forms from proteolysis of
PACT presumably corresponds to either of the dsRBDs or D3 which are all approximately equal
in size and expected to have molecular weights of ~15 kDa. Taken together, these analyses
indicate PACT is refolded and suitable for further characterization.
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Figure 6.4 Characterization of full length PACT. (A) Circular dichroism analysis of the
refolded protein. (B) Sedimentation velocity analysis. Sedimentation was monitored at 50,000
rpm by the interference optical system in AU200 buffer at 4 °C. c(s20,w) distributions normalized
by amplitude are shown with the raw data in the inset. PACT sediments as a strongly
associated dimer with s20,w = 3.8 S. The data were fit to a discrete species model yielding a
molecular weight of 65.3 kDa (predicted monomer = 34.7 kDa). (C) Interaction with duplex 20
bp RNA. g^(s20,w) distributions are normalized by area. Samples contained 1.5 µM 20 bp dsRNA
and the indicated equivalence ratio of PACT. The data were fit a model where the PACT dimer
binds the RNA to form a 2:1 complex. The fit produced a Kd = 94 nM (76, 114) with an RMSD of
0.00816 OD. The fitted complex sedimentation coefficient was s20,w = 5.98 S (5.90, 6.05). (D)
Limited proteolysis of PACT. Full length PACT(his) was incubated at 0.67 mg/ml with various
ratios of PACT/trypsin for one hour at 4 °C. A 3 hour incubation yielded the same digestion

6.4 Interaction studies with PKR
Sedimentation velocity was used to investigate the interaction between PACT and PKR
at 4 °C in 200 mM NaCl (Fig. 6.5A). Under these conditions, PKR exists as a monomer with s20,w
= 3.5 S and PACT is a dimer with s20,w = 3.8 S. Mixtures were prepared at multiple PACT:PKR
ratios. Formation of a complex would result in the appearance of higher s species. However, the
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c(s20,w) distributions of the mixtures appear as sums of the individual components, indicating that
PACT and PKR do not interact under these conditions. We introduced the phosphomimetic
mutations within D3 purported to enhance PKR affinity (263). S246D/S287D PACT has a
slightly higher sedimentation coefficient (s20,w = 3.9 S) than the wild-type protein indicating that it
may adopt a more compact structure (Fig. 6.5B). Like wild-type PACT, the c(s20,w) distributions
are the sum of individual components indicating that in our analysis the phosphomimetic
mutations do not promote a PACT PKR interaction. Activation of PKR by PACT was assayed by
monitoring the stimulation of

32

P incorporation from [γ-32P]ATP into PKR (Fig. 6.5C). The data

are quantitated in Figure 6.5D and normalized to the autophosphorylation of PKR in the
absence of an external activator. Control samples demonstrate that a 40 bp dsRNA activates
PKR. However, both wild-type and S246D/S287D PACT fail to activate PKR and actually inhibit
the baseline activation. At elevated PACT concentrations an additional band appears lower on
the gel which corresponds to phosphorylated PACT. Thus, PKR can phosphorylate PACT
indicating the two proteins must at least transiently interact. PACT activation is allegedly RNAindependent (92) yet RNA can contaminate purification of RNA-binding proteins (291).
Additional samples were included in the S246D/S287D PACT experiment to ask whether PACT
promotes dsRNA-induced activation of PKR. PACT inhibits activation by 40 bp dsRNA at higher
concentration (1.8 µM), presumably due to competition for the RNA. At lower concentrations
(0.2 µM) PACT facilitates a slight increase in ds40 induced activation. An assay to investigate
this result has not been performed.
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Figure 6.5 Full length PACT and PKR. (A) Sedimentation velocity analysis of WT PACT and
PKR. c(s20,w) distributions are normalized by amplitude and offset. Sedimentation was monitored
at 50,000 rpm by the interference optical system in AU200 buffer at 4 °C. Loading
concentrations of PACT and PKR are indicated along the traces. A dashed vertical line indicates
the sedimentation coefficient of PKR and a solid line is drawn for PACT. (B) Sedimentation
velocity analysis of S246D/S287D PACT and PKR. Experimental conditions and data
representation are as in (A). (C) Activation assays with PACT. 200 nM PKR was assayed for
activation by both wild-type (top) and S246D/S287D PACT (bottom). The assay was performed
in P50 buffer at 32 °C over a 20 min time course. A duplex RNA consisting of 40 bp served as a
positive control. PKR phosphorylates PACT and the position of the two proteins are indicated on
the gel. The symbols correspond to quantitated values shown in (D). (D) Quantitation of
6.5 PACT domain 3
Our functional analysis of refolded PACT confirmed the protein was competent to bind
dsRNA indicating at least one of the dsRBDs was properly folded. However the only functional
analysis for D3 is PKR activation and our results disagree with published observations (92).
Previous studies have had success with purification of a recombinant isolated D3 construct from
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the soluble fraction of E. coli lysates (94). We created domain constructs to match the previous
report (94). A construct encoding dsRBD1 and 2 consists of residues 1-194. The isolated D3
construct contains residues 195-313. The dsRBD1+2 construct is insoluble indicating this is the
region responsible for insolubility of the full length protein. However the D3 construct is soluble
and was purified to high yield. As a first step toward characterizing the interaction of D3 with
PKR we measured the protein concentration dependence of self-association of the newly
isolated construct. D3 was much more stable than the full length protein permitting experiments
at 20 °C. Like the full length protein, D3 sediments as a strongly associated dimer with an s20,w =
2.41 S (Fig. 6.6A). Others have found that domain 3 induces dimerization of full length PACT
and its homologue Xlrbpa (292). In Xlrbpa, the region which mediates dimerization has been
mapped to the last five residues at the C-terminus.
Next, we performed binding assays with PKR. The analyses on full length PACT were
performed at 4 °C in AU200 buffer (200 mM NaCl). We have probed for a D3-PKR interaction at
20 °C in AU200, AU75 (75 mM NaCl), and P50 (50 mM KCl, 5 mM MgCl2) buffers and the
sedimentation profiles are similar. The data generated in P50 buffer is presented in Figure 6.6B
since P50 is the buffer used in activation assays. PACT-D3 and PKR have different
sedimentation coefficients so the two species are resolved by c(s) analysis. Like full length
PACT we do not detect a complex between D3 and PKR. However, domain 3 induces
concentration-dependent activation of PKR (Fig. 6.6C). Activation is weak, with a maximum
~1.8-fold over PKR background activity occurring at 6 µM D3, corresponding to a 30-fold molar
excess over PKR. Similar to activation by RNA (63) and heparin (91), the activation curve is
bell-shaped, implying that PACT induces dimerization similar to other activators. Activation
implies, of course, that D3 and PKR interact. The complex may be transient or too weak to
detect by sedimentation velocity. To trap the complex we employed chemical crosslinking with
the homobifunctional amine-reactive crosslinker disuccinimidyl suberate (DSS) (Fig. 6.6D).
Samples were prepared with a fixed concentration of PKR and titration of D3 up to a 10-fold
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molar excess. Addition of DSS induces concentration-dependent formation of D3 dimer adducts
but a PKR-D3 crosslink is not detected. Additional samples were included to ask whether ATP
and magnesium facilitates complex formation. However no PACT-D3 crosslink was detected in
these samples either. We have extended the titration to higher D3-PKR stoichiometries (up to
700 µM D3) but still did not detect a complex (data not shown). At elevated concentrations of
D3, crosslinking by DSS induces a laddering effect indicating D3 may form even higher
oligomeric species than dimer.
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Figure 6.6 PACT domain 3 and PKR. (A) Sedimentation velocity analysis of PACT D3
construct. Sedimentation was monitored at 50,000 rpm by the interference optical system in
AU200 buffer at 20 °C. Domain 3 sediments as a strongly associated dimer with s20,w = 2.41 S.
The data were fit to a discrete species model to yield a molecular weight of 30,591 Da
(expected monomeric weight = 15,173 Da). (B) Sedimentation velocity analysis of PACT-D3
and PKR. The experiment was conducted in P50 buffer at 20 °C. Each distribution is normalized
to peak amplitude and offset along the y-axis. Loading concentrations of PACT-D3 and PKR are
indicated along each distribution. Vertical lines indicate the sedimentation coefficients for PACTD3 (solid line) and PKR (dashed line). (C) Activation assays with PACT-D3. 200 nM PKR was
assayed for activation by the domain 3 construct in P50 buffer at 32 °C over a 20 min time
course. The 40 bp dsRNA serves as a positive control. The phosphorimage is shown on the top.
The data and quantitated in the plot below and normalized to the activation of PKR in the
absence of activator. Activation by ds40 is indicated by a red square. (D) Chemical crosslinking.
PKR was titrated with PACT-D3 in P50 buffer. DSS was added to 10-fold molar excess and the
reaction was allowed to proceed for 30 min at RT. Samples were resolved on a 4-12%
acrylamide tris-glycine gel run under denaturing conditions and visualized by Coomassie Blue
staining. The final three lanes contain 400 µM ATP plus 5 mM MgCl2. The molecular weights of
the protein ladder are indicated on the left (kDa) and the species within the gel are indicated on
the right. Concentration dependent formation of a PACT-D3 dimer is detected however a PACTPKR adduct is not formed.
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6.6 Discussion
This study reports the analysis of two RNA-binding proteins reported to interact with
PKR and elicit opposite effects. However, our analyses do not detect complex formation with
either protein. The commonality between all the proteins under investigation is their RNAbinding activity and this behavior may rationalize the experimental differences. Coimmunoprecipitation in cell extracts or two-hybrid experiments are the primary assays which
have defined the interactions between PKR and NS1 (100-102) or PACT (92, 94-97).
Convincing control experiments are sometimes included to rule out co-precipitation of proteins
on a single RNA (92, 101). However, these controls are often not incorporated into the studies
which have defined the protein-protein interaction sites. One study has demonstrated that the
RNA-binding domains of NS1 are required for PKR interaction (102) and another showed that
NS1 interacts with a region encompassing the dsRBDs and linker on PKR (101). The models for
PACT and TRBP modulation of PKR activity postulate that high-affinity interactions between the
dsRBDs anchor protein-protein interactions and the third domains of PACT or TRBP elicit
opposite enzymatic effects (269). Mutations to RNA-binding residues within PKR’s dsRBDs
(K60A, K64A, K150A, K154E, see Fig. 1.2) diminish interaction with both PACT or TRBP in a
two-hybrid assay (269). Based on these effects the residues have been implicated in direct
protein-protein interactions. However, it seems more likely that an interaction facilitated by
dsRNA produced false positive results in the two-hybrid assays. PACT, TRBP, and NS1 belong
to an expanding family of RNA-binding proteins reported to directly engage PKR. ADAR (293),
NF90 (294), DUS2 (295), and the herpes simplex virus type 1 protein Us11 (296) have all been
identified by pulldown assays and are implicated in PKR inhibition by direct protein-protein
interactions.
Additional experimental differences may contribute to the divergent outcomes between
our analysis of PACT- and NS1-PKR interactions and earlier reports. In previous PACT and
NS1 studies, PKR is typically obtained from cellular extracts of human cell lines and partially
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purified using an affinity tag. Cellular components which remain bound to PKR or posttranslational modifications which would not be present in our PKR preparations may contribute
to the interaction between PACT or NS1. Both the NS1 and PACT protein constructs used in the
studies are also different. We have used NS1 from the H1N1 influenza A/Puerto Rico/8/1934
(PR8) virus whereas PKR-NS1 interactions have primarily been characterized in the context of
NS1 from H3N2 A/Udorn/1972 (Udorn) (100, 101). PR8 contains the residues at positions 123127 which have been implicated in PKR interaction (100). However, Udorn NS1 has a 7 residue
addition to the C-terminal tail and additional amino acid changes which may be important for
binding PKR. We have obtained a plasmid encoding full length Udorn NS1 to test for strain
specific PKR interactions.
Our NS1 study supports the PKR inhibition model in which NS1 shields duplex RNA
from PKR (275, 276). The alternative model suggests that residues 123-127 within NS1 directly
engage the N-terminal region of PKR to lock PKR in an autoinhibited state (100, 101). Residues
123-127 were identified by the effects of mutagenesis on co-immunoprecipitation in cell extracts
(100). However, RNase was not added to the assay and residues 123-127 are located proximal
to the effector domain dimeric interface (see Fig. 6.2C, D). The dimerization activity of the
effector domain is critical for cooperative association of NS1 molecules onto duplex RNA (286,
297). Thus, it is possible that mutagenesis of residues 123-127 affects RNA binding rather than
PKR interaction. Filamentous assemblies of NS1 onto RNA has been observed by cryo-EM
(287) and a model has been proposed in which NS1 encapsulates the RNA with effector
domains forming an oligomeric chain along the outside of the complex (289) (Fig. 6.2D). NS1
has been implicated in the inhibition of other antiviral proteins which respond to viral RNA
including 2′-5′-oligo (A) synthetase (298) and RIG-I (299). The encapsulating assembly of NS1
molecules around an RNA would provide a common mechanism to inhibit a variety of
intracellular immune receptors.
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Similar to our NS1 analysis, we do not detect formation of a PKR-PACT complex in
sedimentation

velocity

experiments.

Full

length

PACT

does

not

activate

in

PKR

autophosphorylation assays, however, the isolated D3 construct weakly activates. We are
unable to characterize the activation mechanism since a complex is not formed in sedimentation
velocity experiments or captured by chemical crosslinking. The absence of measurable complex
formation may be explained by a weak, transient interaction between PKR and D3 below the
detection limits of the optical system in the analytical ultracentrifuge. Phosphorylation enhances
PKR dimerization affinity by ~ 500-fold and we have previously proposed a branched chain
reaction model to explain how strong PKR activation can be induced by dimerization at
concentrations well below the Kd for latent enzyme (61). By analogy, weak complex formation
between the PACT-D3 and PKR may serve to initiate a cascade of PKR autophosphorylation
resulting in activation.
The experimental differences previously addressed in the context of NS1-PKR
interaction studies extend to the PACT-PKR investigations. PKR prepared from cellular extracts
of human cell lines may contain post-translational modifications or additional components which
contribute to the interaction. In support of this, the results from one study indicates the PACTPKR interaction may be specific to certain cell lines (300). Others have found that PACT
actually inhibits PKR activation in some cell types (271). Also analogous to the NS1 interaction
study, the PACT constructs used here are different from those previously analyzed. The original
PACT expression vector contained a frameshift mutation at the 3′-end which results in a
construct encoding the wild-type sequence at residues 1-300 with five random amino acids at
the C-terminal end (KLCSI) (92). The mutation is addressed in a subsequent study (95)
although it was not corrected and it appears as though this mutated form of PACT is used in all
subsequent analyses. Others have had difficulties recapitulating the stimulatory effect of PACT
in vivo and have analyzed the mutant form of PACT (PACT∆13) to resolve the discrepancy
(271). PACT∆13 activates PKR more potently than wild-type PACT in certain cell lines but both
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forms of PACT have no effect in others. The C-terminal residues in the PACT homologue Xlrbpa
mediate protein dimerization (292). We have expressed PACT∆13 and characterized its
association state by sedimentation velocity. The experiment was performed under different
conditions than wild-type PACT. However, PACT∆13 was monomeric up to the highest
concentration assayed. It may be worthwhile to extend the analysis to further characterize
PACT∆13 and the effect of PACT oligomerization on PKR activation. A PACT-TRBP interaction
is proposed to inhibit the stimulatory interaction between PKR and PACT (271). Likewise,
formation of the PACT dimer may prohibit PKR binding and activation by a similar mechanism.
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Chapter 7: Conclusions
The canonical activators of PKR are long stretches of duplex RNA regions (>30 bp)
present in viral transcripts. However, an expanding family of RNAs characterized by limited
regions of extended duplex has been described as PKR activators. These RNAs lack the
minimal duplex length requirements for PKR activation and alternative structural elements are
proposed to modulate PKR activity. Notably, single-stranded regions and a 5′-triphosphate (5′ppp) were reported to be important determinants for activation when attached to minimally
structured regions. This class of minimally structured RNAs has been defined as ss-dsRNAs
although the structural variability of RNAs within this category has become increasingly broad.
We began our analysis of the ss-dsRNA motif by creating a 15 bp duplex stem capped
by a tetraloop and flanked by 15 nt single-stranded tails. To gain insight into the contribution of
the single-stranded regions to PKR activity we systematically dissected each tail in 5 nt
increments and characterized the effects on binding affinity and activation. Activation
distributions reveal a bell-shaped activation profile suggesting that, like duplex RNAs, ssdsRNAs mediate PKR dimerization to induce activation by formation of the RP2 complex. We
have previously characterized the length dependence of perfect duplexes on binding affinity and
activation. Activation by dsRNAs requires a 2:1 binding stoichiometry and activation potency
increases with the population of the RP2 species. Under the conditions we analyzed the ssdsRNAs all bind two PKR, however, not all activate. Thus, ss-dsRNAs do not exhibit the same
strict requirement for binding stoichiometry as perfect duplexes. Our measurements detect a
weak correlation between tail length, binding affinity, and activation potency. Deletion of the tails
drastically reduces binding affinity and abolishes activation. However, some constructs with
intermediate tail lengths bind with only moderate affinity yet activate potently. Conversely, other
constructs bind tightly but fail to activate. The composition of nucleotides within the tails is not
identical and there may be nucleotide identity preferences for activation. Alternatively, the
variability may reflect specific conformational requirements which determine how two PKR
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molecules interact on the RNA. Our model for PKR activation by duplex regions postulates that
dsRNA serves as a scaffold for the assembly of PKR monomers. Single-stranded regions may
have a more activate role in coordinating the orientation of interacting PKR molecules. In this
scenario longer tail lengths may not promote the appropriate assembly of PKR monomers
bound to the RNA.
More broadly, the results imply that single-stranded regions interact with PKR and can
induce activation. The isolated dsRBD construct does not exhibit the same magnitude increase
in affinity toward an ss-dsRNA containing tails as observed in full length PKR indicating singlestranded region engage a region outside the dsRBD. Based on this analysis we extended our
study to examine interactions between isolated ssRNAs and PKR domain constructs. We used
analytical ultracentrifugation to determine the affinity of single-stranded RNA and other nucleic
acids toward different regions of PKR and the contribution of the 5′-ppp to binding. Our analysis
identifies a previously unrecognized RNA binding site N-terminal to the canonical kinase domain
boundary (the basic region). The basic region and the dsRBD bind single-stranded nucleic acids
with low micromolar affinities. Both regions also engage dsRNA although the affinity of the
dsRBD for duplex region is ~100-fold tighter. We developed a crosslinking assay to gain insight
into the how an RNA containing duplex and single-stranded regions engages these two distinct
regions on PKR. PKR constructs containing a TEV protease cleavage site were crosslinked to
32

P-15-15-15 containing 4-thiouridine. The TEV cleavage distributions indicate that RNA

contacts the basic region in the context of full length PKR. Isolated ssRNA weakly activates full
length PKR and a kinase domain construct containing the basic region. The affinity and
activation potency of isolated ssRNA is most likely insufficient to elicit an effect in vivo.
However, anchoring interactions between the dsRBD and duplex regions may promote an
interaction between auxiliary single-stranded RNA and the basic region by induced proximity
effects (166). This type of bivalent complex may be responsible for PKR activation by ssdsRNAs.
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Activation by ss-dsRNAs has been reported to be dependent on a 5′-ppp. However, our
analysis of the ss-dsRNA motif does not recapitulate these observations. We show that RNAs
produced by in vitro transcription reactions are efficiently dephosphorylated by enzymatic
treatment yet PKR stimulation is not affected. The relative binding affinities support the activity
measurements. In the context of 15-15-15 affinity is only moderately enhanced for the 5′-ppp
form so that the populations of RP2 species formed by interaction with 5′-ppp and 5′-OH 15-1515 are similar. We extended our analysis of single-stranded RNA interactions to localize the 5′ppp recognition site using the PKR domain constructs. However, we find there is no specific 5′ppp binding site. Instead, affinity toward both the dsRBD and the basic region is enhanced by
the presence of a 5′-ppp. The enhancement is moderate and similar in magnitude as observed
in the context of full length PKR binding 15-15-15. The isolated helicase domain of RIG-I also
binds 5′-ppp RNAs with slightly enhanced affinities and this activity has been attributed to a
nonspecific electrostatic effect (197). However, RIG-I contains a C-terminal domain which
imparts 5′-ppp specificity by a cluster of basic residues molded to cradle the triphosphate (196).
The isolated CTD binds to an RNA containing a 5′-ppp with 12,000-fold enhanced affinity
relative to the 5′-OH form (197).
The basic region binds nucleic acids with moderate affinity, contributes to enzymatic
activation, and is conserved among PKR orthologs. These observations provided the impetus
for structural analysis of this region. We crystallized a kinase domain construct containing the
basic region and obtained an atomic resolution structure by X-ray diffraction. Unfortunately, the
basic region is unresolved in the structure and we are currently attempting to stabilize the basic
region by co-crystallization with heparin and ssRNA. However, a unique arrangement of PKR
molecules within the crystalline lattice challenges the current models for PKR activation. PKR
forms an oligomeric chain consisting of alternating back-to-back and front-to-front interfaces.
The back-to-back interface is similar to those previously reported (29, 30). Two front-to-front
interfaces are formed. One is formed by crystallographic symmetry across two asymmetric units
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and involves interactions between αG and αEF helices. The other occurs within the asymmetric
unit and is formed by activation segments which are exchanged between reciprocal protomers.
Similar arrangements have been reported for other kinases and functional data indicate that
they represent trans-autophosphorylation complexes (33, 230). Mutational analysis indicates the
back-to-back PKR dimer interface is critical for function (39). Experiments to investigate the
front-to-front interface have not yet been performed. A structural homolog to PKR, PknB, may
provide insight, both into the allosteric coupling between dimer interface and active site residues
and the mechanistic relevance of the front-to-front interface. PknB forms a back-to-back
interface similar to PKR which is also important for function (206, 208). In the monomeric
structure of PknB, the N- and C-lobes are misaligned and the αC helix is rotated, positioning the
catalytically important glutamate away from the active site (225). A front-to-front interface has
also been reported for PknB and is also essential for enzymatic function (212). Based on these
observations, a model has been proposed in which the back-to-back dimer interface activates
the enzyme. Subsequently, the active dimer phosphorylates other PknB molecules in trans via
the front-to-front interface (212, 225). The proposed model is strikingly similar to the
arrangement of molecules within the asymmetric unit of structure 2 (Fig. 5.3B) suggesting PKR
may achieve activation loop phosphorylation by a similar mechanism. The functional assays
proposed in Section 5.12 are required to assess the role of the front-to-front interface during
PKR activation. If experiments support the front-to-front interface, models for PKR activation
must be revised to account for a trimeric complex. Previously, we have correlated activation
potency with the ability of molecules to facilitate PKR dimerization (62, 63, 91, 119). However, a
trimeric PKR complex may be the more enzymatically relevant species.
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Appendix 1: Nucleic acid sequences and molar extinction coefficients
Table A1.1 Sequences and molar extinction coefficients of nucleic acids.
Nucleic acid

Sequencea

ε260b
(M-1cm-1)

15-15-15

GGAGAACUUAAUGCCGGAGACCAAAGACUUUCCGAAGUCUUUGGUCU
CCCUUACAAACCUGACU

517184

15-15-15 ∆T
(GAAA)

GGAGAACUUAAUGCCGGAGACCAAAGACUUGAAAAAGUCUUUGGUCU
CCCUUACAAACCUGACU

531851

15-15-15 ∆T
(UUUU)

GGAGAACUUAAUGCCGGAGACCAAAGACUUUUUUAAGUCUUUGGUCU
CCCUUACAAACCUGACU

519511

15-15-15 ∆T

5′-GGAGAACUUAAUGCCGGAGACCAAAGACUU-3′
3′-UCAGUCCAAACAUUCCCUCUGGUUUCUGAA-5′

500938

15-15-10

GGAGACAAUAAUACAGGAGACCAAAGACUUUCCGAAGUCUUUGGUCU
CCAAACCUGACU

497376

15-15-5

GGAGAACUUAAUGCCGGAGACCAAAGACUUUCCGAAGUCUUUGGUCU
CCAGACU

453418

10-15-15

GGACAUAAUAGGAGACCAAAGACUUUCCGAAGUCUUUGGUCUCCCAA
ACAAACAUAACU

490269

10-15-10

GGAGAACUUAGGAGACCAAAGACUUUCCGAAGUCUUUGGUCUCCAAA
CCUGACU

414156

13-15-10

GGACCAUAAUAUAGGAGACCAAAGACUUUCCGAAGUCUUUGGUCUCC
AAACCUGACU

485892

13-15-5

GGACCAUAAUAUAGGAGACCAAAGACUUUCCGAAGUCUUUGGUCUCC
AGACU

444663

10-15-5

GGACAAUAUAGGAGACCAAAGACUUUCCGAAGUCUUUGGUCUCCAAA
CU

416785

5-15-15

GGACAGGAGACCAAAGACUUUCCGAAGUCUUUGGUCUCCCAAACAAA
CAUAACU

447230

5-15-10

GGAUAGGAGACCAAAGACUUUCCGAAGUCUUUGGUCUCCAAACAUAA
CU

413329

5-15-5

GGAGAGGAGACCAAAGACUUUCCGAAGUCUUUGGUCUCCAGACU

341236

15-15-0

GGAGAACUUAAUGCCGGAGACCAAAGACUUUCCGAAGUCUUUGGUCU
CC

404417

0-15-15

GGAGACCAAAGACUUUCCGAAGUCUUUGGUCUCCCUUACAAACCUGA
CU

380311

0-15-0

GGAGACCAAAGACUUUCCGAAGUCUUUGGUCUCC

340834

GGAGACAAUAAUACAGGAGACCAAAUCCGUUUGGUCUCCCAAACAAA
CAUAACG

455786

15-10-15
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Table A1.1 Continued.
Sequencea

Nucleic acid
15-5-15

ε260b
(M-1cm-1)

GGAGAAUAGAAUACAGCGACUCCGGUCGCACAUAAGAUAAGAGG

404000

0-5-0

GCGACUCCGGUCGC

117499

U30

UUUUUUUUUUUUUUUUUUUUUUUUUUUUUU

291200

U15

UUUUUUUUUUUUUUU

145700

ppp-Het30

GGAGAACUUAAUGCCGGAGACCAAAGACUU

309700

Het30

GGAGAACUUAAUGCCGGAGACCAAAGACUU

309700

dT30

dTdTdTdTdTdTdTdTdTdTdTdTdTdTdTdTdTdTdTdTdTdTdTd
TdTdTdTdTdTdT

243600

dHet30

dGdGdAdGdAdAdCdUdUdAdAdUdGdCdCdGdGdAdGdAdCdCdAd
AdAdGdAdCdUdU

298300

ds20

5′-GGAGAACUUCAUGCCCUUCG-3′
3′-CCUCUUGAAGUACGGGAAGC-5′

321800

ds30

5’-GGAGAACUUCAUGCCCUUCGGAUAAGGACU-3’
3’-CCUCUUGAAGUACGGGAAGCCUAUUCCUGA-5’

514375

ds40

5'-GGAGGAUGUUAAUUGGCGUGUCUUGUCUGCAACGGUAUUC-3'
3'-CCUCCUACAAUUAACCGCACAGAACAGACGUUGCCAUAAG-5'

661950

a

Sequences are written 5′ to 3′ with duplex regions underlined.
ss-dsRNA ε260 values are determined by the protocol outlined in Materials and Methods. Duplex RNAs
are derived from the hypochromic effect upon annealing the single-stranded RNAs. For single-stranded
nucleic acids the extinction coefficient provided by the commercial supplier was used.
b
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Appendix 2: Hydrodynamic parameters from sedimentation velocity
Table A2.1 Hydrodynamic properties of nucleic acids.
Nucleic acid

Buffer

Massa

s
(Svedbergs)b

s20,w
(Svedbergs)c

f/f0d

IVT ppp-15-15-15

AU75

20,659

3.12

3.21

1.54

IVT HO-15-15-15

AU75

20,359

3.19

3.28

1.49

Synthetic HO-15-15-15

AU75

20,359

3.06

3.17

1.56

∆T-ppp-15-15-15

AU75

19,398

2.79

2.89

1.38

∆T-HO-15-15-15

AU75

19,098

2.86

2.96

1.63

ppp-5′UCCG-15-15-15

AU75

20,583

2.98

3.09

1.54

ppp-3′UCCG-15-15-15

AU75

20,583

2.98

3.09

1.63

ppp-15-15-15-GAAA

AU75

20,730

3.15

3.26

1.63

ppp-15-15-15-UUUU

AU75

20,622

3.12

3.23

1.76

ppp-15-15-10

AU75

19,138

2.87

2.95

1.69

ppp-15-15-5

AU75

17,532

2.82

2.90

1.78

ppp-10-15-15

AU75

19,106

2.93

3.01

2.05

ppp-10-15-10

AU75

17,516

2.93

3.01

1.88

ppp-13-15-10

AU75

18,443

2.95

3.05

1.71

ppp-13-15-5

AU75

16,866

2.82

2.92

1.70

ppp-10-15-5

AU75

15,909

2.77

2.85

1.84

ppp-5-15-15

AU75

17,506

2.90

2.97

1.87

ppp-5-15-10

AU75

15,909

2.80

2.88

1.64

ppp-5-15-5

AU75

14,366

2.73

2.80

1.76

ppp-15-15-0

AU75

15,917

2.80

2.88

1.86

ppp-0-15-15

AU75

15,798

2.66

2.73

1.59

ppp-0-15-0

AU75

11,057

2.46

2.52

1.65

ppp-15-10-15

AU75

17,577

2.66

2.74

1.53

ppp-15-5-15

AU75

14,522

2.43

2.50

1.82

ppp-0-5-0

AU75

4,658

1.54

1.60

1.39
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Table A2.1 Continued Hydrodynamic properties of nucleic acids.
s
Nucleic acid
Buffer
Massa
(Svedbergs)b

s20,w
(Svedbergs)c

f/f0d

ppp-15-15-15

AU200

20,659

3.21

3.36

1.58

ppp-15-15-0

AU200

15,917

2.90

3.03

1.73

ppp-0-15-15

AU200

15,798

2.66

2.78

1.83

ppp-0-15-0

AU200

11,057

2.47

2.58

1.55

ppp-15-15-15

AU75+Mg2+

20,659

3.36

3.45

1.78

ppp-0-15-0

AU75+Mg2+

11,057

2.54

2.61

1.60

ppp-15-15-15

AU60+Mg2+

20,659

3.43

3.53

1.74

ppp-0-15-0

AU60+Mg2+

11,057

2.53

2.60

1.90

U30

AU75

9,123

1.67

1.74

1.66

U15

AU75

4,528

1.21

1.25

1.70

Het30

AU75

9,683

2.05

2.12

1.41

ppp-Het30

AU75

9,923

2.12

2.19

1.39

dT30

AU75

9,064

1.43

1.48

1.93

dHet30

AU75

9,203

1.67

1.73

1.67

ds20

AU200 (4 °C)

12,108

1.64

2.74

1.27

ds30

AU75

19,164

3.16

3.27

1.44

a

Masses predicted based on composition.
Uncorrected sedimentation coefficient obtained by fitting to a single discrete species model.
c
Sedimentation coefficient corrected to standard conditions (water at 20 °C).
d
Frictional ratio.
b
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Table A2.2 Hydrodynamic properties of ss-dsRNA ∙ PKR complexes.
s
ss-dsRNA∙Protein
Buffer
Massa
(Svedbergs)b

s20,w
(Svedbergs)c

f/f0d

ppp-15-15-15∙PKR

AU75

82,754

4.88

5.04

1.60

ppp-15-15-15∙PKR2

AU75

144,848

8.02

8.30

1.33

IVT HO-15-15-15∙PKR

AU75

82,454

4.76

4.91

1.64

IVT HO-15-15-15∙PKR2

AU75

144,548

8.39

8.68

1.27

Synthetic HO-15-15-15∙PKR

AU75

82,514

4.64

4.79

1.80

Synthetic HO-15-15-15∙PKR2

AU75

144,608

8.23

8.51

1.34

∆T-ppp-15-15-15∙PKR

AU75

81,492

4.46

4.61

1.63

∆T-ppp-15-15-15∙PKR2

AU75

143,587

7.42

7.68

1.36

ppp-15-15-15-GAAA∙PKR

AU75

82,825

4.88

5.04

1.60

ppp-15-15-15-GAAA∙PKR2

AU75

144,919

8.02

8.30

1.33

ppp-15-15-15-UUUU∙PKR

AU75

82,717

4.73

4.89

1.73

ppp-15-15-15-UUUU∙PKR2

AU75

144,811

7.97

8.25

1.36

ppp-5′UCCG-15-15-15∙PKR

AU75

82,677

4.88

5.04

1.60

ppp-5′UCCG-15-15-15∙PKR2

AU75

144,772

8.02

8.30

1.33

ppp-15-15-10∙PKR

AU75

81,233

5.01

5.17

1.61

ppp-15-15-10∙PKR2

AU75

143,327

7.57

7.83

1.44

ppp-15-15-5∙PKR

AU75

79,627

4.71

4.86

1.71

ppp-15-15-5∙PKR2

AU75

141,721

7.86

8.13

1.39

ppp-10-15-15∙PKR

AU75

81,201

4.84

4.99

1.78

ppp-10-15-15∙PKR2

AU75

143,295

7.80

8.06

1.45

ppp-13-15-10∙PKR

AU75

80,538

5.46

5.65

1.77

ppp-13-15-10∙PKR2

AU75

142,632

7.43

7.69

1.69

ppp-13-15-5∙PKR

AU75

78960.9

5.05

5.23

1.55

ppp-13-15-5∙PKR2

AU75

141055

7.09

7.34

1.49

ppp-10-15-10∙PKR

AU75

79,611

4.88

5.04

1.70

ppp-10-15-10∙PKR2

AU75

141,705

7.36

7.61

1.50
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Table A2.2 Continued Hydrodynamic properties of ss-dsRNA ∙ PKR complexes.
s
s20,w
ss-dsRNA∙Protein
Buffer
Massa
b
(Svedbergs)
(Svedbergs)c

f/f0d

ppp-10-15-5∙PKR

AU75

78,004

4.80

4.96

1.67

ppp-10-15-5∙PKR2

AU75

140,098

7.40

7.65

1.47

ppp-5-15-15∙PKR

AU75

79,601

4.43

4.57

1.86

ppp-5-15-15∙PKR2

AU75

141,695

7.13

7.37

1.55

ppp-5-15-10∙PKR

AU75

78,004

4.64

4.79

1.68

ppp-5-15-10∙PKR2

AU75

140,098

6.94

7.18

1.54

ppp-5-15-5∙PKR

AU75

76,460

4.67

4.82

1.67

ppp-5-15-5∙PKR2

AU75

138,555

7.12

7.36

1.50

ppp-15-15-0∙PKR

AU75

78,012

4.75

4.90

1.70

ppp-15-15-0∙PKR2

AU75

140,106

7.19

7.43

1.52

ppp-0-15-15∙PKR

AU75

77,893

4.95

5.11

1.54

ppp-0-15-15∙PKR2

AU75

139,987

6.82

7.05

1.54

ppp-0-15-0∙PKR

AU75

73,151

4.58

4.73

1.60

ppp-0-15-0∙PKR2

AU75

135,246

6.19

6.40

1.66

ppp-15-10-15∙PKR

AU75

79,671

4.76

4.92

1.60

ppp-15-10-15∙PKR2

AU75

141,766

6.48

6.70

1.62

ppp-15-5-15∙PKR

AU75

76,616

4.71

4.87

1.63

ppp-15-5-15∙PKR2

AU75

138,711

6.87

7.10

1.54

ppp-0-15-0∙PKR

AU75

66752.5

4.16

4.32

1.46

ppp-15-15-15∙PKR

AU200

82,754

5.17

5.46

1.60

ppp-15-15-0∙PKR

AU200

78,012

4.96

5.23

1.62

ppp-0-15-15∙PKR

AU200

77,893

4.72

4.98

1.68

ppp-0-15-0∙PKR

AU200

73,151

4.52

4.78

1.60

ppp-15-15-15∙PKR

AU75+Mg2+

82,754

5.48

5.73

1.60

ppp-15-15-15∙PKR2

AU75+Mg2+

144,848

6.98

7.23

1.63

ppp-0-15-0∙PKR

AU75+Mg2+

73,151

4.58 (fixed)e

4.80

1.62
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Table A2.2 Continued Hydrodynamic properties of ss-dsRNA ∙ PKR complexes.
s
s20,w
ss-dsRNA∙Protein
Buffer
Massa
b
(Svedbergs)
(Svedbergs)c

f/f0d

ppp-0-15-0∙PKR2

AU60+Mg2+

135,246

6.19 (fixed)e

6.40

1.70

ppp-0-15-0∙dsRBD

AU75

31,319

3.07

3.18

1.58

ppp-0-15-0∙dsRBD2

AU75

51,581

4.34

4.49

1.37

ppp-15-15-15∙dsRBD

AU75

40,922

3.56

3.69

1.78

ppp-15-15-15∙dsRBD2

AU75

61,184

4.74

4.91

1.54

ppp-15-15-15∙dsRBD3

AU75

84,446

5.90

6.11

1.39

a

Masses predicted based on composition.
Uncorrected sedimentation coefficient obtained by fitting to a single discrete species model.
c
Sedimentation coefficient corrected to standard conditions (water at 20 °C).
d
Frictional ratio.
e
The value of s(RP) and s(RP2) could not be measured for these RNAs and were fixed to the values
measured in AU75 buffer.
b

Table A2.3 Hydrodynamic properties of single-stranded nucleic acid ∙ PKR complexes.
s
s20,w
Nucleic acid∙Protein
Buffer
Massa
(Svedbergs)b (Svedbergs)c

f/f0d

U30∙PKR

AU75

71,218

4.34

4.50

1.50

U30∙PKR2

AU75

133,312

6.31

6.54

1.50

U15∙PKR

AU75

66,623

4.04

4.18

1.50

ppp-Het30∙PKR

AU75

72,017

4.40

4.56

1.50

ppp-Het30∙PKR2

AU75

134,112

6.36

6.59

1.50

Het30∙PKR

AU75

71,778

4.38

4.54

1.50

Het30∙PKR2

AU75

133,872

6.36

6.58

1.50

dT30∙PKR

AU75

71,159

4.33

4.49

1.50

dT30∙PKR2

AU75

133,253

6.31

6.53

1.50

dHet30∙PKR

AU75

71,298

4.34

4.50

1.50

dHet30∙PKR2

AU75

133,392

6.32

6.54

1.50

U30∙dsRBD

AU75

29385

2.71

2.80

1.50

U30∙dsRBD2

AU75

49,647

3.53

3.65

1.50

ppp-Het30∙dsRBD

AU75

30,185

3.55

3.67

1.18

ppp-Het30∙dsRBD2

AU75

50,447

4.85

5.02

1.11
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Table A2.3 Continued Hydrodynamic properties of single-stranded nucleic acid ∙ PKR
complexes.
s
s20,w
Nucleic acid∙Protein
Buffer
Massa
(Svedbergs)b (Svedbergs)c

f/f0d

Het30∙dsRBD

AU75

29,945

3.55

3.67

1.18

Het30∙dsRBD2

AU75

50,207

4.85

5.02

1.11

dT30∙dsRBD

AU75

29,326

2.70

2.80

1.50

dT30∙dsRBD2

AU75

49,588

3.52

3.65

1.50

dHet30∙dsRBD

AU75

29,465

2.70

2.80

1.50

dHet30∙dsRBD2

AU75

49,727

3.52

3.65

1.50

U30∙185-kinase

AU75

51,030

3.81

3.95

1.50

U30∙185-kinase2

AU75

92,938

5.09

5.27

1.50

U30∙229-kinase

AU75

46,559

3.39

3.51

1.50

U30∙229-kinase2

AU75

83,995

4.71

4.88

1.50

ppp-Het30∙229-kinase

AU75

47,359

3.46

3.58

1.50

ppp-Het30∙229-kinase2

AU75

84,795

4.77

4.94

1.50

Het30∙229-kinase

AU75

47,119

3.44

3.56

1.50

Het30∙229-kinase2

AU75

84,555

4.75

4.92

1.50

ds30∙229-kinase

AU75

59,600

4.25

4.40

1.50

ds30∙229-kinase2

AU75

94,035

5.44

5.63

1.50

dT30∙229-kinase

AU75

46,450

3.38

3.50

1.50

dT30∙229-kinase2

AU75

83,936

4.71

4.87

1.50

U30∙242-kinase

AU75

44,934

3.31

3.43

1.50

U30∙242-kinase2

AU75

80,745

4.59

4.75

1.50

ds30∙242-kinase

AU75

54,975

4.19

4.33

1.50

ds30∙242-kinase2

AU75

90,786

5.32

5.51

1.50

a

Masses predicted based on composition.
Uncorrected sedimentation coefficient. In most fits the sedimentation coefficient is calculated from a
frictional ratio of 1.50.
c
Sedimentation coefficient corrected to standard conditions (water at 20 °C).
d
Frictional ratio.
b
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Table A2.4 Hydrodynamic properties of ds20 ∙ PACT complex.
s
dsRNA∙PACT
Buffer
Massa
(Svedbergs)b
ds20∙PACT2

AU200 (4 °C)

81,480

a

3.68

Masses predicted based on composition.
Uncorrected sedimentation coefficient.
c
Sedimentation coefficient corrected to standard conditions (water at 20 °C).
d
Frictional ratio.
b
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s20,w
(Svedbergs)c

f/f0d

5.98

1.26

References
1. Toth AM, Zhang P, Das S, George CX, Samuel CE (2006) Interferon Action and the Double
Stranded RNA Dependent Enzymes ADAR1 Adenosine Deaminase and PKR Protein Kinase.
Progress in Nucleic Acid Research and Molecular Biology 81:369–434.
2. Nallagatla SR, Toroney R, Bevilacqua PC (2011) Regulation of innate immunity through RNA
structure and the protein kinase PKR. Current Opinion in Structural Biology 21(1):119.
3. Nussbaum JM, Gunnery S, Mathews MB (2002) The 3′-untranslated regions of cytoskeletal
muscle mRNAs inhibit translation by activating the double-stranded RNA-dependent protein
kinase PKR. Nucleic Acids Research 30(5):1205–1212.
4. Cohen-Chalamish S et al. (2009) Dynamic refolding of IFN-γ mRNA enables it to function as
PKR activator and translation template. Nature Chemical Biology 5(12):896–903.
5. Davis S, Watson JC (1996) In vitro activation of the interferon-induced, double-stranded
RNA-dependent protein kinase PKR by RNA from the 3' untranslated regions of human alphatropomyosin. Proceedings of the National Academy of Sciences 93(1):508–513.
6. Ben-Asouli Y, Banai Y, Pel-Or Y, Shir A, Kaempfer R (2002) Human Interferon-γ mRNA
Autoregulates Its Translation through a Pseudoknot that Activates the Interferon-Inducible
Protein Kinase PKR. Cell 108(2):221.
7. Youssef OA et al. (2015) Potential role for snoRNAs in PKR activation during metabolic
stress. Proceedings of the National Academy of Sciences 112(16):5023–5028.
8. Pindel A, Sadler A (2011) The Role of Protein Kinase R in the Interferon Response. Journal
of Interferon & Cytokine Research 31(1):59–70.
9. Langland JO, Cameron JM, Heck MC, Jancovich JK, Jacobs BL (2006) Inhibition of PKR by
RNA and DNA viruses. Virus Research 119:100–110.
10. Nakamura T et al. (2010) Double-Stranded RNA-Dependent Protein Kinase Links Pathogen
Sensing with Stress and Metabolic Homeostasis. Cell 140(3):338–348.
11. García MA et al. (2006) Impact of Protein Kinase PKR in Cell Biology: from Antiviral to
Antiproliferative Action. 70(4):1032–1060.
12. Lunde BM, Moore C, Varani G (2007) RNA-binding proteins: modular design for efficient
function. Nature Reviews Molecular Cell Biology 8(6):479–490.
13. Masliah G, Barraud P, Allain FHT (2012) RNA recognition by double-stranded RNA binding
domains: a matter of shape and sequence. Cell Mol Life Sci 70(11):1875–1895.
14. Nanduri S, Carpick BW, Yang Y (1998) Structure of the double stranded RNA-binding
domain of the protein kinase PKR reveals the molecular basis of its dsRNA-mediated activation.
The EMBO Journal 70(18):5458–5465.
15. Bevilacqua PC (1996) Minor-Groove Recognition of Double-Stranded RNA by the DoubleStranded RNA-Binding Domain from the RNA-Activated Protein Kinase PKR. Biochemistry
35(31):9983–9994.

171

16. Stefl R, Xu M, Skrisovska L, Emeson RB, Allain FHT (2006) Structure and Specific RNA
Binding of ADAR2 Double-Stranded RNA Binding Motifs. Structure 14(2):345–355.
17. Stefl R et al. (2010) The Solution Structure of the ADAR2 dsRBM-RNA Complex Reveals a
Sequence-Specific Readout of the Minor Groove. CelI 143(2):225-237.
18. Leulliot N et al. (2004) A new alpha-helical extension promotes RNA binding by the dsRBD
of Rnt1p RNAse III. The EMBO journal 23:2468–2477.
19. Bycroft M, Grunert S, Murzin AG, Proctor M, St Johnson D (1995) NMR solution structure of
a dsRNA binding domain from Drosophila staufen protein reveals homology to the N-terminal
domain of ribosomal protein S5. The EMBO journal 14:3563–3571.
20. Ramos A et al. (2000) RNA recognition by a Staufen double-stranded RNA-binding domain.
The EMBO journal 19:997–1009.
21. Yamashita S et al. (2011) Structures of the first and second double-stranded RNA-binding
domains of human TAR RNA-binding protein. Protein Science 20:118–130.
22. Jayachandran U, Grey H, Cook A (2016) Nuclear factor 90 uses an ADAR2-like binding
mode to recognize specific bases in dsRNA. Nucleic Acids Research 44(4):1924-1936.
23. Ryter JM, Schultz SC (1998) Molecular basis of double-stranded RNA-protein interactions:
structure of a dsRNA-binding domain complexed with dsRNA. The EMBO journal 17(24):7505–
7513.
24. Wu H, Henras A, Chanfreau G, Feigon J (2004) Structural basis for recognition of the AGNN
tetraloop RNA fold by the double-stranded RNA-binding domain of Rnt1p RNase III.
Proceedings of the National Academy of Sciences 101(22):8307–8312.
25. Stefl R et al. (2010) The Solution Structure of the ADAR2 dsRBM-RNA Complex Reveals a
Sequence-Specific Readout of the Minor Groove. CelI 143(2):225-237.
26. Vuyisich M, Spanggord RJ, Beal PA (2002) The binding site of the RNA-dependent protein
kinase (PKR) on EBER1 RNA from Epstein-Barr virus. EMBO Reports 3(7):622.
27. Kim I, Liu CW, Puglisi JD (2006) Specific Recognition of HIV TAR RNA by the dsRNA
Binding Domains (dsRBD1–dsRBD2) of PKR. Journal of Molecular Biology 358(2):430–442.
28. Spanggord RJ, Beal PA (2001) Selective Binding by the RNA Binding Domain of PKR
Revealed by Affinity Cleavage†. Biochemistry 40(14):4272.
29. Dar AC, Dever TE, Sicheri F (2005) Higher-Order Substrate Recognition of eIF2α by the
RNA-Dependent Protein Kinase PKR. Cell 122(6):887.
30. Li F et al. (2013) Structure of the kinase domain of human RNA-dependent protein kinase
with K296R mutation reveals a face-to-face dimer. Chinese Science Bulletin 58(9):998–1002.
31. Endicott JA, Noble MEM, Johnson LN (2012) The Structural Basis for Control of Eukaryotic
Protein Kinases. Annual Review of Biochemistry 81(1):587–613.
32. Nolen B, Taylor S, Ghosh G (2004) Regulation of protein kinases: controlling activity through
activation segment conformation. Molecular Cell 15:661–675.

172

33. Beenstock J, Mooshayef N, Engelberg D (2016) How Do Protein Kinases Take a Selfie
(Autophosphorylate)? Trends in biochemical sciences 41(11):938.
34. Dey M, Mann BR, Anshu A, Mannan MA-U (2013) Activation of Protein Kinase PKR
Requires Dimerization-inducedcis-Phosphorylation within the Activation Loop. Journal of
Biological Chemistry 289(9):5747–5757.
35. Lemaire PA, Lary J, Cole JL (2005) Mechanism of PKR Activation: Dimerization and Kinase
Activation in the Absence of Double-stranded RNA. Journal of Molecular Biology 345(1):81–90.
36. Thomis DC, Samuel CE (1993) Mechanism of interferon action: evidence for intermolecular
autophosphorylation and autoactivation of the interferon-induced, RNA-dependent protein
kinase PKR. Journal of Virology 67(12):7695–7700.
37. Thomis DC, Samuel CE (1995) Mechanism of interferon action: characterization of the
intermolecular autophosphorylation of PKR, the interferon-inducible, RNA-dependent protein
kinase. Journal of Virology 69(8):5195–5198.
38. McKenna SA et al. (2007) Molecular Framework for the Activation of RNA-dependent
Protein Kinase. Journal of Biological Chemistry 282(15):11474–11486.
39. Dey M et al. (2005) Mechanistic Link between PKR Dimerization, Autophosphorylation, and
eIF2α Substrate Recognition. Cell 122(6):901–913.
40. Lavoie H, Li JJ, Thevakumaran N, Therrien M, Sicheri F (2014) Dimerization-induced
allostery in protein kinase regulation. Trends in biochemical sciences 39(10):475.
41. Johnson DA, Akamine P, Radzio-Andzelm E, Madhusudan, Taylor SS (2001) Dynamics of
cAMP-Dependent Protein Kinase. Chemical Reviews 101(8):2243–2270.
42. Kornev AP, Taylor SS (2010) Defining the conserved internal architecture of a protein
kinase. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 1804(3):440–444.
43. Taylor SS, Kornev AP (2011) Protein kinases: evolution of dynamic regulatory proteins.
Trends in biochemical sciences 36(2):65–77.
44. Johnson LN, Noble MEM, Owen DJ (1996) Active and Inactive Protein Kinases: Structural
Basis for Regulation. Cell 85(2):149.
45. Adams JA, McGlone ML, Gibson R, Taylor SS (1995) Phosphorylation Modulates Catalytic
Function and Regulation in the cAMP-Dependent Protein Kinase. Biochemistry 34(8):2447–
2454.
46. Adams JA (2003) Activation Loop Phosphorylation and Catalysis in Protein Kinases: Is
There Functional Evidence for the Autoinhibitor Model?. Biochemistry 42(3):601–607.
47. Dey M et al. (2011) Requirement for kinase-induced conformational change in eukaryotic
initiation factor 2 (eIF2 ) restricts phosphorylation of Ser51. Proceedings of the National
Academy of Sciences 108(11):4316.
48. Zhang X et al. (1998) Autophosphorylation in the Activation Loop Is Required for Full Kinase
Activity In Vivo of Human and Yeast Eukaryotic Initiation Factor 2α Kinases PKR and GCN2.
Molecular and Cellular Biology 18(4):2282–2297.

173

49. Madhusudan et al. (1994) cAMP-dependent protein kinase: crystallographic insights into
substrate recognition and phosphotransfer. Protein Science 3(2):176–187.
50. Pérez-Gallegos A, Garcia-Viloca M, González-Lafont À (2015) A QM/MM study of Kemptide
phosphorylation catalyzed by protein kinase A. The role of Asp166 as a general acid/base
catalyst. Phys Chem Chem Phys 17(5):3497–3511.
51. Huse M, Kuriyan J (2002) The conformational plasticity of protein kinases. Cell 109(3):275282.
52. Wu S, Kaufman RJ (1997) A Model for the Double-stranded RNA (dsRNA)-dependent
Dimerization and Activation of the dsRNA-activated Protein Kinase PKR. Journal of Biological
Chemistry 272(2):1291.
53. Galabru J, Hovanessian AG (1987) Autophosphorylation of the protein kinase dependent on
double-stranded RNA. Journal of Biological Chemistry 262(32):15538–15544.
54. Nanduri S, Rahman F, Williams BRG, Qin J (2000) A dynamically tuned double-stranded
RNA binding mechanism for the activation of antiviral kinase PKR. The EMBO journal
19(20):5567.
55. Gelev V et al. (2006) Mapping of the Auto-inhibitory Interactions of Protein Kinase R by
Nuclear Magnetic Resonance. Journal of Molecular Biology 364(3):352.
56. Spanggord RJ, Vuyisich M, Beal PA (2002) Identification of Binding Sites for Both dsRBMs
of PKR on Kinase-Activating and Kinase-Inhibiting RNA Ligands. Biochemistry 41(14):4511–
4520.
57. Ucci JW, Kobayashi Y, Choi G, Alexandrescu AT, Cole JL (2007) Mechanism of Interaction
of the Double-Stranded RNA (dsRNA) Binding Domain of Protein Kinase R with Short dsRNA
Sequences. Biochemistry 46(1):55–65.
58. Robertson HD (1996) The regulation of the protein kinase PKR by RNA. Biochimie 78:909–
914.
59. Anderson E, Cole JL (2008) Domain Stabilities in Protein Kinase R (PKR): Evidence for
Weak Interdomain Interactions. Biochemistry 47(17):4887–4897.
60. VanOudenhove J, Anderson E, Krueger S, Cole JL (2009) Analysis of PKR Structure by
Small-Angle Scattering. Journal of Molecular Biology 387(4):910–920.
61. Cole JL (2007) Activation of PKR: an open and shut case? Trends in biochemical sciences
32(2):57–62.
62. Husain B, Mukerji I, Cole JL (2012) Analysis of High-Affinity Binding of Protein Kinase R to
Double-Stranded RNA. Biochemistry 51(44):8764.
63. Lemaire PA, Anderson E, Lary J, Cole JL (2008) Mechanism of PKR Activation by dsRNA.
Journal of Molecular Biology 381(2):351.
64. Manche L, Green SR, Schmedt C (1992) Interactions between double-stranded RNA
regulators and the protein kinase DAI. Molecular and Cellular Biology 12(11):5238–5248.
65. Husain B, Hesler S, Cole JL (2015) Regulation of PKR by RNA: Formation of Active and
Inactive Dimers. Biochemistry 54(44):6663–6672.
174

66. Hunter T, Hunt T, Jackson RJ, Robertson HD (1975) The characteristics of inhibition of
protein synthesis by double-stranded ribonucleic acid in reticulocyte lysates. Journal of
Biological Chemistry 250(2):409–417.
67. Kostura M, Mathews MB (1989) Purification and activation of the double-stranded RNAdependent eIF-2 kinase DAI. Molecular and Cellular Biology 9(4):1576–1586.
68. Butcher SE, Pyle A (2011) The Molecular Interactions That Stabilize RNA Tertiary Structure:
RNA Motifs, Patterns, and Networks. Accounts of Chemical Research 44(12):1302–1311.
69. Zheng X, Bevilacqua PC (2000) Straightening of bulged RNA by the double-stranded RNAbinding domain from the protein kinase PKR. Proceedings of the National Academy of Sciences
97(26):14162–14167.
70. Heinicke LA, Nallagatla SR, Hull CM, Bevilacqua PC (2011) RNA helical imperfections
regulate activation of the protein kinase PKR: Effects of bulge position, size, and geometry.
RNA 17(5):957.
71. Kaempfer R (2003) RNA sensors: novel regulators of gene expression. EMBO Reports
4(11):1043.
72. Osman F, Jarrous N, Ben-Asouli Y, Kaempfer R (1999) A cis-acting element in the 3′untranslated region of human TNF-α mRNA renders splicing dependent on the activation of
protein kinase PKR. Genes & Development 13:3280–3293.
73. Osman F, Jarrous N, Ben-Asouli Y, Kaempfer R (1999) A cis-acting element in the 3'untranslated region of human TNF-alpha mRNA renders splicing dependent on the activation of
protein kinase PKR. Genes & Development 13:3280–3293.
74. Dauber B et al. (2009) Influenza B Virus Ribonucleoprotein Is a Potent Activator of the
Antiviral Kinase PKR. PLOS Pathog 5(6):e1000473.
75. Weber F, Wagner V, Rasmussen SB, Hartmann R, Paludan SR (2006) Double-stranded
RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable
amounts by negative-strand RNA viruses. Journal of Virology 80:5059–5064.
76. Hsu MT, Parvin JD, Gupta S, Krystal M, Palese P (1987) Genomic RNAs of influenza
viruses are held in a circular conformation in virions and in infected cells by a terminal
panhandle. Proceedings of the National Academy of Sciences of the United States of America
84:8140–445.
77. Zheng X, Bevilacqua PC (2004) Activation of the protein kinase PKR by short doublestranded RNAs with single-stranded tails. RNA 10(12):1934–1945.
78. Nallagatla SR et al. (2007) 5'-Triphosphate-Dependent Activation of PKR by RNAs with
Short Stem-Loops. Science 318(5855):1455–1458.
79. Leung DW, Amarasinghe GK (2016) When your cap matters: structural insights into self vs
non-self recognition of 5′ RNA by immunomodulatory host proteins. Current Opinion in
Structural Biology 36:133–141.
80. Dauber B, Wolff T (2009) Activation of the Antiviral Kinase PKR and Viral Countermeasures.
Viruses 1(3):523–544.

175

81. Nallagatla SR et al. (2013) Native Tertiary Structure and Nucleoside Modifications Suppress
tRNA’s Intrinsic Ability to Activate the Innate Immune Sensor PKR. PloS one 8(3):e57905–
e57905.
82. Nallagatla SR, Bevilacqua PC (2008) Nucleoside modifications modulate activation of the
protein kinase PKR in an RNA structure-specific manner. RNA 14(6):1201–1213.
83. Langland JO, Cameron JM, Heck MC, Jancovich JK, Jacobs BL (2006) Inhibition of PKR by
RNA and DNA viruses. Virus Research 119(1):100–110.
84. Launer-Felty K, Wong CJ, Wahid AM, Conn GL, Cole JL (2010) Magnesium-Dependent
Interaction of PKR with Adenovirus VAI. Journal of Molecular Biology 402(4):638–644.
85. Launer-Felty K, Cole JL (2014) Domain Interactions in Adenovirus VAI RNA Mediate HighAffinity PKR Binding. Journal of Molecular Biology 426(6):1285–1295.
86. Launer-Felty K, Wong CJ, Cole JL (2015) Structural Analysis of Adenovirus VAI RNA
Defines the Mechanism of Inhibition of PKR. Biophysical Journal 108(3):748–757.
87. Glickman JN, Howe JG, Steitz JA (1988) Structural analyses of EBER1 and EBER2
ribonucleoprotein particles present in Epstein-Barr virus-infected cells. Journal of Virology
62(3):902–911.
88. Weber F, Wagner V, Rasmussen SB, Hartmann R, Paludan SR (2006) Double-Stranded
RNA Is Produced by Positive-Strand RNA Viruses and DNA Viruses but Not in Detectable
Amounts by Negative-Strand RNA Viruses. Journal of Virology 80(10):5059–5064.
89. Hovanessian AG, Galabru J (1987) The double-stranded RNA-dependent protein kinase is
also activated by heparin. European Journal of Biochemistry 167(3):467.
90. George CX, Thomis DC, McCormack SJ, Svahn CM, Samuel CE (1996) Characterization of
the Heparin-Mediated Activation of PKR, the Interferon-Inducible RNA-Dependent Protein
Kinase. Virology 221(1):180.
91. Anderson E, Pierre-Louis W, Wong CJ, Lary JW, Cole J (2011) Heparin Activates PKR by
Inducing Dimerization. Biophysical Journal 100(3):973–984.
92. Patel RC, Sen GC (1998) PACT, a protein activator of the interferon-induced protein kinase,
PKR. The EMBO journal 17(15):4379–4390.
93. Gleghorn ML, Maquat LE (2014) 'Black sheep' that don’t leave the double-stranded RNAbinding domain fold. Trends in biochemical sciences 39(7): 328-340.
94. Huang X, Hutchins B (2002) The C-terminal, third conserved motif of the protein activator
PACT plays an essential role in the activation of double-stranded-RNA-dependent protein
kinase (PKR). Biochemical Journal 366(1):175–186.
95. Peters GA, Hartmann R, Qin J, G. Sen (2001) Modular Structure of PACT: Distinct Domains
for Binding and Activating PKR. Mol. Cell Biol. 21(6):1908–1920.
96. Patel CV, Handy I, Goldsmith T, Patel RC (2000) PACT, a Stress-modulated Cellular
Activator of Interferon-induced Double-stranded RNA-activated Protein Kinase, PKR. Journal of
Biological Chemistry 275(48):37993–37998.

176

97. Peters GA, Li S, G. Sen (2006) Phosphorylation of Specific Serine Residues in the PKR
Activation Domain of PACT Is Essential for Its Ability to Mediate Apoptosis. Journal of Biological
Chemistry 281(46):35129–35136.
98. Li S et al. (2006) Molecular basis for PKR activation by PACT or dsRNA. Proceedings of the
National Academy of Sciences 103(26):10005–10010.
99. Hale BG, Randall RE, Ortin J, Jackson D (2008) The multifunctional NS1 protein of
influenza A viruses. Journal of General Virology 89(10):2359–2376.
100. Min J, GC Sen, Krug R (2007) A site on the influenza A virus NS1 protein mediates both
inhibition of PKR activation and temporal regulation of viral RNA synthesis. Virology 363(1):236243.
101. Li S, Min J-Y, Krug RM, Ganes Sen (2006) Binding of the influenza A virus NS1 protein to
PKR mediates the inhibition of its activation by either PACT or double-stranded RNA. Virology
349(1):13–21.
102. Tan S-L, Katze MG (1998) Biochemical and Genetic Evidence for Complex Formation
Between the Influenza A Virus NS1 Protein and the Interferon-induced PKR Protein Kinase.
Journal of Interferon & Cytokine Research 18(9):757–766.
103. van den Berg S, Löfdahl P-Å, Härd T, Berglund H (2006) Improved solubility of TEV
protease by directed evolution. Journal of biotechnology 121(3):291–298.
104. Ucci JW, Cole JL (2004) Global analysis of non-specific protein–nucleic interactions by
sedimentation equilibrium. Biophysical Chemistry 108(1-3):127–140.
105. Gurevich VV (1996) Use of bacteriophage RNA polymerase in RNA synthesis. Methods in
enzymology 275:382–397.
106. Walker SC, Avis JM, Conn GL (2003) General plasmids for producing RNA in vitro
transcripts with homogeneous ends. Nucleic Acids Research 31(15):82e.
107. Uhlenbeck OC (1987) Oligoribonucleotide synthesis using T7 RNA polymerase and
synthetic DNA templates. Nucleic Acids Research 15(21):8783–8798.
108. Milligan JF, Uhlenbeck OC (1989) Synthesis of small RNAs using T7 RNA polymerase.
Methods in enzymology 180:51–62.
109. Schurer H, Lang K, Schuster J, Morl M (2002) A universal method to produce in vitro
transcripts with homogeneous 3′ ends. Nucleic Acids Research 30(12):56e.
110. Bloomfield VA, Crothers DM, Tinoco I (2000) Nucleic Acids: structures, properties and
functions (University Science Books, Sausalito, CA).
111. Cavaluzzi MJ, Borer PN (2004) Revised UV extinction coefficients for nucleoside-5'monophosphates and unpaired DNA and RNA. Nucleic Acids Research 32(1):13e.
112. Shih I-H, Been MD (1999) Ribozyme cleavage of a 2′,5′-phosphodiester linkage:
Mechanism and a restricted divalent metal-ion requirement. RNA 5(9):1140–1148.
113. Das U, Shuman S (2012) Mechanism of RNA 2′,3′-cyclic phosphate end healing by T4
polynucleotide kinase-phosphatase. Nucleic Acids Research 41(1):355–365.

177

114. Zhu H, Smith P, Wang LK, Shuman S (2007) Structure–function analysis of the 3′
phosphatase component of T4 polynucleotide kinase/phosphatase. Virology 366(1):126–136.
115. Stafford WF (1992) Boundary analysis in sedimentation transport experiments: A
procedure for obtaining sedimentation coefficient distributions using the time derivative of the
concentration profile. Analytical Biochemistry 203(2):295–301.
116. Philo JS (2006) Improved methods for fitting sedimentation coefficient distributions derived
by time-derivative techniques. Analytical Biochemistry 354(2):238.
117. Schuck P (2000) Size-Distribution Analysis of Macromolecules by Sedimentation Velocity
Ultracentrifugation and Lamm Equation Modeling. Biophysical Journal 78(3):1606–1619.
118. Stafford WF, Sherwood PJ (2004) Analysis of heterologous interacting systems by
sedimentation velocity: curve fitting algorithms for estimation of sedimentation coefficients,
equilibrium and kinetic constants. Biophysical Chemistry 108:231–243.
119. Mayo CB, Wong CJ, Lopez PE, Lary JW, Cole JL (2016) Activation of PKR by short stem–
loop RNAs containing single-stranded arms. RNA 22(7):1065–1075.
120. Laue TM, Shah B, Ridgeway TM, Pelletier SL (1992) Computer-aided interpretation of
sedimentation data for proteins (Royal Society of Chemistry, Cambridge, England), pp 90–125.
121. Durchschlag H (1986) Specific Volumes of Biological Macromolecules and Some Other
Molecules of Biological Interest. Thermodynamic Data for Biochemistry and Biotechnology, ed
Hinz H-J (Springer-Verlag, Berlin, Berlin), pp 45–128.
122. Petoukhov MV et al. (2012) New developments in theATSASprogram package for smallangle scattering data analysis. Journal of Applied Crystallography 45(2):342–350.
123. Semenyuk AV, Svergun DI (1991) GNOM – a program package for small-angle scattering
data processing. Journal of Applied Crystallography 24(5):537.
124. Svergun DI, Barberato C, Koch MJ (1995) CRYSOL– a Program to Evaluate X-ray Solution
Scattering of Biological Macromolecules from Atomic Coordinates. Journal of Applied
Crystallography 28(6):768.
125. Hornung V et al. (2006) 5'-Triphosphate RNA Is the Ligand for RIG-I. Science
314(5801):994.
126. Pichlmair A et al. (2006) RIG-I-Mediated Antiviral Responses to Single-Stranded RNA
Bearing 5'-Phosphates. Science 314(5801):997–1001.
127. Luo D, Kohlway A, Vela A, Pyle A (2012) Visualizing the Determinants of Viral RNA
Recognition by Innate Immune Sensor RIG-I. Structure 20(11):1983–1988.
128. Cui S et al. (2008) The C-Terminal Regulatory Domain Is the RNA 5′-Triphosphate Sensor
of RIG-I. Molecular Cell 29(2):169–179.
129. Ranjith-Kumar CT (2010) Crystal structure of RIG-I C-terminal domain bound to bluntended double-strand RNA without 5' triphosphate. Nucleic Acids Research 39(4):1565–1575.
130. Takahasi K et al. (2008) Nonself RNA-Sensing Mechanism of RIG-I Helicase and
Activation of Antiviral Immune Responses. Molecular Cell 29(4):428–440.

178

131. Toroney R, Hull CM, Sokoloski JE, Bevilacqua PC (2012) Mechanistic characterization of
the 5'-triphosphate-dependent activation of PKR: Lack of 5'-end nucleobase specificity,
evidence for a distinct triphosphate binding site, and a critical role for the dsRBD. RNA
18(10):1862–1874.
132. Dale T, Smith R, Serra MJ (2000) A test of the model to predict unusually stable RNA
hairpin loop stability. RNA 6(4):608–615.
133. Zuker M (2003) Mfold web server for nucleic acid folding and hybridization prediction.
Nucleic Acids Research 31(13):3406–3415.
134. Heinicke LA et al. (2009) RNA Dimerization Promotes PKR Dimerization and Activation.
Journal of Molecular Biology 390(2):319–338.
135. Heinicke LA, Bevilacqua PC (2012) Activation of PKR by RNA misfolding: HDV ribozyme
dimers activate PKR. RNA 18(12):2157.
136. Svergun DI, Koch M (2003) Small-angle scattering studies of biological macromolecules in
solution. Reports on Progress in Physics 66(10):1735–1782.
137. Svergun DI (1992) Determination of the regularization parameter in indirect-transform
methods using perceptual criteria. Journal of Applied Crystallography 25(4):495.
138. Wong CJ, Launer-Felty K, Cole JL (2011) Analysis of PKR–RNA Interactions by
Sedimentation Velocity. Methods in enzymology 488:59–79.
139. Clarke PA, Pe'eru T, Ma Y, Mathews MB (1994) Structural features of adenovirus 2 virusassociated RNA required for binding to the protein kinase DAI. Nucleic Acids Research
22(21):4364–4374.
140. Draper DE (2004) A guide to ions and RNA structure. RNA 10(3):335–343.
141. Bizarro CV, Alemany A, Ritort F (2012) Non-specific binding of Na+ and Mg2+ to RNA
determined by force spectroscopy methods. Nucleic Acids Research 40(14):6922–6935.
142. Chen H, Meisburger S, Pabit S, Sutton J, Webb W, Pollack L (2012) Ionic strengthdependent persistence lengths of single-stranded RNA and DNA. Proceedings of the National
Academy of Sciences 109(3):799–804.
143. Ryter JM, Schultz SC (1998) Molecular basis of double-stranded RNA-protein interactions:
structure of a dsRNA-binding domain complexed with dsRNA. The EMBO journal 17:7505–
7513.
144. Kuo MY, Sharmeen L, Dinter G (1988) Characterization of self-cleaving RNA sequences
on the genome and antigenome of human hepatitis delta virus. Journal of Virology 62(12):44394444.
145. Cameron V, Uhlenbeck OC (1977) 3'-Phosphatase activity in T4 polynucleotide kinase.
Biochemistry 16(23):5120.
146. Pak J, Fire A (2007) Distinct populations of primary and secondary effectors during RNAi in
C. elegans. Science 315(5809):238.
147. Huang F, Yarus M (1997) Versatile 5′ phosphoryl coupling of small and large molecules to
an RNA. Proceedings of the National Academy of Sciences 94(17):8965–8969.
179

148. Scaringe SA, Wincott FE, Caruthers MH (1998) Novel RNA Synthesis Method Using 5‘-OSilyl-2′-O-orthoester Protecting Groups. Journal of the American Chemical Society
120(45):11820–11821.
149. Scaringe SA (2001) RNA Oligonucleotide Synthesis via 5′-Silyl-2′-Orthoester Chemistry.
Methods 23(3):206.
150. Nikcevic I, Wyrzykiewicz TK, Limbach PA (2011) Detecting low-level synthesis impurities in
modified phosphorothioate oligonucleotides using liquid chromatography–high resolution mass
spectrometry. International Journal of Mass Spectrometry 304(2-3):98-104.
151. Hölzl G, Oberacher H, Pitsch S, Stutz A (2005) Analysis of Biological and Synthetic
Ribonucleic Acids by Liquid Chromatography−Mass Spectrometry Using Monolithic Capillary
Columns. Analytical Chemistry 77(2):673.
152. Gilar M (2001) Analysis and Purification of Synthetic Oligonucleotides by Reversed-Phase
High-Performance Liquid Chromatography with Photodiode Array and Mass Spectrometry
Detection. Analytical Biochemistry 298(2):196.
153. Schmid K et al. (2015) Variable presence of 5-methylcytosine in commercial RNA and
DNA. RNA Biology 12(10):1152.
154. Kurata C et al. (2006) Characterization of high molecular weight impurities in synthetic
phosphorothioate oligonucleotides. Bioorganic & Medicinal Chemistry Letters 16(3):607.
155. Cazenave C, Bathany K, Rayner B (2006) Formation of N -Branched Oligonucleotides as
By-products in Solid-Phase Oligonucleotide Synthesis. Oligonucleotides 16(2):181.
156. Woese CR, Winker S, Gutell RR (1990) Architecture of ribosomal RNA: constraints on the
sequence of "tetra-loops". Proceedings of the National Academy of Sciences 87(21):8467–
8471.
157. Tuerk C et al. (1988) CUUCGG hairpins: extraordinarily stable RNA secondary structures
associated with various biochemical processes. Proceedings of the National Academy of
Sciences 85(5):1364–1368.
158. Antao VP, Lai SY, Tinoco I (1991) A thermodynamic study of unusually stable RNA and
DNA hairpins. Nucleic Acids Research 19(21):5901.
159. Wu L, Chai D, Zimmerly S (2012) Structural Variation and Uniformity among TetraloopReceptor Interactions and Other Loop-Helix Interactions in RNA Crystal Structures. PloS one
7(11):e49225.
160. Koplin J, Mu Y, Richter C, Schwalbe H, Stock G (2005) Structure and Dynamics of an RNA
Tetraloop: A Joint Molecular Dynamics and NMR Study. Structure 13(9):1255.
161. Sashital DG, Venditti V, Angers CG, Cornilescu G, Butcher SE (2007) Structure and
thermodynamics of a conserved U2 snRNA domain from yeast and human. RNA 13(3):328.
162. Norberg J, Nilsson L (1995) Stacking Free Energy Profiles for All 16 Natural
Ribodinucleoside Monophosphates in Aqueous Solution. Journal of the American Chemical
Society 117(44):10832.

180

163. Bass BL, Hurst SR, Singer JD (1994) Binding properties of newly identified Xenopus
proteins containing dsRNA-binding motifs. Current Biology 4(4):301–314.
164. Johnston DS, Brown NH, Gall JG, Jantsch M (1992) A conserved double-stranded RNAbinding domain. Proceedings of the National Academy of Sciences 89(22):10979–10983.
165. Sen GC, Taira H, Lengyel P (1978) Interferon, double-stranded RNA, and protein
phosphorylation. Characteristics of a double-stranded RNA-activated protein kinase system
partially purified from interferon treated Ehrlich ascites tumor cells. Journal of Biological
Chemistry 253(17):5915–5921.
166. Zhou H-X, Gilson MK (2009) Theory of Free Energy and Entropy in Noncovalent Binding.
Chemical Reviews 109(9):4092–4107.
167. Shimoike T, McKenna SA, Lindhout DA, Puglisi JD (2009) Translational insensitivity to
potent activation of PKR by HCV IRES RNA. Antiviral Research 83(3):228–237.
168. Toroney R, Nallagatla SR, Boyer JA, Cameron CE, Bevilacqua PC (2010) Regulation of
PKR by HCV IRES RNA: Importance of Domain II and NS5A. Journal of Molecular Biology
400(3):393–412.
169. Dauber B et al. (2009) Influenza B Virus Ribonucleoprotein Is a Potent Activator of the
Antiviral Kinase PKR. PLoS Pathogens 5(6):e1000473.
170. Puthenveetil S et al. (2006) Controlling activation of the RNA-dependent protein kinase by
siRNAs using site-specific chemical modification. Nucleic Acids Research 34(17):4900–4911.
171. Sledz CA, Holko M, de Veer MJ, Silverman RH, Williams BRG (2003) Activation of the
interferon system by short-interfering RNAs. Nature Cell Biology 5(9):834.
172. Hull CM, Bevilacqua PC (2015) Mechanistic Analysis of Activation of the Innate Immune
Sensor PKR by Bacterial RNA. Journal of Molecular Biology 427(22):3501–3515.
173. Anmangandla A (2016) Bacterial riboswitches and ribozymes potently activate the human
innate immune sensor PKR. ACS chemical biology 11(4):1118–1127.
174. Gredell JA, Dittmer MJ, Wu M, Chan C, Walton SP (2010) Recognition of siRNA
asymmetry by TAR RNA binding protein (TRBP). Biochemistry 49(14):3148–3155.
175. Barraud P et al. (2011) An extended dsRBD with a novel zinc-binding motif mediates
nuclear retention of fission yeast Dicer. The EMBO journal 30(20):4223–4235.
176. Lee SB, Green SR, Mathews MB, Esteban M (1994) Activation of the double-stranded
RNA (dsRNA)-activated human protein kinase in vivo in the absence of its dsRNA binding
domain. Proceedings of the National Academy of Sciences of the United States of America
91:10551–10555.
177. Wu S, Kumar KU, Kaufman RJ (1998) Identification and Requirement of Three Ribosome
Binding Domains in dsRNA-Dependent Protein Kinase (PKR). Biochemistry 37(39):13816–
13826.
178. Stanton P, Sen GC (1994) Role of the amino-terminal residues of the interferon-induced
protein kinase in its activation by double-stranded RNA and heparin. Journal of Biological
Chemistry 269(28):18593–18598.
181

179. Fasciano S, Hutchins B, Handy I, Patel RC (2005) Identification of the heparin-binding
domains of the interferon-induced protein kinase, PKR. FEBS Journal 272(6):1425–1439.
180. McWilliam H et al. (2013) Analysis Tool Web Services from the EMBL-EBI. Nucleic Acids
Research 41(W1):W597–W600.
181. Waterhouse AM, Procter JB, Martin DMA, Clamp M, Barton GJ (2009) Jalview Version 2--a
multiple sequence alignment editor and analysis workbench. Bioinformatics 25(9):1189.
182. Zhang X, Szczepanowska J, Brzeska H, Hinnebusch AG, Qin J (1998) Identification of
Phosphorylation Sites in Proteins Separated by Polyacrylamide Gel Electrophoresis. Analytical
Chemistry 70(10):2050–2059.
183. Hellman L, Fried M (2007) Electrophoretic mobility shift assay (EMSA) for detecting
protein–nucleic acid interactions. Nature Protocols, Published online: 18 October 2007; |
doi:101038/nprot2007380 2(8):1849–1861.
184. Wong I, Lohman TM (1993) A double-filter method for nitrocellulose-filter binding:
application to protein-nucleic acid interactions. Proceedings of the National Academy of
Sciences 90(12):5428–5432.
185. Liu J-J (1981) Sequence dependence of the circular dichroism of synthetic doublestranded RNAs. Biopolymers 20(7):1337–1382.
186. Steely T, Gray D, Ratliff R (1986) CD of homopolymer DNA-RNA hybrid duplexes and
triplexes containing A.T or A.U base pairs. Nucleic Acids Research 14(24):10071–10090.
187. Auweter SD, Oberstrass FC, Allain FHT (2006) Sequence-specific binding of singlestranded RNA: is there a code for recognition? Nucleic Acids Research 34(17):4943–4959.
188. Frankel AD (2000) Fitting peptides into the RNA world. Current Opinion in Structural
Biology 10(3):332–340.
189. Favre A, Saintomé C, Fourrey J-L, Clivio P, Laugâa P (1998) Thionucleobases as intrinsic
photoaffinity probes of nucleic acid structure and nucleic acid-protein interactions. Journal of
Photochemistry and Photobiology B: Biology 42(2):109.
190. Ennifar E et al. (2000) The crystal structure of UUCG tetraloop. Journal of Molecular
Biology 304(1):35–42.
191. Turner DH, Kierzek R (1999) Thermodynamics of RNA−RNA Duplexes with 2- or 4Thiouridines: Implications for Antisense Design and Targeting a Group I Intron. Biochemistry
38(50):16655.
192. Kumar R, Davis D (1997) Synthesis and studies on the effect of 2-thiouridine and 4thiouridine on sugar conformation and RNA duplex stability. Nucleic Acids Research 25(6):1272.
193. Hull CM, Bevilacqua PC (2016) Discriminating Self and Non-Self by RNA: Roles for RNA
Structure, Misfolding, and Modification in Regulating the Innate Immune Sensor PKR. Accounts
of Chemical Research 49:1242–1249.
194. McGhee JD, Hippel von PH (1974) Theoretical aspects of DNA-protein interactions: Cooperative and non-co-operative binding of large ligands to a one-dimensional homogeneous
lattice. Journal of Molecular Biology 86(3):469–489.
182

195. Cole JL (2004) Analysis of Heterogeneous Interactions. Methods in enzymology 384:212–
232.
196. Lu C et al. (2010) The Structural Basis of 5′ Triphosphate Double-Stranded RNA
Recognition by RIG-I C-Terminal Domain. Structure 18(8):1032–1043.
197. Vela V, Fedorova O, Ding SC, Pyle AM (2012) The Thermodynamic Basis for Viral RNA
Detection by the RIG-I Innate Immune Sensor. Journal of Biological Chemistry 287(51):42564.
198. Pichlmair A et al. (2011) IFIT1 is an antiviral protein that recognizes 5′-triphosphate RNA.
Nature Immunology 12(7):624–630.
199. Pichlmair A, Superti-Furga G, Nagar B (2013) Structural basis for viral 5′-PPP-RNA
recognition by human IFIT proteins. Nature 494(7435):60–64.
200. Katibah GE, Qin Y, Sidote DJ, Yao J, Lambowitz AM, Collins K (2014) Broad and
adaptable RNA structure recognition by the human interferon-induced tetratricopeptide repeat
protein IFIT5. Proceedings of the National Academy of Sciences 111(33):12025–12030.
201. Katibah GE et al. (2013) tRNA Binding, Structure, and Localization of the Human
Interferon-Induced Protein IFIT5. Molecular Cell 49(4):743–750.
202. Kelley LA, Mezulis S, Yates CM, Wass MN, Sternberg MJE (2015) The Phyre2 web portal
for protein modeling, prediction and analysis. Nature Protocols, Published online: 18 October
2007; | doi:101038/nprot2007380 10(6):845–858.
203. Jones DT (1999) Protein secondary structure prediction based on position-specific scoring
matrices. Journal of Molecular Biology 292(2):195–202.
204. Kornev A, Taylor S (2015) Dynamics-driven allostery in protein kinases. Trends in
biochemical sciences.
205. Lee KPK et al. (2008) Structure of the Dual Enzyme Ire1 Reveals the Basis for Catalysis
and Regulation in Nonconventional RNA Splicing. Cell 132(1):89–100.
206. Young TA, Delagoutte B, Endrizzi JA, Falick AM, Alber T (2003) Structure of
Mycobacterium tuberculosis PknB supports a universal activation mechanism for Ser/Thr
protein kinases. Nature Structural Biology 10(3):168–174.
207. Gay LM, Ng H-L, Alber T (2006) A Conserved Dimer and Global Conformational Changes
in the Structure of apo-PknE Ser/Thr Protein Kinase from Mycobacterium tuberculosis. Journal
of Molecular Biology 360(2):409–420.
208. Ortiz-Lombardia M, Pompeo F, Boitel B, Alzari PM (2003) Crystal Structure of the Catalytic
Domain of the PknB Serine/Threonine Kinase from Mycobacterium tuberculosis. Journal of
Biological Chemistry 278(15):13094–13100.
209. Greenstein AE, Echols N, Lombana TN, King DS, Alber T (2007) Allosteric Activation by
Dimerization of the PknD Receptor Ser/Thr Protein Kinase from Mycobacterium tuberculosis.
Journal of Biological Chemistry 282(15):11427–11435.
210. Korennykh AV et al. (2008) The unfolded protein response signals through high-order
assembly of Ire1. Nature 457(7230):687.

183

211. Ali MMU et al. (2011) Structure of the Ire1 autophosphorylation complex and implications
for the unfolded protein response. The EMBO journal 30(5):894–905.
212. Mieczkowski C, Iavarone AT, Alber T (2008) Auto-activation mechanism of the
Mycobacterium tuberculosis PknB receptor Ser/Thr kinase. The EMBO journal 27(23):3186–
3197.
213. Kontogiannis L, Johnson O (2011) iMOSFLM: a new graphical interface for diffractionimage processing withMOSFLM. Acta Crystallographica Section D Biological Crystallography
67(4):271–281.
214. Airlie M et al. (2007) Phaser crystallographic software. Journal of Applied Crystallography
40(4):658–674.
215. Emsley P et al. (2010) Features and development of Coot. Acta Crystallographica Section
D Biological Crystallography 66(4):486–501.
216. Krissinel E, Henrick K (2007) Inference of Macromolecular Assemblies from Crystalline
State. Journal of Molecular Biology 372(3):774–797.
217. Cui W, Li J, Ron D, Sha B (2011) The structure of the PERK kinase domain suggests the
mechanism for its activation. Acta Crystallographica Section D Biological Crystallography
67(5):423.
218. Padyana AK et al. (2005) Structural Basis for Autoinhibition and Mutational Activation of
Eukaryotic Initiation Factor 2 Protein Kinase GCN2. Journal of Biological Chemistry
280(32):29289–29299.
219. Akamine P, Madhusudan, Wu J, Xuong N-H, Taylor SS (2003) Dynamic Features of
cAMP-dependent Protein Kinase Revealed by Apoenzyme Crystal Structure. Journal of
Molecular Biology 327(1):159–171.
220. Chen P et al. (2000) Implications for Chk1 Regulation: The 1.7 Å Crystal Structure of
Human Cell Cycle Checkpoint Kinase Chk1. Cell 100(6):681–692.
221. McClendon CL, Kornev AP, Gilson MK, Taylor SS (2014) Dynamic architecture of a protein
kinase. Proceedings of the National Academy of Sciences 111(43):4623–4631.
222. Bao ZQ, Jacobsen DM, Young MA (2011) Briefly Bound to Activate: Transient Binding of a
Second Catalytic Magnesium Activates the Structure and Dynamics of CDK2 Kinase for
Catalysis. Structure 19(5):675–690.
223. Cook A et al. (2002) Structural Studies on Phospho-CDK2/Cyclin A Bound to Nitrate, a
Transition State Analogue: Implications for the Protein Kinase Mechanism. Biochemistry
41(23):7301.
224. Madhusudan, Akamine P, Xuong N-H, Taylor SS (2002) Crystal structure of a transition
state mimic of the catalytic subunit of cAMP-dependent protein kinase. Nature Structural Biology
9(4):273.
225. Lombana TN et al. (2010) Allosteric Activation Mechanism of the Mycobacterium
tuberculosis Receptor Ser/Thr Protein Kinase, PknB. Structure 18(12):1667.

184

226. Wang J, Wu J-W, Wang Z-X (2011) Structural Insights into the Autoactivation Mechanism
of p21-Activated Protein Kinase. Structure 19(12):1752.
227. Rousseau F, Itzhaki LS (2003) The Unfolding Story of Three-Dimensional Domain
Swapping. Structure 11(3):243–251.
228. Oliver AW et al. (2006) Trans-activation of the DNA-damage signalling protein kinase Chk2
by T-loop exchange. The EMBO journal 25(13):3179.
229. Ma X et al. (2012) Molecular basis of Tank-binding kinase 1 activation by
transautophosphorylation. Proceedings of the National Academy of Sciences 109(24):9378.
230. Pike ACW et al. (2008) Activation segment dimerization: a mechanism for kinase
autophosphorylation of non-consensus sites. The EMBO journal 27(4):704–714.
231. Lee SJ et al. (2009) Crystal structure of domain-swapped STE20 OSR1 kinase domain.
Protein Science 18(2):304.
232. Juang Y-C, Earnest S, Sengupta S (2015) Domain-Swapping Switch Point in Ste20 Protein
Kinase SPAK. Biochemistry 54(32):5063.
233. Oliver AW, Knapp S, Pearl LH (2007) Activation segment exchange: a common
mechanism of kinase autophosphorylation? Trends in biochemical sciences 32(8):351.
234. Xu Q et al. (2015) Identifying three-dimensional structures of autophosphorylation
complexes in crystals of protein kinases. Science Signaling 8(405):rs13.
235. Meyer AS et al. (2003) Closing the Folding Chamber of the Eukaryotic Chaperonin
Requires the Transition State of ATP Hydrolysis. Cell 113(3):369–381.
236. Kornev AP, Kornev AP (2011) Protein kinases: evolution of dynamic regulatory proteins.
Trends in biochemical sciences 36(2):65-77.
237. Yang J, Ten Eyck L, Xuong N-H, Taylor SS (2004) Crystal Structure of a cAMP-dependent
Protein Kinase Mutant at 1.26Å: New Insights into the Catalytic Mechanism. Journal of
Molecular Biology 336(2):473–487.
238. Patel O et al. (2016) Biochemical and Structural Insights into Doublecortin-like Kinase
Domain 1. Structure 24(9):1550–1561.
239. Christie M, Boland A, Huntzinger E, Weichenrieder O, Izaurralde E (2013) Structure of the
PAN3 Pseudokinase Reveals the Basis for Interactions with the PAN2 Deadenylase and the
GW182 Proteins. Molecular Cell 51(3):360–373.
240. Olesen C et al. (2007) The structural basis of calcium transport by the calcium pump.
Nature 450(7172):1036–1042.
241. Paliwal S, Gray K (2010) Structural basis of CX-4945 binding to human protein kinase
CK2. FEBS Letters 585(1):104–110.
242. Parthasarathy G, Zuck P (2015) Structure and Function of the Hypertension Variant A486V
of G Protein-coupled Receptor Kinase 4. Journal of Biological Chemistry 290(33):20360–20373.
243. Subramanian C, Yun M-K, Yao J, Sharma LK, Jackowski S (2016) Allosteric Regulation of
Mammalian Pantothenate Kinase. Journal of Biological Chemistry 291(42):22302–22314.
185

244. Yount RG, Babcock D, Ballantyne W, Ojala D (1971) Adenylyl imidiodiphosphate, an
adenosine triphosphate analog containing a PNP linkage. Biochemistry 10(13):2484-2489.
245. Heppel L, Harkness DR, Hilmoe RJ (1962) A Study of the Substrate Specificity and Other
Properties of the Alkaline Phosphatase of Escherichia coli. Journal of Biological Chemistry
237(3):841–846.
246. Tomaszek TA Jr, Schuster SM (1986) Hydrolysis of adenyl-5-yl imidodiphosphate by beef
heart mitochondrial ATPase. Journal of Biological Chemistry 261(5):2264–2269.
247. Taylor JS et al. (1981) Sarcoplasmic reticulum ATPase catalyzes hydrolysis of adenyl-5'-yl
imidodiphosphate. Journal of Biological Chemistry 256(19):9793–9795.
248. Suzuki Y, Shimizu T, Morii H, Tanokura M (1997) Hydrolysis of AMPPNP by the motor
domain of ncd, a kinesin-related protein. FEBS Letters 409(1):29–32.
249. Guo Y, Wu J, Taylor SS (2013) Phosphoryl Transfer by Protein Kinase A Is Captured in a
Crystal Lattice. Journal of the American Chemical Society 135(12):4788–4798.
250. Adams JA (2001) Kinetic and Catalytic Mechanisms of Protein Kinases. Chemical Reviews
101(8):2271–2290.
251. O’Brien P et al. (2012) Price To Be Paid for Two-Metal Catalysis: Magnesium Ions That
Accelerate Chemistry Unavoidably Limit Product Release from a Protein Kinase. Journal of the
American Chemical Society 134(37):15357–15370.
252. Taylor DR et al. (2001) Hepatitis C Virus Envelope Protein E2 Does Not Inhibit PKR by
Simple Competition with Autophosphorylation Sites in the RNA-Binding Domain. Journal of
Virology 75(3):1265–1273.
253. Young TS, Ahmad I, Yin JA, Schultz PG (2010) An Enhanced System for Unnatural Amino
Acid Mutagenesis in E. coli. Journal of Molecular Biology 395(2):361–374.
254. Chin JW, Martin AB, King DS, Wang L, Schultz PG (2002) Addition of a photocrosslinking
amino acid to the genetic code of Escherichia coli. Proceedings of the National Academy of
Sciences 99(17):11020–11024.
255. Zhang F et al. (2001) Binding of Double-stranded RNA to Protein Kinase PKR Is Required
for Dimerization and Promotes Critical Autophosphorylation Events in the Activation Loop.
Journal of Biological Chemistry 276(27):24946–24958.
256. Taylor SS, Haste NM, Ghosh G (2005) PKR and eIF2α: Integration of Kinase Dimerization,
Activation, and Substrate Docking. 122(6):823–825.
257. Tan R, Frankel AD (1995) Structural variety of arginine-rich RNA-binding peptides.
Proceedings of the National Academy of Sciences 92(12):5282–5286.
258. Casu F, Duggan BM, Hennig M (2013) The Arginine-Rich RNA-Binding Motif of HIV-1 Rev
Is Intrinsically Disordered and Folds upon RRE Binding. Biophysical Journal 105(4):1004–1017.
259. Tan R, Frankel AD (1994) Costabilization of peptide and RNA structure in an HIV Rev
peptide-RRE complex. Biochemistry 33(48):14579–14585.
260. Madhusudan et al. (2008) cAMP-dependent protein kinase: Crystallographic insights into
substrate recognition and phosphotransfer. Protein Science 3(2):176–187.
186

261. Alber T (2009) Signaling mechanisms of the Mycobacterium tuberculosis receptor Ser/Thr
protein kinases. Current Opinion in Structural Biology 19(6):650–657.
262. Ito T et al. (1999) RAX, a Cellular Activator for Double-stranded RNA-dependent Protein
Kinase during Stress Signaling. Journal of Biological Chemistry 274(22):15427–15432.
263. Dickerman B, Sen GC (2009) Biochemical analysis of PKR activation by PACT.
Biochemistry 48(31):7441–7447.
264. Gleghorn ML, Gong C, Kielkopf CL, Maquat LE (2013) Staufen1 dimerizes through a
conserved motif and a degenerate dsRNA-binding domain to promote mRNA decay. Nature
Structural & Molecular Biology 20(4):515–524.
265. Daniels SM, Gatignol A (2012) The Multiple Functions of TRBP, at the Hub of Cell
Responses to Viruses, Stress, and Cancer. Microbiology and Molecular Biology Reviews
76(3):652–666.
266. Buckler-White A et al. (1991) Characterization of a human TAR RNA-binding protein that
activates the HIV-1 LTR. Science 251(5001):1597–1600.
267. Park H et al. (1994) TAR RNA-binding protein is an inhibitor of the interferon-induced
protein kinase PKR. Proceedings of the National Academy of Sciences 91(11):4713–4717.
268. Daher A, Meurs EF, Gatignol A (2001) Two Dimerization Domains in the Trans-activation
Response RNA-binding Protein (TRBP) Individually Reverse the Protein Kinase R Inhibition of
HIV-1 Long Terminal Repeat Expression. Journal of Biological Chemistry 276(36):33899–
33905.
269. Gupta V, Huang X, Patel RC (2003) The carboxy-terminal, M3 motifs of PACT and TRBP
have opposite effects on PKR activity. Virology 315(2):283–291.
270. Laraki G et al. (2008) Interactions between the double-stranded RNA-binding proteins
TRBP and PACT define the Medipal domain that mediates protein-protein interactions. RNA
Biology 5(2):92–103.
271. Daher A, Meurs EF, Patel RC, Gatignol A (2009) TRBP Control of PACT-Induced
Phosphorylation of Protein Kinase R Is Reversed by Stress. Molecular and Cellular Biology
29(1):254–265.
272. Singh M, Castillo D (2011) Stress-Induced Phosphorylation of PACT Reduces Its
Interaction with TRBP and Leads to PKR Activation. Biochemistry 50(21):4550–4560.
273. Chen Z, Krug RM (2000) Selective nuclear export of viral mRNAs in influenza-virusinfected cells. Trends in Microbiology 8(8):376–383.
274. Bergmann M et al. (2000) Influenza Virus NS1 Protein Counteracts PKR-Mediated
Inhibition of Replication. Journal of Virology 74(13):6203–6206.
275. Lu Y, Wambach M, Katze MG, Krug RM (1995) Binding of the Influenza Virus NS1 Protein
to Double-Stranded RNA Inhibits the Activation of the Protein Kinase That Phosphorylates the
eIF-2 Translation Initiation Factor. Virology 214(1):222–228.
276. Hatada E, Saito S, Fukuda R (1999) Mutant Influenza Viruses with a Defective NS1 Protein
Cannot Block the Activation of PKR in Infected Cells. Journal of Virology 73(3):2425–2433.
187

277. Lin D, Lan J, Zhang Z (2007) Structure and function of the NS1 protein of influenza A virus.
Acta biochimica et biophysica Sin 39(3):155–162.
278. Hale BG (2014) Conformational plasticity of the influenza A virus NS1 protein. Journal of
General Virology 95(10):2099–2105.
279. Liu J, Lynch PA, Chien CY, Montelione GT (1997) Crystal structure of the unique RNAbinding domain of the influenza virus NS1 protein. Nature structural biology 4(11):896–899.
280. Chien CY et al. (2004) Biophysical Characterization of the Complex between DoubleStranded RNA and the N-Terminal Domain of the NS1 Protein from Influenza A Virus: Evidence
for a Novel RNA-Binding Mode. Biochemistry 43(7):1950–1962.
281. Cheng A, Wong SM, Yuan YA (2009) Structural basis for dsRNA recognition by NS1
protein of influenza A virus. Cell Research 19(2):187.
282. Xia S, Monzingo AF, Robertus JD (2009) Structure of NS1A effector domain from the
influenza A/Udorn/72 virus. Acta Crystallographica Section D Biological Crystallography
65(1):11–17.
283. Hale BG, Barclay WS, Randall RE, Russell RJ (2008) Structure of an avian influenza A
virus NS1 protein effector domain. Virology 378(1):1–5.
284. Bornholdt ZA, Prasad BVV (2006) X-ray structure of influenza virus NS1 effector domain.
Nature Structural & Molecular Biology 13(6):559–560.
285. Ayllon J, Hass C, Lewis A, García-Sastre A (2011) A Transient Homotypic Interaction
Model for the Influenza A Virus NS1 Protein Effector Domain. PloS one 6(3):e17946.
286. Aramini et al. (2011) Dimer Interface of the Effector Domain of Non-structural Protein 1
from Influenza A Virus: AN INTERFACE WITH MULTIPLE FUNCTIONS. Journal of Biological
Chemistry 286(29):26050–26060.
287. Bornholdt Z, Prasad BV (2008) X-ray structure of NS1 from a highly pathogenic H5N1
influenza virus. Nature 456(7224):985–988.
288. Wang X et al. (2002) Functional replacement of the carboxy-terminal two-thirds of the
influenza A virus NS1 protein with short heterologous dimerization domains. Journal of Virology
76(24):12951–12962.
289. Carillo B et al. (2014) The Influenza A Virus Protein NS1 Displays Structural
Polymorphism. Journal of Virology 88(8):4113–4122.
290. Greenfield NJ (2006) Using circular dichroism spectra to estimate protein secondary
structure. Nature Protocols 1(6):2876–2890.
291. Marenchino M, Armbruster DW, Hennig M (2009) Rapid and efficient purification of RNAbinding proteins: Application to HIV-1 Rev. Protein Expression and Purification 63(2):112–119.
292. Hitti EG, Sallacz NB, Schoft VK, Jantsch MF (2004) Oligomerization activity of a doublestranded RNA-binding domain. FEBS Letters 574(1-3):25–30.
293. Clerzius G, Daher A, Bonnet M, Meurs EF, Gatignol A (2009) ADAR1 Interacts with PKR
during Human Immunodeficiency Virus Infection of Lymphocytes and Contributes to Viral
Replication. Journal of Virology 83(19):10119–10128.
188

294. Wen X et al. (2014) NF90 Exerts Antiviral Activity through Regulation of PKR
Phosphorylation and Stress Granules in Infected Cells. The Journal of Immunology
192(8):3753–3764.
295. Mittelstadt M et al. (2007) Interaction of human tRNA-dihydrouridine synthase-2 with
interferon-induced protein kinase PKR. Nucleic Acids Research 36(3):998–1008.
296. Peters GA et al. (2002) Inhibition of PACT-Mediated Activation of PKR by the Herpes
Simplex Virus Type 1 Us11 Protein. Journal of Virology 76(21):11054–11064.
297. Ayllon J et al. (2012) Contribution of NS1 Effector Domain Dimerization to Influenza A
Virus Replication and Virulence. Journal of Virology 86(23):13095–13098.
298. Min JY, Krug RM (2006) The primary function of RNA binding by the influenza A virus NS1
protein in infected cells: Inhibiting the 2'-5' oligo (A) synthetase/RNase L pathway. Proceedings
of the National Academy of Sciences 103(18):7100–7105.
299. Leung DW, Basler CF, Amarasinghe GK (2012) Molecular mechanisms of viral inhibitors of
RIG-I-like receptors. Trends in Microbiology 20(3):139–146.
300. Marques JT, White CL, Peters GA, Williams BRG, Sen GC (2008) The Role of PACT in
Mediating Gene Induction, PKR Activation, and Apoptosis in Response to Diverse Stimuli.
Journal of Interferon & Cytokine Research 28(8):469–476.

189

